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Abstract
Hospital administrators were interviewed to explore their perceptions of the strategic alignment
of PaLM value-based activities (VBAs). Hospital based PaLM leaders were interviewed to
explore their communication of the VBAs. This study identified a misalignment between the
assessments utilized by healthcare administrators for PaLM services and the value contributions
of laboratorians. PaLM leaders offered insight into the laboratory’s value chain. Three themes
emerged from the data: PaLM VBAs, PaLM communication efforts, and PaLM VBA strategic
alignment. Together these findings suggest that hospital laboratorians offer untapped value in
healthcare, and hospital administrators failing to recognize this value miss opportunities to
improve value and capture cost savings. Suggestions to improve the communication of PaLM
VBAs and the perceptions of hospital administrators are made.
Keywords: pathology, hospital laboratory, healthcare administrators, VBHC, value-based
healthcare, value chain, laboratory science, laboratory medicine
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Section 1: Foundation of the Study
According to the Centers for Medicare and Medicaid Services (CMS) (2019a), healthcare
expenditures in the United States topped $3.6 trillion in 2018 with the costs of care reaching
17.7% of gross domestic product. CMS adds that expenditures under the existing healthcare law
will nearly double to $6.0 trillion by 2027. This escalating cost of healthcare is unsustainable
and inefficient according to the Institute of Medicine (2013). To curb healthcare’s cost growth,
government payers modified reimbursement structures from volume-based to value-based
purchasing (VBP), offering financial incentives based on quality and performance improvements
(Centers, 2017; Centers, 2016b; Porter & Lee, 2016). Yet according to the Institute for
Healthcare Improvement (IHI) (2019), efforts to improve the per capita costs of care must not be
pursued at the expense of patient satisfaction, quality of care, or population health. Thus, with a
simultaneous pursuit of the patient experience, population health, and cost reductions, the Center
for Medicare and Medicaid Services (CMS) began penalizing and rewarding hospitals, based on
outcome measures and patient satisfaction scores (Austin, Bentkover, & Chait, 2016; Berwick et
al., 2008; Centers, 2019b).
According to the American College of Healthcare Executives (ACHE) (2019), healthcare
administrators confronted with balancing competing priorities, list top strategic concerns as the
financial challenges of lower reimbursements with rising costs, government mandates, safety and
quality, and personnel shortages. The pursuit of a value-based healthcare (VBHC) strategy
requires an open-ended commitment to perpetual change, the adoption of value-based goals and
cultural development, and a focus on keeping the patient first (Kash, Spaulding, Johnson, &
Gamm, 2014; Porter & Lee, 2013). Emerging VBHC strategies are examples of management
innovation, particularly complex to implement and holding a variety of different meanings to
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different people (Colldén & Hellström, 2018). VBHC strategies require an increase in value to
lower the overall cost of care (Kaplan et al., 2014). Value increases with lower costs, improved
quality and services, and enhanced capabilities (Gambel et al., 2019). The current climate in
healthcare requires a justification of activities and expenditures from every sector through
demonstrations of value to the patient and the health system (Nadder et al., 2018).
Costs associated with the clinical laboratory account for only 4% of healthcare
expenditures, yet drive downstream medical decisions of hospital admissions, length of stay,
subsequent testing, and therapeutics (Hallworth et al., 2015; Lewandrowski, Baron, & Dighe,
2017; Warren, 2017). According to Center for Disease Control’s Division of Laboratory Systems
(CDC DLS, 2018), medical laboratories perform 14 billion high-quality and essential tests
annually with an estimated 53% of testing performed in hospital-based laboratories (Weinert et
al., 2015). Hospital executives seek value from laboratory services in the interactions with the
rest of the health system (Schmidt et al., 2016). Certain laboratory activities demonstrate value
by directly improving costs (Halstead et al., 2018; Price et al., 2016) while other laboratory
activities improve efficiency and/or quality (Kaushik et al., 2018; Schmidt & Ashwood, 2015).
Background of the Problem
The focus of this applied business study is on the communication of Pathology and
Laboratory Medicine’s (PaLM) value-based activities (VBAs) to hospital administrators
implementing VBHC strategies. PaLM’s value contributions involve more than patient testing,
although many of these activities remain poorly understood, ill defined, unrecognized, and
unincentivized under existing funding models (Anonychuk et al., 2012; Price et al., 2016; St.
John et al., 2015). Many PaLM VBAs target process improvements, efficiency, quality of care,
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and cost reductions (Protzman, Kerpchar, & Mayzell, 2015; Schmidt & Ashwood, 2015; Van
Cott, 2014; White et al., 2015;).
Implementation of a successful strategy requires linking internal business unit activities
to organizational objectives (Gambel et al., 2019). Hospitals that align best practices with
strategy, improve effectiveness and competitive advantage (Srivastava & Sushil, 2017).
However, hospital administrators implementing the rich objectives of value-based strategies are
unaware of PaLM’s roles and scope of activities (Branda et al., 2014) and tend to overlook the
laboratory (Downs & McMinn, 2017; Shrinkman, 2016). Hospital administrators need awareness
and inclusion of the laboratory for optimal success (Misialek, 2014).
Problem Statement
The general problem is the failure of laboratory leadership to communicate PaLM VBAs
to healthcare administrators, resulting in lost opportunities to demonstrate cost savings. Gross et
al. (2019) discussed the need for value-defending conversations to healthcare executives from
laboratory leadership, championing the laboratory as core asset of the health system, offering
“high value to vast array of enterprise strategies” (p. 616). Dixon (2019) noted that laboratory
leadership has failed to connect critical activities to the strategic imperatives of the broader
organization. Laboratorians report increased pressures to articulate value as reimbursement
policies shift from volume to value (Epner, 2017). While laboratory directors and pathologists
see the value of their services, hospital administrators remain unconvinced (Small, 2016), and
ineffective at explaining their full range of clinical and management activities (Burns, 2018).
Laboratory cost savings may occur as cost effectiveness, cost containment, or operational
efficiencies (COLA, 2015). Schmidt and Ashwood (2015) noted that certain laboratory activities
provide cost improvements. Halstead et al. (2018) and Price et al. (2016) discussed laboratory
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cost savings activities as a value demonstration. Schmidt and Ashwood (2015) noted that
laboratory utilization activities improve direct costs and downstream costs. Addressing test result
comments reduces costs (Schmidt et al., 2016). Laboratorians demonstrate cost reduction by
providing guided expertise for new technologies (Price et al., 2016) and consultative services
(Davis et al., 2018; Thakkar et al., 2015). Laboratory activities associated with sourcing (Weinert
et al., 2015), benchmarking (Kadauke, 2017), and data analytics (Gross et al., 2019; Xu, Higgins,
& Cembrowski, 2015) demonstrate significant cost savings. Systems-based laboratory
interventions produce sustained cost savings (Sadowski et al., 2017). The specific problem is that
laboratory leadership in acute care hospitals fail to communicate VBAs to healthcare
administrators in Texas, resulting in lost opportunities to demonstrate cost savings.
Purpose Statement
The purpose of this qualitative case study is to add to the body of knowledge by
exploring laboratory leadership’s communication of VBAs to hospital administrators. This
problem was explored through interviews with acute care hospital administrators and laboratory
leaders to discover if and how value-based initiatives are communicated. Laboratory leaders may
use this information to improve communication strategies for value-based initiatives.
Communicating value effectively requires research and a well thought plan (Raman, 2014). A
concerted effort by laboratory leadership is required to keep senior management informed of
recent developments and accomplishments (Kridelbaugh, 2018), and to align initiatives with
organizational objectives and strategy (Karuppan et al., 2016; Passiment & Linscott, 2014).
Hospital administrators can use this information to gain further insight into the value
contributions of PaLM services and ensure implementation of cost savings measures. VBHC
strategies necessitate the identification of improvement opportunities (IOM, 2013).
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Implementation success requires a clear communication plan and an alignment of leadership (Fry
& Baum, 2016). Successful strategies link internal business unit activities with broader
organizational objectives (Bryson, 2018; Gambel et al., 2019). Optimal success requires an
alignment at all levels of the organization for better understanding, acceptance, and support of
the value proposition (Austin et al., 2016).
Value must increase for the overall cost of care to decrease (Kaplan et al., 2014). VBHC
delivery requires reducing costs and improving processes without sacrificing outcomes (Porter,
Kaplan, & Frigo, 2017). Value increases with lower costs, as well as improved quality and
services, and enhanced capabilities (Gambel et al., 2019). Certain PaLM activities demonstrate
value by directly improving costs (Halstead et al., 2018; Price et al., 2016), while others improve
efficiency, quality, and skills (Kushik et al., 2018; Lewandrowski et al., 2018; Schmidt &
Ashwood, 2015). The literature remains sparse regarding the value contributions of laboratories,
which are under recognized as an essential care component (Davis et al., 2018), and requires a
broader perspective assessment (Anonychuk et al., 2012).
Research Questions
RQ1. What value-based cost savings opportunities has the laboratory leadership
presented to hospital administrators?
RQ2. What value-based opportunities are perceived as effectively communicated by
laboratory leaders to hospital administrators?
RQ3. How do hospital-based laboratory leaders communicate Palm VBAs to hospital
administrators?
RQ4. What PaLM VBAs do administrators perceive as aligning with value-based
objectives?
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Nature of the Study
A carefully chosen research design forms the framework for the data collection and
research questions, and the scientific structure to analyze and validate the data. The method for
this research is the qualitative case study which requires gathering data and exploring situations
to gain better understanding (Leedy & Ormrod, 2015). Yin (2018) warns that the qualitative case
study’s demands on the researcher’s “intellect, ego, and emotions are far greater than those of
any other research method” (p. 119), due to lack of routinization of the data collection. The case
study provides an opportunity to gain insight into each case by gathering interview data from a
variety of sources (Baxter & Jack, 2008). The collective nature of the multi-case study allows for
analysis of individual cases, as well as a cross-case analysis (Stake, 2006).
Discussion of Research Paradigms
Qualitative inquiry research designs other than the case study include narrative,
phenomenology, ethnography, and grounded theory. The narrative design distinguishes themes
from interviews but is more appropriate for capturing the rich details of stories or describing the
essence of an experience (Creswell & Poth, 2018). The phenomenology design seeks
understanding of the essence of the phenomenon by exploring lived experiences (Creswell &
Poth, 2018). Phenomenology was not appropriate for this inquiry, as the purpose of this study
was to identify the communication of common VBAs among multiple sites, not to seek an
understanding of lived experiences. The ethnography design was also not appropriate for this
study, as it focuses on a chosen culture for understanding how a group works, exploring beliefs,
behaviors, or issues (Creswell & Poth, 2018).
Two qualitative designs offer applicability for VBHC research - grounded theory
(Hysong, Teal, Khan, & Haidet, 2012) and the case study (Kirkpatrick et al., 2015). Grounded
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theory research is applicable for this study as the literature does not yet offer an explanation or
an understanding regarding the communication of PaLM VBAs, other than analytical testing and
performance. The grounded theory design allows new theories to emerge from data collections
(Astalin, 2013). Grounded theory has been applied in health sciences to improve professional
practices and to provide a conceptual tool to guide a future work (Butina, Campbell, & Miller,
2015). However, Creswell and Poth (2018) recommend that grounded theory studies have 20 to
60 individual interviews with clarifying re-interviews, which are not feasible due to the time
constraints.
Quantitative studies include descriptive (nonexperimental), correlational (experimental),
and casual comparative (quasi experimental) designs (Drummond & Murphy-Reyes, 2018).
Quantitative designs permit an accurate assessment of cause-and-effect relationships between
variables, seeking an explanation from causal relationships or variable correlations for a
prediction, generalization, or explanation (Creswell, 2013). A quantitative design was not
applicable since cause-and-effect was not the intent of this study.
Mixed-method inquiry expands and strengthens research conclusions using quantitative
and qualitative research methods within a single study (Tashakkori & Creswell, 2007). Mixmethod is the most comprehensive flexible design. However, as a novice researcher the
management of dual methods was too difficult for this research (Creswell, 2013).
Discussion of Design
Case study permits an exploration of programs, events, processes, or activities (Creswell,
2013). Multi-case case studies address the how and why of a phenomenon, as explanatory in
nature (Yin, 2014). Creswell and Poth (2018) noted that why questions suggest a cause-andeffect as directional language and recommend the use of what and how questions instead. Yin
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(2014) described a collective-case design similar to the multiple-case design described by Stake
(2006). The collective case study is appropriate for contemporary issues to study programs at
multiple sites (Creswell & Poth, 2018), and when the subject of inquiry has indefinable cases
within boundaries (Creswell, 2007: Yin, 2014). The qualitative case study is the design of choice
when the problem is not understood and needs inductive research.
Discussion of Method
The employed qualitative multi-case study design was conducive to explore the
phenomenon of communication between hospital laboratory leaders and hospital administrators
concerning PaLM VBAs, allowing for a descriptive account from multiple cases with
generalizable results (Creswell & Poth, 2018; Stake, 2006). The case study design provided an
in-depth analysis of the multiple cases, using logic of replication in inquiry procedures for each
case, within the well-defined boundaries of the multiple participant cases (Yin, 2014). This study
did not exceed nine interviews from purposely selected cases to achieve the objective (Creswell
& Poth, 2018).
Discussion of Reliability, Validity, and Triangulation
LeCompte and Goetz (1982) noted that if quantitative research had a scientific process
for reliability and validity, then qualitative research requires parallel internal and external
validation processes. Lincoln and Guba (1985) refined qualitative research concepts for
credibility, transferability, dependability, and confirmability. Reliability in a thematic analysis
involves the reproducibility of the study, ensuring a minimization of error and bias, so that
another researcher repeating the same study could reach the same conclusions (Yin, 2018).
Reliability in the case study design involves the protocol and the database (Yin, 2018), bringing
credibility to the research with confidence in the data and the findings (Burns & Groves, 2007).
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Credibility enhances with prolonged involvement, triangulation, and peer examination of the
data (Baxter & Jack, 2008). The analysis of the data requires enough detail to enable the reader
to determine the credibility of the methods and the interpretations (Nowell et al., 2017).
Reliability.
Reliability occurs within the interview protocols, participation packet, and approval of
the human relations review board (Creswell & Poth, 2018). Reliability occurred by documenting
and following the same protocol for each case and by using the same interview scripts with openended questions to ensure credibility and trustworthiness of the data (Castillo-Montoya, 2016;
Stake, 2006; Yin, 2018). Case protocols included a pre-interview analysis of publicly reported
value-based measures and site variability factors (Yin, 2018). Reliability of the interview data
was enhanced with quality audio recording, same day transcription (Creswell & Poth, 2018), and
use of NVivo to calculate encoding (Silverman, 2017).
Validity.
Validation is essential for the inquiry to be of value to other researchers (Creswell &
Poth, 2018). The qualitative case study provided a framework for data collection and using a
scientific structure for the analysis and validation of the findings (Creswell & Poth, 2018).
Validity reduces the likelihood of misinterpretation (Stake, 2006). Strategies of validation
attempted to assess the accuracy of the study’s findings with several steps (Creswell, 2016). The
researcher’s philosophical orientation influences the chosen validation strategy (Creswell, 2016).
The validation strategy encompassing the reader’s lens utilizes rich data and thick
descriptions (Creswell & Poth, 2018) allowing the reader to make inference regarding the
finding’s transferability (Lincoln & Guba, 1985; Merriam & Tisdell, 2015). Validation from the
reader’s lens occurred with peer debriefing and allowing others to ask questions about the
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methods, meanings, and interpretations (Creswell & Poth, 2018). The participant lens validation
occurred by permitting participants to review his or her own interview transcript and to offer
clarifying statements (Creswell & Poth, 2018). My post-positivist philosophical orientation
influenced my chosen validation strategy (Creswell, 2016) of triangulation connecting the
findings to corroborating evidence (Creswell & Poth, 2018; Yin, 2014).
A thick description from the researcher validates the information enabling the reader to
transfer findings to other situations (Stake, 2010) as with the use of action verbs and quotes
(Creswell & Poth, 2018). Grady (1998) purports that data saturation occurs at the point in which
the interviewer begins to hear the same comments again and again. Hennink et al. (2017) pointed
out that code saturation occurs at the point in which no additional codes are identifiable in the
data set and the codebook begins to stabilize, which typically occurs with nine interviews, as
opposed to meaning saturation requiring 16-24 interviews for an understanding of issues. This
study utilized nine interviews to achieve data saturation with rich details from multiple
perspectives. Yin (2014) points out that even within a small number of cases the concept of data
saturation can be achieved.
Triangulation.
The literature was used in tandem with the newly acquired data, a process called
triangulation through the researcher’s lens (Creswell & Poth, 2018). Triangulation uses multiple
sources, including the literature to develop a comprehensive understanding (Carter et al., 2014).
Corroborating evidence for this study derived from different sources including multiple
interviews within each case, evaluation of data across multiple cases, and correlation of findings
with the literature (Creswell & Poth, 2018). Controversial and important findings required more
than a single source as supportive evidence to ensure that meaning was not overlooked (Stake,
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2006). Denzin (1989) suggested that triangulation requires two or more perspectives for
correlation. Triangulation from a variety of sources promoted the credibility or trueness of the
findings (Baxter & Jack, 2008). Triangulated evidence is credible and substantiated. Although
Stake (2010) warns that a qualitative researcher may realize through the triangulation process
that situations are more complex than initially thought and data disagreements require scrutiny.
Summary of the Nature of the Study.
PaLM practitioners live in a quantitative scientific world, performing experiments, data
collections, and test validations (Butina et al., 2015). Laboratory practitioners understand the
need to define the intended use of a test, examine possible sources of error from sample
variation, and follow appropriate testing procedures (Jennings et al., 2009). Qualitative research
methods, however, remain largely unknown in the medical laboratory profession (Butina et al.,
2015). Reliability occurred in this study by repeating the same procedures for each case, utilizing
quality audio recordings, interview protocols, and NVivo to calculate encoding. Multiple data
sources enhanced the credibility of the findings. Trustworthiness was improved with the openendedness of the interview questions and participants’ review of transcripts for clarifications.
Validation in medical laboratories involve determining if a test is ready to be
implemented into clinical practice by identifying and quantifying potential sources of variation
and analyzing the closeness of agreement between a discovered value and an accepted as
conventionally true value, or the reference value (Jennings et al., 2009). Similarly, validation in
qualitative studies involves analyzing data for similarities and differences across cases and
examining findings close in agreement with evidence from peer data. Creswell (2016) and
Creswell and Poth (2018) recommend choosing at least two comfortable validation strategies
considering the perspective of the researcher, the participant, and the reader. I utilized
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triangulation to substantiate the evidence (Stake, 2010) and rich contextual data from
purposively selected cases with a minimum of nine interviews to reach code saturation (Hennink
et al., 2017).
Conceptual Framework for Communication and VBAs
“Effective communication is a prerequisite for attaining organizational goals, although it
remains a significant problem” (Gardner & Winder, 1998, p. 202). The communication model by
Robbins et al. (1994), shown in figure 1, provides a simplistic framework for message transfer
and aids in identifying the barriers and facilitators in communication efforts (Gardner & Winder,
1998). For this study, the sender of the VBA message was the laboratory leader(s)
knowledgeable of value-based cost savings opportunities, and the receiver was the hospital
administrator making strategic decisions.
Figure 1.
Communication Model

(Robbins et al., 1994), modified.
Another conceptual framework used for this study combined the concepts from Porter’s
value chain model (VCM) (Porter, 1985) with a contemporary healthcare activities framework
developed for the Agency for Healthcare Research and Quality (Carman et al., 2014). This
modified VCM (mVCM) was useful for analysis of laboratory activities within the value-chain
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(see Figure 2) by outlining the basic activities that contribute value on two tracks - service
delivery and support activities (Swayne, Duncan, & Ginter, 2006). The mVCM framework offers
a “strategic thinking map for evaluating the strengths and weakness of the organization”
(Swayne et al., 2006, p. 334). The service delivery track defines the activities within service
points, i.e., the pre-service, the point-of-service, and the post-service, while the support activities
track defines the value enhancement activities that support organizational culture, structure, and
strategic resources (Burns et al., 2001; Porter, 1985; Swayne et al., 2006). The components
defined in the VCM framework are the essential elements that create value (Swayne et al., 2006).
The mVCM combines the concepts of the Value-Chain Model by Porter (1985), and the
healthcare concepts discussed by Swayne et al., (2006).
Figure 2.
mVCM Conceptual Framework for Discovery of VBAs

(Carman et al., 2014; Porter, 1985; Swayne et al., 2006).
The Laboratory Medicine Best Practices Phase 3 report indicates that value analytic
frameworks be used outside of laboratory medicine to increase the likelihood “that evidence of
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effectiveness from these other domains will be regarded as relevant to laboratory medicine
practices” (Snyder et al., 2010, p. ix). Application of the mVCM framework aided the
identification of value-adding support activities that improve efficiency and effectiveness,
satisfaction, quality, safety, cost, as well as skills development and technological advancement
(Swayne et al., 2006). Tierney (2017) discusses a similar value realization framework for
quantifying the value associated with strategic outcomes.
Definition of Terms
1. Analytical testing – Analysis of human blood, body fluids, tissues, and other substances
(Bureau, 2019; Centers, 2019c).
2. Analytical performance – The quality factors associated with the product of laboratory
testing, the test result, within the total testing phases and the extra-analytical testing
phases (Plebani & EFLM, 2017).
3. Laboratory director - A generic term referring to a medical physician or PhD director
authorized by federal regulations to exercise independent medical judgment in diagnosis
and treatment decisions relative to laboratory tests; or an administrative director,
authorized to exercise independent technical judgment as a designee relative to policies,
procedures, protocols, quality assurance, and other activities (College, 2018a, 2018b).
4. Pathology and Laboratory Medicine (PaLM) – The medical science disciplines that
permeate all other branches of medicine with a focus on patient testing and effectiveness
occurring in and beyond the boundaries of the laboratory (Ashwood, 2015; Davis et al.,
2018; Schmidt &). This study makes no distinction between pathology and clinical
laboratory disciplines, as pressures to produce and demonstrate value affect both
(Schmidt et al., 2016). This study makes no distinction between the subspecialties of the
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PaLM workforce, which according to the American Society for Clinical Laboratory
Science (ASCLS) (2018) is made up of pathologists in clinical and anatomic disciplines,
pathology assistants, cytologists and histologists, doctorate clinical laboratory scientists
(DCLS), medical laboratory scientists (MLS), medical laboratory technicians (MLT),
laboratory assistants, and phlebotomists. According to Wolcott et al. (2008) each has a
vital role in the delivery of quality healthcare, managing and applying evidence-based
testing that supports patient care and protects the public’s health. A high functioning
laboratory requires a complex mixture of skill sets to function seamlessly as a team
(Kroft, 2018).
5. Value-based activities (VBAs) – Activities that improve value, identifiable within the
value-chain (see Figure 2). VBAs encompass a variety of concepts, tools, and models
generally referred to as improvement approaches (Colldén et al., 2017). VBAs add value
by transforming patient care, materials, information, decisions, or risks. Other types of
activities are enabling which are necessary to complete a care cycle process, or nonvalueadding which unnecessarily consume resources (Tierney, 2017). VBAs result in
improvements in quality, the patient experience, or costs (Øvretveit, 2009). Kirkpatrick et
al. (2015) used VBA to describe value-based analysis, a management strategy to
determine the change in value, measured in the cost reductions and quality
improvements, occurring when a best practice replaces a usual practice.
6. Value-based strategy – A strategy that lowers costs, improves quality or the provision of
service excellence, or surpasses rival capabilities (Gambel et al., 2019). The delivery of a
VBHC strategy requires improving processes and reducing costs without sacrificing
outcomes (Porter et al., 2017). At the time of this study some hospitals were beginning to
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establish value management offices; however, most still “cannot articulate or demonstrate
value” (Tierney, 2017, p.22).
Assumptions, Limitations, Delimitations
Assumptions are somewhat out of the researcher’s control, yet without them, the study
becomes irrelevant (Simon, 2011). The assumptions of interest include only those that affect the
quality of the structure, within the reasoning of conclusions or in an argument where ambiguity
exists (Brown & Keeley, 2007). The assumptions of this study include those relative to the
chosen method, the data collection, and the analysis. Limitations expose a potential weakness
and delimitations define the boundaries and scope of the study (Simon, 2011).
Assumptions
It was assumed that hospital site administrators would grant access for this study, and that
laboratory leaders and administrators would participate by answering interview questions
truthfully. Assumptions also included that hospital-based laboratory leaders were aware of and
contributed to value-based initiatives and had knowledge of PaLM VBAs within their
organization. It was assumed that a cross-case analysis of an adequate sample size would detect
communication themes of PaLM VBAs (Yin, 2014). A key assumption was that the chosen
hospital cases in this multi-case study were representative of the larger population of acute care
hospitals. I also held the assumption that the findings would benefit the industry and contribute
to the broader body of knowledge. Further assumptions were that PaLM VBAs contribute value
in healthcare in accordance with the literature, at least in part by improving satisfaction,
effectiveness, efficiency, and/or costs reduction.
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Limitations
Limitations beyond the researcher’s control need to be revealed to the readers and
participants of the case study (Brutus, Aguinis, & Wassmer, 2013; Simon, 2011). The research
questions limit the findings of a case study (Creswell & Poth, 2018). A potential for error was
thought to exist the inability of participant(s) to describe VBAs based on the interview questions.
Interpretations may be limiting as findings depend “on the experience of the researcher, the
experience of those being studied, and the experience of those to whom information will need to
be conveyed” (Stake, 2010, p. 199). Additionally, interviewees were not equally communicative
or responsive in depth to the interview questions (Creswell, 2007). While I had knowledge of
most PaLM workflows and VBAs, I was limited in experience on the communication of value or
the perceptions of hospital administrators.
Delimitations
The cases chosen for this study were bound by acute care-type hospitals. The purposively
selected hospital cases were bound by provision of acute care with on-site emergency and
laboratory services, and online access to PaLM results. Case bindings ensured that participant
hospitals were similar, improving the generalizability of the findings. Any transferability of the
findings to other hospital types depends on the prudent judgment of the reader.
Significance of the Study
Implementation of a successful VBHC strategy requires effectively communicating the
plan at all levels of the organization, and leaders that model “how to act in line with the plan” (Fry
& Baum, 2016, p.148). This study adds to the body of knowledge by expanding the understanding
of the communication of PaLM VBAs to hospital administrators, furthering an appreciation of the
laboratory’s vital role and recognition of this important work (Adeli, 2017). Understanding

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

18

PaLM’s value contributions is vital for ensuring the provision of services, optimal use of testing,
and minimization of resources and financial waste (Hallworth et al., 2015). Reengineering of
clinical and administrative processes is the best opportunity for lowering healthcare costs without
sacrificing quality, safety, or outcomes (Kaplan et al., 2014).
Laboratory leaders need to be more knowledgeable of the programs designed to increase
value and reduce waste and need more proactive communication of their value contributions
(Schmidt & Hussong, 2016). When operational awareness increases and the contributions of
employees are recognized, worker engagement and retention improve (Harrison, 2010; Phipps,
2016). Recognition and appreciation improve the support necessary for the adoption and
continuation of VBAs (Carman et al., 2014).
Reduction in Literature Gaps
The literature reviewed at the time of this study offers no research regarding the efforts of
laboratory leaders to communicate value to hospital administrators. The evidence of the
communication of VBAs gathered in this study adds to the body of knowledge. Generating
evidence of the value contributions from healthcare systems fills knowledge gaps and fosters
continuous learning (Montori et al., 2019). It is expected that this study will further the
understanding of the communication of PaLM’s value contributions in healthcare.
Implications for Biblical Integration
Everyone has philosophical assumptions (Creswell & Poth, 2018) and, either consciously
or subconsciously, a worldview (Tackett, 2006). Those who grasp the worldview concept and
reflect seriously on the subject, develop a more coherent belief system (Samples, 2007). The
Christian worldview, also called a biblical worldview, provides an overarching assumption of God
as the Creator (Genesis 1:1; Genesis 1:26-27). Of the Creator, Nehemiah 9:6 says, “You alone are
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the Lord. You have made the heavens. The heaven of heavens with their entire host, the earth, and
all that is on it, the seas, and all that is in them. You give life to all of them, and the heavenly hosts
bow down before You.” (New American Standard Bible, 1960/1995). The Christian worldview
provides a foundational reality with moral absolutes and truths, and a framework for the meaning
of life, and life after death (Barna, 2003). This master narrative describes what human life should
be like, what knocked things off balance, and how to make things right again (Smith, 2009). A
Christian worldview does not necessarily conflict with academia, but rather provides a way to live,
steeped in integrity and offers a comprehensive understanding of all aspects of creation (Dockery
& Thornbury, 2002). The authority of scripture is foundational, perhaps described best by C.S.
Lewis (n.d.) who said, “I believe in Christianity as I believe that the sun has risen, not only because
I see it, but because by it I see everything else” (p.1).
Regardless of one’s religious orientation, all of humanity is inherently hard-wired to create
and to desire meaningful work (Genesis 2:15; VanDuzer, 2010). Humanity, created in God’s
image, is inherently gifted to do excellent work, even non-believers through grace and providence
(Keller & Alsdorf, 2012). God defines the value of His work as “very good” in Genesis 1:31. As
a reflection of His image, we are designed and assigned to create value, bring order, and
communicate with others (Genesis 1:27; Van Duzer, 2010). Studies show that spirituality in
healthcare plays an important role in whole being care and positively influences organizational
performance (Brémault-Phillips et al., 2015), as well as the patient experience (Graber & Johnson,
2001). Realization and appreciation of personal spiritual depth increases leadership capacity and
productivity (Byrum, 2004).
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Benefit to Business Practice and Relationship to the Cognate
The field of study reviewed is healthcare administration. The business practice analyzed
is organizational communication and the knowledge of VBAs required for VBHC strategic
implementation. Implementation of a successful VBHC strategy requires an effective
communication plan at all levels of the organization” (Fry & Baum, 2016, p. 148).
Implementation success requires linking internal business unit activities to organizational
objectives (Bryson, 2018; Gambel et al., 2019). VBHC creates an imperative for organizational
cooperation and teamwork (Nilsson et al., 2017). Effective internal communication is necessary
for strategic consensus. A limited knowledge of strategic priorities leads to an underestimation of
the priority’s relevance (Desmidt & George, 2016), whereas an overestimation is detrimental to
resource allocation (Saaty, 2008). If internal communications are failing then several other areas
will be too (Hartland, 2018).
Viability in a VBHC environment requires the identification of improvement approaches
yielding net cost savings (IOM, 2013). Understanding PaLM’s value contributions is vital for
ensuring the provision of services, the optimal use of testing, and the minimization of resources
and financial waste (Hallworth et al., 2015). Reengineering of clinical and administrative
processes offers the best opportunity for lowering healthcare costs without sacrificing quality,
safety, or outcomes (Kaplan et al., 2014). VBHC implementation requires energy, teamwork,
employee engagement, and conversations about cost (Van Engen et al., 2022). Healthcare
administrators are still discovering appropriate organizational responses to VBHC (Spaulding,
Edwardson, & Zhao, 2018). Administrators implementing VBHC strategies must carefully
consider the internal strengthening actions, resource allocations (Bryson, 2018), and weaknesses
of the organization (Karuppan et al., 2016).
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Summary of the Significance of the Study
Hospital administrators lack a clear understanding of the value streams or the
interconnectivity of processes in hospitals (Protzman et al., 2015). The value-adding services of
hospital laboratories (COLA, 2015) need to be communicated to hospital administrators making
strategic decisions. Researchers of medical laboratories point toward value creation in the vast
amounts of patient laboratory test data, which offers insights for patient diagnosis, care
management, population care, risk stratification, and evidence-based clinical guidelines (Kim et
al., 2011; Hallworth et al., 2015; Sikaris et al., 2017; Swanson et al., 2018). Other researchers
focus on PaLM’s value in terms of personalized medicine, genomics, pharmacogenetics, and
utilization relative to the cost of care (Crawford et al., 2017; Zhi et al., 2013). To improve the
communication of value, an understanding of stakeholders and how information reaches them is
necessary (Raman, 2014). Certainly, the communication of value depends on the perspectives of
the stakeholders (Raman, 2014), but the recognition of value is the critical first step in achieving
successful evidence-based policies, leading to more cost-effective and high-value healthcare
(Misialek, 2014).
A Review of Professional and Academic Literature
Scholarly literature was essential for gaining a better understanding of the
communication of value-based initiatives by PaLM leadership. As this study was focused within
the acute care hospital setting, the value discussed falls under the Medicare Hospital Value
Based Payment (VBP) program, which financially incentivizes improvements in outcomes and
safety, engagement, efficiency, and cost reductions (Centers, 2019b). A hospital’s value is
currently defined by Medicare in quality star ratings (Centers, 2021). Hospital executives seek
value from PaLM services in the interactions with the rest of the health system (Schmidt et al.,
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2016), although value in healthcare is an ambiguous concept embracing most everything good
(Colldén, Gremyr, Hellström, & Sporraeus, 2017). Defining value as quality/costs presents
difficulty due to the soft descriptives of safety, effectiveness, efficiency, and satisfaction
(Kirkpatrick et al., 2015). Additionally, value can mean many things for patients (Nilsson,
Bääthe, Andersson, & Sandoff, 2017).
PaLM Roles and Responsibilities
Evidence indicates that the responsibilities and roles for laboratorians are evolving (Lippi
& Mattiuzzi, 2019) and the lines of subspecialties blurring (Wilson, 2014). The term laboratory
professional is broad (Straseki, 2013). Nine different boards certify laboratory directors (Centers,
2020), representing more than 24 pathology and medical organizations (Lorenz et al., 2018). The
changing scope and roles within PaLM are increasingly important regarding the contributions of
useful information and presentations of economic value (Pennestri & Banfi, 2019). However,
U.S. insurers offer little incentive for the pathologist to participate in hospital improvement
projects by reimbursing only anatomic work (Laposata, 2018a). While pathologists can
demonstrate value by communicating effectively and being involved in activities (Wagar,
Eltoum, & Cohen, 2019), most hospital pathologists already have a day job with little time left to
devote elsewhere (Henricks et al., 2015).
The non-pathologist laboratorian plays a role promoting patient safety and quality of care
(Kim et al., 2011). The advanced practice doctorate clinical laboratory scientist (DCLS) offers a
new leadership role capable of communicating value by optimizing test selection and utilization,
interpreting test results, and participating on medical care teams as a diagnostic expert (Laposata,
2018b; Nadder et al., 2018; Rutgers, 2017; University of Kansas, 2018; University of Texas,
2017). The advanced practice DCLS may hold roles as an educator, consultant, and/or
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administrator (Nadder, 2013; Rutgers, 2017), playing a vital role in cost-effectiveness, error
reduction, and improved patient outcomes (Nadder, 2013). Non-pathologist laboratorians are
involved in computational pathology as new roles emerge for biomedical informaticists,
computer scientists, mathematicians, and statisticians (Louis et al., 2016). The senior
credentialed clinical laboratory scientist (CLS) supervising test quality in the accredited
laboratory participates in many aspects of results interpretations and communicates with nurses
and doctors (Unsworth & Lock, 2013; Wagar et al., 2019). CLS managers apply improvement
approaches daily, aimed at increasing value in a variety of ways (Colldén et al., 2017). As a
motivator, the laboratory manager needs effective communication skills to oversee, lead, coach,
and train (Otto, 2017). These varying types of laboratory leaders and roles set the culture and
pace of the department (COLA, 2015).
The Value Chain
The literature provides clear evidence of healthcare value relative to improvements in
productivity, clinical quality, safety, patient and staff satisfaction, and cost efficiencies
(D’Andreamatteo et al., 2015). Pfannstiel & Rasche (2017) discussed a service business model
for healthcare requiring a focus on value creation with a two-dimensional value proposition – the
operational dimension involving the VBAs that improve quality and safety, efficiency,
effectiveness, satisfaction, profitability, and cost containment, and the environmental dimension
with enhancements to the organization’s culture, policy and procedures, collaborations, and
partnerships. Similarly, Porter’s (1985) value-chain includes a service delivery and support track
for the evaluation of value creation. A modified value-chain model (mVCM) provides guidance
for assessing the literature, aiding discovery of some types of service and support activities (see
Figure 2). Although not always apparent, the activities in the value chain are critical in value
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creation for an efficient and effective organization (Swayne et al., 2006). Strategic planning
efforts require analysis of the internal business environment, resources, and capabilities;
beginning with the identification of key internal factors that contribute value to the organization.
Internal activities are part of larger processes, needing to be designed and managed to deliver
optimal customer value. Hospital operational units provide a strategic advantage by developing
superior operations in service quality, costs, on-time delivery, and flexibility (Karuppan et al.,
2016).
Value improves with lower costs, quality improvements, service excellence, and
surpassing the capabilities of rivals (Gambel et al., 2019). These categories within the valuechain are the essentials for value creation (Swayne et al., 2006). Yet, the real value contributions
from PaLM practices still need understood, defined, communicated, and applied for all
stakeholders (Price et al., 2016). Laboratory medicine is an area where laboratorians have an
opportunity to demonstrate value in the delivery of healthcare (Schmidt & Ashwood, 2015),
especially when rethinking the full continuum of care (Porter & Lee, 2016). VBA assessments,
including those for hospital laboratories, provide evidence for incorporation into practice and
alignment with value-based strategies (Carman et al., 2014).
VBA Knowledge Sharing.
Medical knowledge and accepted practices change rapidly as the volume of research
expands exponentially (Duke, n.d.). Research findings are slow to integrate, taking an average of
17 years for integration into medical policy and practices (Morris, Wooding, & Grant, 2011).
Knowledge dissemination improves operations, refining and updating the organization with
improved skills and methods (Grove et al., 2019; Lewandrowski et al., 2018; McFadden, 2014).
Laboratory leaders can serve as knowledge brokers that rapidly translate evidence-based
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practices in healthcare (Birken et al., 2018; Price & St. John, 2014), serving as the go-betweens
of the knowledge producers and the end users (Puddy & Hall, 2017). The role of the middle
manager as a knowledge broker shapes the climate for implementations (Birken et al., 2018).
Knowledge brokers translate and implement new knowledge transferring industry knowledge
between and across systems (Puddy & Hall, 2017).
Laboratorians provide expert knowledge on miniaturized point-of-care testing platforms
associated with improvements in service delivery and wait times, which need to be weighed
against the limitations of testing accuracy and costs (Nadder et al., 2018). PaLM’s expertise
connects science with medicine, integrating and upgrading healthcare policies and practices
(Grove et al., 2019; Lewandrowski et al., 2018; Morris et al., 2011), as well as clinical guidelines
(Eaton et al., 2017; Misra et al., 2016; Sikaris, 2018). Many laboratory VBAs target process
improvements for better efficiency, quality of care, and cost reduction (Protzman et al., 2015;
Schmidt et al., 2016; Van Cott, 2014; White et al., 2015).
VBA Utilization.
Best estimates indicate that 30% of laboratory test orders are inappropriate (Baird et al.,
2018). Government payers attempting to control laboratory expenditures simply reduce
reimbursement rates, without consideration for medical necessity (Wilson, 2015). As a result,
laboratories expect a 15% decline in reimbursements by 2023 (Halstead et al., 2018). Porter et al.
(2017) suggests that such arbitrary spending reductions lack sustainability and may even harm
patient outcomes. VBAs associated with test utilization and demand management are a more
effective way to decrease the associated costs in hospitals and outpatient settings (Lewandrowski
et al., 2017; Wilson, 2015). Successfully tackling inappropriate laboratory utilization requires
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laboratory leaders to drive this process improvement effort, analyze the data, and communicate
with physicians and other stakeholders (Lewandrowski et al., 2017; Sadowski et al., 2017).
VBA Efficiency and Effectiveness.
Laboratory services affect hospital reimbursement in clinical care process domains, i.e.,
efficiency, patient experience, outcomes, and cost reductions (Davis et al., 2018). Efficient
organizations seek to improve processes, complications, and time (Worster, Weirich, & Andera,
2017). Efficient organizations eliminate the duplication of services, products, or delays (Inal et
al., 2018), and utilize contractual relationships to minimize cost (Harrison, Harrison, Howey, &
Walters, 2017; Schwartz & Pearson, 2013); although only half of U.S. physician societies
consider costs when developing clinical guidelines (Schwartz & Pearson, 2013). Efficient
laboratories utilize a managerial focus on operations (Schmidt et al., 2016) with autoverification
of test results (Krintus et al., 2017). Effective organizations utilize best practices (Srivastava &
Sushil, 2018) and develop a culture of learning continuous improvement, optimization of
clinical, economic, and operational outcomes (Glanzman, 2017; Hallworth et al., 2015; Swayne
et al., 2006).
VBA Competitiveness and Customer Services
Value enhancements involve improving strategic resources and core competencies of the
organization, i.e., internal skills, capabilities, and technologies (Fottler, Ford, & Heaton, 2002;
Kratz & Laposata, 2002; Swayne et al., 2006). Internal resources and capabilities require
development and nurturing for a sustained competitive advantage (Gambel et al., 2019).
Successfully achieving a strategic vision requires development of internal capabilities and
effective managerial talent (Gambel et al., 2019). Skills and knowledge are developed with
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activity implementations and experience-based learning with adequate time to reflect-on
outcomes (Kim, Kumar, & Kumar, 2012; Nilsson et al., 2018).
Realization of PaLM’s value proposition requires working with hospital administrators
and colleagues (Louis et al., 2016). Laboratory’s visibility, within and outside the organization,
improves with value-added services like consultations, team efforts, and research projects
(COLA, 2015). Laboratorians demonstrate clinical expertise participating on multidisciplinary
teams (IOM, 2015; Wagar et al., 2019), providing consultations (Davis et al., 2018;
Fydryszewski, 2019; Laposata, 2018b), and liaising with physicians and nurses (Unsworth &
Lock, 2013; Wagar et al., 2019). Laboratory professionals add value in healthcare as clinical
consultants, sharing clinical expertise on care teams, tumor boards, infection prevention
committees, clinical utilization and antibiotic stewardship committees, performance
improvement teams, and transfusion management programs (Davis et al., 2018; Morgan, Malani,
& Diekema, 2017). Laboratory expertise improves patient outcomes, reduces infections, and
increases throughput (Gupta et al., 2019). The hospital-based pathologist participates on
interdisciplinary committees, interacting with clinicians and engaging in the broader role of
healthcare (Wilson, 2014). The CLS offers valuable expertise for test selection and
interpretation, reducing diagnostic errors, and avoiding unnecessary testing (ASCLS, 2018).
VBA Quality Testing and Data.
The value of the laboratory test is in the information communicated from the test result,
which enables clinicians to make better patient treatment decisions that positively affect clinical
outcomes (Price & St. John, 2014). Laboratory test results gauge the effectiveness of nutritional
and medical treatments such as drug or cancer therapies and the source of infection for antibiotic
therapies (ASCLS, 2005). Laboratory diagnostic testing provides real-time decision support to
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clinicians (Schmidt et al., 2016), informs patients and providers of disease states and disorders,
and monitors the efficacy of treatment (Collinson, 2017; Nam, 2015). The diagnostic value of the
laboratory testing has been explored in a number of papers (Price & St. John, 2014).
The analytical dimension of laboratories are arguably the best performing sector of
healthcare (Hawkins, 2012), given that medical laboratory testing is among the most regulated
and inspected areas of healthcare, and the high quality of testing is well developed and efficient
(IOM, 2015; Schmidt & Ashwood, 2015). Laboratory accreditation bodies have clear standards
for testing and for testing personnel (Centers, 2019c; COLA, 2019a; Hawkins, 2012). The Food
and Drug Administration regulates four categories of patient testing complexity (Lorenz et al.,
2018). Accreditation bodies such as the College of American Pathologists (CAP), the Joint
Commission (JC), the Joint Commission International (JCI), COLA, and others have clear
standards for human specimen testing, and the personnel that perform and interpret test results
(Centers, 2019b; COLA, 2019; Hawkins, 2012). The optimal analytical performance depends on
quality assurance standards within the total testing phases, as well as extra-analytical
performance specifications (Plebani & EFLM, 2017). Many quality and cost savings
opportunities exist in the management of the extra-analytical phases of laboratory testing
(Hawkins, 2012; MacMillan, 2014; Waibel et al., 2018).
PaLM is a data driven specialty and pathologists are information specialists (Henricks et
al., 2015; Wagar et al., 2019). Medical laboratorians are not merely generators of data, but
managers of information and creators of knowledge (Kroft, 2018) with the adequate skill set and
expertise for population health management strategies (Swanson et al., 2018), and provider
education (Wagar et al., 2019; University of Kansas, 2019). Data whether clinical, financial, or
process related, needs to be collected, analyzed, and protected as a resource for managing care,
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improving processes, and generating knowledge (IOM, 2013). Laboratory data analytics generate
the knowledge for cost reductions in healthcare (Xu et al., 2015), as well as improvements in
utilization, quality, service efficiencies, and health outcomes (Shirts et al., 2015). Analysis of
laboratory testing data identifies the opportunities to improve utilization, service efficiency, and
meaningful use (Shirts et al., 2015). It identifies gap areas for risk stratification and improving
outcomes (Ducatman et al., 2018; Gross et al., 2019). The value of the laboratory becomes more
transparent as health systems delve into population health strategies (Downs & McMinn, 2017).
The term big data in healthcare refers to the collection of information so large that
bioinformatics solutions are required to process and make meaningful (Baudhuin, 2015).
Advances in data analytics permit the examination of laboratory’s big data, identifying valuebased opportunities (Nadder et al., 2018). Impacts from laboratory data are associated with
quality assurance, process improvements, epidemiology, population health, and predictive
modeling (Crawford et al., 2017; Fitzgerald et al., 2018; Turi, Buchner, & Grigsy-Toussaint,
2017). Pathologists as champions need to communicate the value of the laboratory’s data to
administrators (Gross et al., 2019).
VBA Cost Savings.
Cost effectiveness requires improvement in operational efficiencies, quality, and per unit
costs, and guidance by competent laboratory management (COLA, 2015). Cost effectiveness
involves assessing laboratory services for competitiveness, pricing, and profitability (Downs &
McMinn, 2017). Cost savings come in the form of cost containment, cost effectiveness, or
operational efficiency (COLA, 2015). The University of Mississippi’s laboratory system
identified four types of cost saving activities: a realized savings with a duplication order alert; a
prospective cost savings with an unnecessary combination alert; a downstream cost savings
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utilizing expertise in new instrumentation projects; and a variable cost savings assessing
laboratory data to justify process changes (Shirts et al., 2015). Laboratory cost reductions
contribute to organization-wide savings (Futrell, 2013). The total costs of care are reduced by
VBAs that improve purchasing processes, productivity, or the utilization of equipment, facilities,
or services by enhancing quality (Kim et al., 2012; Niemeijer et al., 2011). Sustainable cost
reductions require the identification and modification of inefficient and ineffective processes
(Porter et al., 2017).
Laboratorian expertise is instrumental in the identification, prioritization, and selection of
improvement initiatives (Raebel et al., 2019). Competent laboratory management assesses
marketplace pricing for relative competitiveness (Bergeron, 2017) and identifies opportunities
within the supply chain (Passiment & Linscott, 2014). PaLM plays a significant role in VBHC
with investigation of new tests and methods, dissemination of information, and guiding
appropriate utilization as well as pricing and reimbursement assessments, stewardship programs,
and consultations (Halstead et al., 2018; Lewandrowski et al., 2017).
VBHC Strategies
VBHC strategies require changes that increase value and lower the overall costs of care
(Kaplan et al., 2014). However, the first step in any performance improvement initiative is
convincing others of a need for change (Green, Greene, & Orsini, 2018). Hospital
reimbursements depend on maximizing operational efficiency, improving quality, and reducing
unnecessary costs (Hamrock et al., 2013). A hospital’s ability to score well under VBHC
reimbursement models depends on the organization’s ability to learn and implement change
(Spaulding et al., 2018). Delivery of VBHC is an uphill battle without improving workflow
efficiencies and communications (Lord, n.d.). Successful strategies link internal business unit
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activities with organizational objectives (Gambel et al., 2019; Bryson, 2018). However, the
complexities of a healthcare organization necessitates that each level take responsibility in
strategy implementation (Batalden & Davidoff, 2007; Nilsson et al., 2017).
While the work of transitioning from volume-based to value-based healthcare is well
underway, the associated challenges should not be underestimated (Porter & Lee, 2016; AHA,
2017). The complexity and pace of the changes required result in all levels of the organization
feeling stress, frustration, and confusion (Chatfield et al., 2017; Delmatoff & Lazarus, 2014). A
hospital’s implementation success requires clear communication and an alignment of leadership
(Fry & Baum, 2016). Service improvements within hospitals require resolution of key sources of
tension (D’Andreamatteo, Ianni, Lega, & Sargiacomo, 2015). All staff have a hospital
citizenship role and a responsibility in the improvement of care and performance (Boland et al.,
2017). Strong leaders understand the factors affecting their employees, and the contributions
toward good citizenship behaviors (Glavas & Goodwin, 2013; Henderson-Carter, 2014).
VBHC Implementation.
Viability in a VBHC environment, especially in a rural hospital setting, requires
identification of improvement approaches to reduce waste, improve outcomes, and yield net cost
savings (IOM, 2013). Evidence based assessments encourage the practice or policy changes
necessary to increase value (Swayne et al., 2006). The dissemination of performance measure
data is not enough to produce improvements (Lemire et al., 2013). Successful improvement
initiatives depend on a variety of factors that influence the reactions to performance information,
such as the clarity of objectives, stakeholder relationships, systems of governance, and incentives
(Lemire et al., 2013). A supportive communication network, teamwork, and staff satisfaction are
essential (Becket & Kipnis, 2009).
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Studies indicate that hospitals belonging to a system are more likely to score high on
value-based purchasing performance (Spaulding et al., 2018). Integrated delivery systems
effectively minimize transaction costs with an improved coordination of care (Harrison et al.,
2017). Some administrators seek acquisition or merger in hopes of delivering lower costs with
economies of scale (Knowles & Barnes, 2013). However, the relationship between cost and
increased volume is not linear (Knowles & Barnes, 2013). Despite moving target measures,
hospitals belonging to a system demonstrate better change management efficiencies by internal
learning from other sites (Spaulding et al., 2018). Transferring information to other units
shortens the improvement cycle (Green et al., 2018).
VBHC Organizational Alignment.
Organizational alignment in VBHC requires that all levels of the organization understand,
accept, and support the value proposition (Austin et al., 2016). Generating alignment is the
primary objective of internal communication (Verčič, Verčič, & Sriramesh, 2012). Davis et al.
(2012) purported that internal information sharing with top executives fosters a closer agreement
in the strategic vision. Both informational and relational dimensions play a role in generating
organizational alignment (Desmidt & George, 2016). Ideally, the entire organization keeps a
watchful eye on opportunities, risks, and trends as organizational transformation requires a team
effort (Chatfield et al., 2017; Stroh, 2015).
The Hospital Administrator
Healthcare administrators’ top strategic concerns are the financial challenges amid lower
reimbursements and rising costs (ACHE, 2019). Executive leadership must set the objectives to
lower costs and increase value (Kaplan et al., 2014). Healthcare administrators implementing a
value-based strategy must carefully consider the specific internal strengthening actions and
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resource allocations necessary for success (Bryson, 2018). Influential factors in the adoption of
improvement initiatives include the characteristics of the hospital’s top management team, the
structure and size of organization, and the local competition (McFadden et al., 2014). Hospital
decision makers need a better understanding of the role and the value offered by laboratories
(Anonychuk et al., 2012). Understanding the current set of business activities is necessary to
justify change (Orwig et al., 2015).
Most executive teams focus on improving quality, efficiency, and reducing costs (Green
et al., 2018). Hospital accreditation requirements, government mandates, and financial incentives
determine the reportable measures chosen by a health system’s leadership (Tierney, 2017;
Tinker, 2018). Top concerns of hospital administrators include government mandates, financial
challenges with lower reimbursements and rising costs, the need to improve safety and quality,
and personnel shortages (ACHE, 2019; Newman, 2018). The hospital CEO focuses on patient
experience and satisfaction, clinical quality, and cost reductions through process improvements
(Marlow et al., 2016). The executive level administrator is the organization’s primary strategic
decision maker (Bryson, 2018), choosing which outcomes to measure with consideration of the
availability and ease of access to the necessary data (Nilsson et al., 2018).
Healthcare executives moving from volume to value-based care acknowledge new
complexities and challenges to long-term financial stability of hospitals (DeMarco et al., 2016).
Healthcare administrators are still discovering the appropriate responses to value-based
purchasing and the necessary organizational behavior adjustments (Spaulding et al., 2018). CEOs
acknowledge that better outcomes at lower costs are achievable with improvement initiatives
(Cosgrove et al., 2012). Hospital CEOs agree that strategy development must occur at “multiple
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levels and involve as many stakeholders as possible” (Chatfield et al., 2017, p. 376). Figure 3
lists the top improvement concerns for hospital administrators in the VBHC era.
Figure 3.
Hospital Administrator’s Top Concerns
Hospital administrator's top seven
improvement concerns
process outcomes / efficiency
patient outcomes / effectiveness
financial / cost reductions
patient satisfaction / patient experience
quality / safety
workforce shortages / skills development
government mandates / VBHC reporting measures
Communication.
Healthcare administrators are responsible for setting the goals and objectives that
increase value in care delivery, as well as allocating resources and evaluating performances for
improved outcomes and lower costs (Kaplan et al., 2014; Kim et al., 2012). A superior execution
strategy strives for continuous improvement within the value-chain, aiming for operational
excellence (Gambel et al., 2019). Strategy implementation requires experience, knowledge, and
charisma (Harrison, 2010). Healthcare administrators agree that as change agents they hold the
responsibility for communicating changes to staff in an understandable way, with frequency and
using multiple methods for optimal effectiveness (Salahshor, 2016). The CEO plays a key role in
fostering a culture of upward communication (Adelman, 2012; Ashford, Sutcliffe, &
Christianson, 2009), although most of the responsibility for improving upward communication
falls on the managers (Alder, Maresh-Feuhrer, Elmhorst, & Lucas, 2019). Upward
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communication occurs more frequently with executive leadership that is genuine, visible, and
approachable (Adelman, 2012). CEOs that openly address bad news create a transparent culture,
allowing for critical upward feedback (Aldeman & Stokes, 2012). The leaders that build
relationships, establish trust, and remain visible to staff encourage feedback for improvement
ideas and concerns (Aldeman & Stokes, 2012). Communication is particularly important when
change involves controlling costs and resource allocations (Madden, 2015). Healthcare
administrators use leadership skills to engage staff in meeting goals (Salahshor, 2016) and
managing change (Liang et al., 2013). Senior level gemba walks improve accessibility for
communicating with frontline employees and demonstrate the commitment of senior leaders
(Protzman et al., 2015). While top-level personnel are responsible for strategic planning and
formulation, the lower-level members implement strategic activities and hold the responsibility
for customer service relationships (Davis, Allen, & Dibrell, 2012).
Frontline Inclusion.
Organizational leadership must ensure the necessary partnerships for the laboratory
(Warren, 2013). Executive administrators acknowledge that employees are experts about what is
happening in the organization (Adelman & Stokes, 2012). An engaged workforce is necessary
for clinical and financial excellence (Adelman & Stokes, 2012). Failure to include the hospital
frontline in discussions of improvement efforts result in staff feeling “demotivated,
disenfranchised, and disenchanted” (Longenecker & Longenecker, 2014, p.8). Administrators
cannot fix organizational deficiencies without tapping into departmental knowledge (Salahshor,
2016). Hospital administrators can leverage front line intelligence to improve safety,
engagement, and identify the areas of vulnerability (Wolpaw et al., 2018).

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

36

Perceptions of PaLM Services.
The relative spend on medical laboratory diagnostics compared to pharmaceuticals
reveals an under-appreciation of the economic and medical value delivered (Jordan et al., 2015).
The paucity of evidence demonstrating PaLM’s impact on healthcare costs and outcomes
contributes to the under-recognition and under-valuation of PaLM services (Anonychuk et al.,
2012). Most hospital administrators have little understanding of laboratory practices, the
associated component costs (Lewandrowski, 2017), or the scope of activities (Branda et al.,
2014). Administrators lack a clear understanding of the value streams or the interconnectivity of
processes (Protzman et al., 2015). When tasked with improving quality and decreasing costs,
hospital groups need an awareness of the PaLM’s role and an inclusion of the laboratory for
optimal success (Misialek, 2014).
Hospital administrators often overlook the laboratory (Downs & McMinn, 2017;
Shrinkman, 2016), and may wonder if laboratory services are merely “a commodity or if
laboratory services offer a higher valuation” (Crawford et al., 2017, p.2). Administrators may
wonder if PaLM services offer enough value to stay “safely ensconced within the facility”
(Futrell, 2013, p.2). In a 2016 survey of laboratorians nearly two-thirds of respondents indicated
feeling administrative pressure to demonstrate the laboratory’s value and to cut costs (Epner,
Gayken, & Kurec, 2019). Hospital leaders fail to recognize the value of laboratorians and
pathologists (Gross et al., 2019). They may even relegate the laboratory department to a cost
center position, such as linen or laundry services for potential of outsourcing as a cost savings
measure (Downs & McMinn, 2017; Mrak, Parslow, & Tomaszewski, 2018).
Laboratory management constrained by space, a lack of qualified personnel and
technology, and regulated mandates face tough choices (Weinert et al., 2015). For example,
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sourcing decisions need to be weighed against stakeholder needs and per test cost (Weinert et al.,
2015). Outsourcing tests may improve costs (Roger et al., 2019), but may also negatively affect
patient care with decreased sample quality, delays in result time (Weinert et al., 2015), and
increased test cancellations (Rogers et al., 2019). Outsourcing of tests enhances the risk for
diagnostic errors (Lippi & Mattiuzzi, 2019) and interrupts the continuity of care (Ferraro &
Panteghini, 2017). Outsourcing of laboratory services foregoes the seamless provision of
services, integration of data, and timeliness of patient reporting (Terese, 2019). STAT turnaround
time, one of the most visible performance measures (Hainen & Coberly, 2018) remains a highpriority reportable quality measure in CMS’s Merit-based Incentive Payment System (MIPS)
(CAP, 2019b).
The people assets of laboratories are also undervalued (Tulsi, 2019) despite their highquality work contributions toward the diagnosis, prognosis, treatment, and management of
human disease (Davis et al., 2018; Anonychuk et al., 2012). Administrators tend to link cost
savings to personnel reductions or reductions in required educational standards for employment,
foregoing the potential negative impacts on patient outcomes (Epner, 2017). Higher-level
directors may not see the value from the insights of lower-level employees (Ahmed, 2019).
According to an American Society for Clinical Pathology (ASCP) (2017) national laboratory
wage survey, 39.4% of laboratory respondents felt underpaid and underappreciated (Garcia,
Kundu, & Fong, 2019). Autonomy and feedback enhance job satisfaction, however the lack of
wage equivalence and administrative support causes dissatisfaction (Han, Carter, & Champion,
2018). According to the Coordinating Council on Clinical Laboratory Workforce (CCCLW)
(2018), appreciation, professional visibility, and wage equivalency with similarly educated
professions are essential for resolving the recruitment and retention issues in laboratories. Strong
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laboratory leadership is necessary to highlight the laboratory as a core asset (Gross et al., 2019),
to build relationship, and to communicate the laboratory’s value to healthcare administrators
(Gross et al., 2019; Wagar et al., 2019).
The Laboratory Leader
Passiment and Linscott (2014) stated “The mystery of the laboratory is perpetuated by the
lack of an organized, systematic, flexible, and bi-directional exchange of information, ideas,
standards, and beliefs between the laboratory and its customers, i.e., effective communication.”
(p.451). Communicating PaLM’s value requires laboratory leaders to present an effective
message (Gross et al., 2019) that aligns recipient concerns and priorities (Gardner & Winder,
1998). Success stories need to be communicated and wins need to be publicized (Green et al.,
2018). PaLM leaders, however, have failed to connect critical activities to the strategic
imperatives of the broader organization (Dixon, 2019). Inadequate communication from
proactive pathologists is a quality gap (Wagar et al., 2013). Among managers of service-oriented
organizations, ineffective communication is the most frequently reported deficiency (Kerns,
2016). Pathologists interested in closing this quality gap must take interest in and learn business
management and clinical operations (Wagar et al., 2013). Effective communication begins with a
desire to communicate (Guo, 2011) and the skills for effective communication can be learned
(Otto, 2017). A technical and clinical background is no longer sufficient for laboratory
leadership. PaLM activities increasingly require a commitment toward managing administrative,
organizational, and economic concerns (Lippi & Plebani, 2017), as well as managing human
resources and informatics (Wilson, 2014).
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PaLM Stakeholders
A key aspect in any value-proposition is considering the stakeholder’s needs and
expectations (Price et al., 2016). Fundamentally, organizations exist to create value for
stakeholders (Austin et al., 2016). The activities that create value for stakeholders increase the
ratio of satisfaction to price, improving quality, effectiveness, and efficiency (Swayne et al.,
2006). Cost improvement strategies need buy-in and awareness from stakeholders (HendersonCarter, 2014), without which the likelihood of maximum performance diminishes greatly
(Longenecker & Longenecker, 2014). A VBHC culture requires an alignment of stakeholders
with newfound partnerships, the creation of new roles, technology investments, and patient
inclusion (Glanzman, 2017). Value creation requires an assessment of the customer’s wants and
needs (Karuppan et al., 2016). High-performing organizations create the structures that enable
stakeholder engagement in priority setting and resource allocation decisions, although the
executive team holds the final responsibility (Carman et al., 2014; Smith et al., 2016).
A value-creating ecosystem depends on the coordination of internal and external
stakeholders as a network of governance (Pfannstiel & Rasche, 2017). External stakeholder
communication, described as boundary spanning, provides an opportunity for organizational
learning (Guo, 2011). At this point, most agree that healthcare costs are too high and support a
common goal of improving outcomes more efficiently (Lee, 2010). However, there is a
disagreement in who is responsible, and what is of value (University of Utah, 2017). The best
value is a shared benefit for all stakeholders (Pennestri & Banfi, 2019), although in healthcare
the stakeholder list can be quite extensive (Austin et al., 2016) with conflicting goals (Porter,
2010).
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PaLM accrediting agencies recognize the importance of understanding stakeholder needs,
expectations, and satisfaction (McCall, Souers, Blond, & Massie, 2016; Koh et al., 2014). The
CCCLW taskforce identifies the laboratory’s stakeholders as clinicians and patients, the
organization, and the national, global, and public healthcare systems (Davis et al., 2018). A 2009
laboratory industry report on value identifies laboratory’s stakeholders as regulators and
government policymakers, clinicians, patients, hospital administrators, payers, and
manufacturers (Wolcott et al., 2009). Epner et al. (2017) described laboratory stakeholders as the
patient, care team, health system, community, and laboratory professionals. Price and St. John
(2014) described the laboratory stakeholders as the government with a need to reduce costs and
improve outcomes; the care provider with a need to meet regulated mandates, improve
operations, and manage disease; and the patient with a need for accessible, affordable, and
accurate test results. Hospital based laboratorians seeking support for new initiatives identified
key stakeholders as the nurses, pharmacists, infection control practitioners, and the finance and
information systems departments (Marlow, Novak-Weekly, & Larocco, 2016). Peters (2019)
added that laboratory vendors as the key stakeholders.
Key stakeholders identified for hospital based laboratories are listed in Figure 4. It is
beyond the scope of this study to explore the communications with PaLM stakeholders other
than the hospital administrator. Passiment & Linscott (2014) recommend that all avenues of
communication by PaLM leaders need further exploration to enhance services.
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Figure 4.
Stakeholders in PaLM’s Value Creating Ecosystem

Patient
Health
Care
System

Providers
Clinicians

Lab
Personnel

PaLM
VBAs

Vendors

Compliance
regulators

Payers

Value to Providers and Patients.
The purchasers of laboratory services, i.e., the government and health insurers, are
responsible for obtaining the best quality services (Price et al., 2016). The ordering provider is
responsible for interpreting and acting upon the lab test results (Schmidt et al., 2016). PaLM
accreditation standards require measurement of physician and patient satisfaction with laboratory
services every two years (CAP, 2014; Hawkins, 2012). Providers are generally satisfied with the
quality and reliability of laboratory testing, the courtesy of the laboratory staff, test menu
adequacy, and indicate a willingness to recommend their laboratory to other physicians (Jones et
al., 2009; McCall, 2016). Published surveys reveal that physicians value being able to provide
precise medical care in a short period of time (Abdallah, 2014) and desire accurate and timely
test results (Inal et al., 2016), especially for stats and esoteric send out tests (Jones et al., 2009;
McCall et al., 2016). Physicians are satisfied with surgical pathology reports (Nakhleh, Souers,
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& Ruby, 2008), but would like patient reports to have more information where a risk for
potential false positives or false negatives exist (Kelman et al., 2016).
Patients seek readability, relevance, and next steps from their laboratory and pathology
results report (Kelman et al., 2016; Poczter & Giugliano, 2014). Patients feel empowered with
face-to-face pathology consults for a better understanding of their disease (Booth et al., 2018).
Patients desire convenient service locations with limited wait times (Karuppan et al., 2016).
Some surveys reveal a dissatisfaction with laboratory services relative to specimen collections,
delivery processes, phlebotomy (Koh et al., 2014), and the ease of order entry (McCall et al.,
2016). Physicians and patients express a desire for patient-friendly laboratory reports (Kelman et
al., 2016; Poczter & Giugliano, 2014) and easily retrievable test results (Passiment & Linscott,
2014).
Communicating with Stakeholders.
Communicating value involves understanding how stakeholders perceive value, and
articulating the benefits of services (Raman, 2014). Communication of value to stakeholders
remains a significant challenge in healthcare (Thaker et al., 2016). Understanding key
stakeholder needs and establishing feedback communication channels for feedback is essential to
managing change (Ryan, 2018). Promoting communication and partnerships among stakeholders
is necessary to facilitate engagement and anticipate the impacts of change (Carman et al., 2014).
Managers are responsible for ensuring bi-directional communication with stakeholders
(Passiment & Linscott, 2014). Establishing relationships with stakeholders builds rapport and
improves credibility (Communication, 2016). Articulating the benefits of a service allows
stakeholders to know its value (Raman, 2014) and establishes the identity of the laboratory
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profession (Passiment & Linscott, 2014). Clinicians need communication and education from
laboratorians to understand the basis for improvement initiatives (Process Improvement, 2017).
Effective Organizational Communication
Effective communication has not occurred until the receiver understands the information
(Guo, 2011). Preconceived notions, perceptions, and interests influence messaging effectiveness
(Karuppan et al., 2016). Best practices for effective communication channels include openness, a
defined channel for all members, short and direct communication lines, and recurrent messaging
(Gardner & Winder, 1998). Intra-organizational communication may be formal or informal
(Gardner & Winder, 1998), and flow upward, downward, diagonally, or horizontally (Guo,
2011). Managers should communicate to executives interested in their efforts (Karuppan et al.,
2016). The importance of internal communication is often overlooked (Kridelbaugh, 2018),
despite that effective communication skills by leadership are associated with improved
organizational outcomes (Otto, 2017). Senior leaders consistently underestimate the need for
communication (Austin et al., 2016).
Strong systems for communication in healthcare improve patient safety (IOM, 2015).
High-impact communications influence policy formulation and outcomes (Kerns, 2016).
Communication is necessary to improve safety, reduce errors, educate, and disseminate
information (Weld et al., 2015). In healthcare, effective communication with education improves
error rates and patient safety (Weld et al., 2015). Additionally, employees report an increase in
job satisfaction with effective upward communications (Gardner & Winder, 1998).
Communicating Top Down with Feedback.
Top-down communication must be frequent, understandable, and use multiple channels
for effectiveness (Salahshor, 2016). Top-down one-way communication is quick and easy, but
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disadvantageous for creating an understanding of change initiatives, importance, or functional
roles (Longenecker & Longenecker, 2014). Feedback allows for clarification of assumptions
(Adelman & Stokes, 2012). Feedback, defined as the reaction to the message, permits
clarification from the sender (Guo, 2011). Without feedback, tone-way communication from a
sender is less accurate, and the sender cannot know the message was accepted and accurately
understood (Gardner & Winder, 1998). A lack of two-way communication causes significant
problems in change or improvement initiatives (Longenecker & Longenecker, 2014). Superior
outcomes require two-way, ongoing communication between the leader and those making the
change happen (Longenecker & Longenecker, 2014).
Communicating Upward.
Upward-communication directs messaging toward higher authority, while horizontal (or
lateral) communication transfers information between different departments and supports task
coordination (Gardner & Winder, 1998). Upward communication, typically the most lacking
communication in organizations (Communication, 2016). Upward communication helps
employees contribute to organizational learning and helps administrators gauge the effectiveness
of downward communication (Bennett, 1968). Politics, a reward system, and coercive powers
negatively affect upward communication (Kumar & Mishra, 2017). Suppression of upward
communication occurs relative to negative information (Adelman & Stokes, 2012), especially
regarding failures or finances (Tourish & Robson, 2004). A culture of blame or a lack of
responsiveness inhibits upward communication (Ahmed, 2019). A lack of experience at a
specific business level or a lower education level hinders upward communication (Adelman &
Stokes, 2012; Bennett, 1968). Upward communication may lose impetus without effective action
or if blame is a concern (Gardner & Winder, 1998). It is important to emphasize collaborative
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efforts and avoid placing blame for failed efforts (Henricks et al., 2015). Employees tend to filter
upward communication to present a positive image or to impress superiors, resulting in an
inaccurate presentation of issues (Ahmed, 2019; Tourish & Robson, 2004).
Effective upward communication requires that the administrator listen (Bennett, 1968).
Meaningful C-suite communication requires an understanding of how the organization makes
money and how it completes the mission (Agovino, 2019). The executive prefers concise,
relevant information (Communication, 2016) and remains skeptical of bold savings solutions
without details on the time, costs, and the necessary efforts (Øvretveit, 2009). When
communicating with a hospital administrator, the sender should write down the objective of the
message with points of clarity before presentation and avoid medical jargon depending on the
administrator’s clinical background (Dhand, 2019). Communication with e-mail, while flexible
and offering time and cost savings, is limited and problematic (Guo, 2011). Information overload
for the executive can present a barrier to effective listening (Communication, 2016).
Communication from Laboratory Leaders.
A concerted effort by laboratory leadership is required to keep senior management
informed of recent developments and accomplishments (Kridelbaugh, 2018). Upward
communication provides status updates concerning department projects, performance results, and
improvement suggestions (Alder et al., 2019). Upward communication allows an opportunity to
coordinate efforts, process information, and reduce ambiguity (Johnson, 1993). Input from below
increases and broadens the information available for leaders to make decisions (Ashford et al.,
2009). Decisions made without lower rank involvement disrupts internal social processes and
creative behaviors (Kauppila et al., 2017).
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Laboratory managers should establish favorable and constructive interfaces with hospital
administrators (Lippi & Mattiuzzi, 2019). It is the responsibility of laboratory management to
provide education and training to laboratory personnel that improves knowledge and verbal
communication skills (Passiment & Linscott, 2014). Laboratory managers should encourage
laboratorians to share expertise by serving on hospital committees or taking assignments with
hospital nursing units as a recognizable liaison (Passiment & Linscott, 2014). Laboratorians that
provide knowledge-based services to clinicians improve the laboratory’s competitive value
(COLA, 2015) and act as knowledge brokers transferring industry knowledge between and
across systems (Puddy & Hall, 2017). Dialog between laboratory professionals, clinicians, and
patients and their families educates all parties and helps to achieve the goal of right patient, right
test, at the right time (Baird et al., 2018).
It is up to leadership to define and communicate the purpose of the organization, and to
establish the necessary work practice teams to create value (IOM, 2001). Wagar et al. (2019)
discussed the importance of the hospital pathologist, as a laboratory leader, having excellent
communication skills and interfacing outside the laboratory. The pathologist ideally plays a
major proactive role in performance improvements and the development of the laboratory’s
value proposition (Wood, 2016).
Communicating Value and Cost Savings with Metrics.
The ability to perform well in a value-based care environment relies on internal
organizational processes more than structural features (Miller, 2019). Transparent and frequent
communication is central to success when restructuring internal processes (Miller, 2019).
Process improvement efforts fail without monitoring progress or communicating with executive
sponsors (Karuppan et al., 2016). Performance metrics alone, however, do not necessarily
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improve cost or quality “to any meaningful degree” (Miller, 2019, p. 445). Kaplan and Porter
(2011) argued that measuring the wrong things the wrong way is a big problem in healthcare.
The more appropriate measurable indicators are organizational learning and value gains (Nordin,
Kork, & Koskela, 2017).
The development of methods to quantify and communicate value in the medical
laboratory is critically important (Davis et al., 2018). VBHC necessitates chief financial officers
think in terms of value ROI, rather than financial ROI (Green et al., 2018). Thaker et al. (2016)
discuss the use of radar charts to visualize and communicate outcomes and the cost of care.
When exercising strategic measures, administrators may benefit from ROI information
determining intrinsic value and associated costs (Henderson-Carter, 2014). Spreadsheets
communicate the clinical and economic benefits of new technology by combining a variety of
data sources (BaseCase, 2012). The SBAR (Situation, Background, Assessment, and
Recommendation) is a structured communication tool used in healthcare (Marder, 2018).
Communicating cost savings may require that laboratorians isolate costs with time-driven
activity-based costing (TDABC) (Kaplan et al., 2014) or utilize a group purchasing organization
(GPO) to help determine actual supply costs (Maul et al., 2019). Laboratory vendors also aid in
developing reports for new technology implementations that demonstrate improved diagnostic
accuracy and timeliness of reporting (Epner et al., 2017). Laboratory professionals need further
development of programs to document and publish the impacts of new technologies and related
clinical, operational, or economic outcomes (Delvin, 2017; Puddy & Hall, 2017). Laboratory
data on solutions offer evidence that communicate the impacts of new methodologies, instrument
comparisons, and clinical practice changes (Landin, 2013). Managers gain political support
demonstrating with certainty the effectiveness of improvement activities and cost savings
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(Øvretveit, 2009). Well-performed public presentations tailored toward the executive level
establish credibility (Weinholdt, 2006). Success reports provide a useful communication tool
(Hartland, 2018) and regularly prepared promotional materials offer the laboratory marketing
collateral (Kridelbaugh, 2018).
Communicating Outcomes with Metric.
Choosing a value-based management strategy triggers process improvements and the
measurement of outcomes (Nilsson et al., 2017). A lack of quantification or verbalization of
outcomes means some projects may go unnoticed (Passiment & Linscott, 2014). VBHC
contributes the structure for the identification and measurement of improvement needs (Kaplan
et al., 2014), albeit there is no single set of core metrics universally accepted for the optimal
measurement of value (Carmichael, Jassar, & Nguyen, 2016). While healthcare resources and
attention are focused on compliance with evidence-based guidelines, ambiguity still exists in
new reportable measures for value-based outcomes (Porter, Larsson, & Lee, 2016). Healthcare’s
value paradigm prompts the need for evidence in operational improvements (Gray, 2012) within
the six strategic outcomes - “clinical, financial, process improvement, employee satisfaction,
patient satisfaction, and learning and growth” (Tierney, 2017, p. 223). The monitoring of these
outcomes enhances patient safety and prevents the underuse, overuse, or misuse of health
services (Katz & Baum, 2018).
The importance and urgency of communicating value-based metrics is growing (Tierney,
2017), although many organizations simply do not know where opportunities exist for value
improvement (Porter & Lee, 2016). Laboratorians communicate well with metrics for quality
improvement projects (Bergeron, 2017; Bixho & Melanson, 2017). The Joint Commission
accreditation standards require monitoring of performance metrics for efficiency, timeliness,
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effectiveness, continuity, and safety (Bergeron, 2017). Medicare’s Total Performance Score
measures lie in four domains: clinical care, engagement, safety, and efficiency and cost reduction
(Centers, 2019a), with two scores in each domain, “one for achievement, and one for
improvement” (QualityNet, 2019, par. 2).
Communicating Performance Outcomes.
There are many motives for measuring activities (see Figure 3). Ideally, the metrics for
diagnostic services demonstrate value as the health outcome achieved relative to cost for an
entire episode of care (European, 2017; Sarwar et al., 2015). Few organizations accurately
measure the costs of care or relate quality to cost (Lee et al., 2016). Some hospital administrators
measure ancillary performances based solely on test volumes and cost-to-charge ratios
(Bergeron, 2017). This method leaves unreimbursed value contributions unaccounted for in the
assessment for resource allocations and staffing decisions (Wilson, 2014). Providing actionable
intelligence useful for reengineering processes offers the best opportunity to lower healthcare
costs without sacrificing quality, safety, or outcomes (Kaplan et al., 2014). Assessments of
internal performance are necessary to identify the needed corrective adjustments (Gambel et al.,
2019) and to develop a corresponding measure (Epner, 2016).
Best practices involve establishing baseline metrics prior to interventions and
continuously reporting of project outcomes to leadership (Brown & Falk, 2013). Best practice
activity measures are those proven to communicate consistency in improving quality,
performance, turnaround time, safety, or another positive operating outcome, or lowering costs
(Gambel et al., 2019). Certain pharmacy activities were found to aid in the achievement of a
hospital’s performance metrics (Carmichael et al., 2016) and several papers explore radiology’s
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value (ESR, 2017). Hallworth et al. (2015) discuss that PaLM value demonstrations need further
development for benchmarking improvements and measures of effectiveness.
A performance measure provides a numeric description for analytical performance,
turnaround time, availability, support services, or costs (Schmidt & Ashwood, 2015).
Performance measures across the organization are useful in coordinating and integrating the
activities, services, or functions across operational units (Bergeron, 2017). Balanced measures
ensure that improvements in an area of the organization do not negatively influence other areas
(Burton, 2016). A benchmark assessment is a numeric description used to evaluate or compare a
business goal, target, trend, or performance (Poister, 2003).
Figure 5.
VBHC – Communicating Activities with Metrics

Leadership utilizes metrics to assess, monitor, and respond (Sarwar et al., 2015) (see
Figure 5). Dashboard metrics communicate performance using key performance indicators
(KPIs) (Azadmanjir et al., 2015). KPIs measure the effectiveness of unit resources, quantifying
performance and outcomes (Bergeron, 2017). Department administrators utilize KPIs to monitor
utilization and compliance (Bergeron, 2017). KPIs may relate to finance, productivity, regulatory
compliance, or processes such as turnaround time, down times, wait times, or staffing efficiency
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(Sarwar et al., 2015). Individuals and teams need ongoing performance measures for feedback of
the progress made toward the desired outcomes (Longenecker & Longenecker, 2014). Metrics
allow leadership to determine the degree of adherence to the organization’s mission (Sarwar et
al., 2015). Ensuring standardization in processes requires measurement to enforce compliance
(Batalden & Davidoff, 2007). Process standardizations lead to quality improvements (Green et
al., 2018). Benchmarking the processes compares and evaluates the goals, targets, trends, or
performances from one organization against another (Poister, 2003). Benchmarking of service
quality and customer value depends on the customer’s perspective (Fottler et al., 2002).
Many performance metrics are visible when rolled up into scorecards or dashboards
(Green et al., 2018). The laboratory’s silo-business-management model is evident in that
laboratory performance metrics match like-kind disciplines, rather than capture process
improvements (Plebani, 2016; Price et al., 2016). PaLM leaders, collaborating with enterprise
warehouse analysts, utilize dashboards to monitor, educate, and communicate improvements
(Baird et al., 2018; Ducatman et al., 2018). Laboratory dashboard analytics identify the
opportunities for team collaboration (Gupta et al., 2019).
Communication of Knowledge.
Achieving the goal of a good communication system requires laboratory leaders to be
involved outside of the laboratory (Passiment & Linscott, 2014). Value creation in healthcare
does not occur within specialty silos, but rather in working with teams across the care cycle
(Porter & Lee, 2016). Laboratory leaders demonstrate value when interfacing with other
healthcare professionals (Wagar et al., 2019) and communicating cross-functionally in hospital
meetings (Adelman, 2012). The ability to work collaboratively and effectively across
organizational boundaries enhances influence and builds strong allies with institutional leaders
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(Henricks et al., 2015). Organizational knowledge improves with shared experiences among and
between employees (Nilsson et al., 2018). Interdepartmental communication and collaboration
may be the best way to promote organizational learning (Nilsson et al., 2018). Interdisciplinary
participation improves diagnostic errors (IOM, 2015), as well as inefficiencies and ineffective
processes (Bodenheimer & Smith, 2013; Laposata, 2018b; Raebel et al., 2019). High-performing
healthcare organizations promote multidisciplinary decision-making (Smith et al., 2016). Team
activities provide opportunities to connect with others, thereby promoting learning, knowledge
dissemination, skills enhancement, and employee satisfaction (Carman et al., 2014; Nilsson et
al., 2018). Networking in healthcare aids the exchange of best practices and protocols (Spaulding
et al., 2018). Distribution of knowledge with integration from differing perspectives refines,
updates, and transforms the organization (McFadden et al., 2014). Enhancement of internal skills
and capabilities improves an organization’s competitive advantage (Gambel et al., 2019).
Laboratory leaders ensure skills development when supporting continuous education, networking
with local and national healthcare professional groups (Dickerson et al., 2017), and requiring
adequately credentialed staff (Delost et al., 2009; Lorenz et al., 2018).
Healthcare’s functional structures foster silos, slowing down decision-making and
inhibiting communication (Swayne et al., 2006). Effective communication efforts minimize
knowledge silos that can undermine an organization’s potential (Guo, 2011). Quality
improvement researchers highlight the need to recognize the nested nature of healthcare, and to
understand the nature of relationships (Carman et al., 2014). Successful improvement initiatives
require planning and spreading knowledge throughout the organization, outside the silo of
leadership (Graber, 2017). Siloed planning processes result from poor communication, while a
shared vision creates a strong alignment and common purpose (Austin et al., 2016). The lack of
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collaboration across teams undermines organizational learning and reinforces silence (Adelman
& Stokes, 2012; Nilsson et al., 2018). Silos cause communication and knowledge gaps, requiring
better processes and more technology to overcome (Lord, n.d.).
Value creation in healthcare does not occur in specialty silos, but rather in working teams
across the care cycle (Porter & Lee, 2016). Hospital units could benefit from the knowledge of
other units (like the laboratory) with more awareness of other’s activities (IOM, 2013).
Communicating improvement activities demonstrates the efforts to transform operations (Fusch
& Gillespie, 2012).
Communication of Value with Scholarly Evidence.
Evidence-based research is an important, yet an underappreciated aspect of PaLM value
(Price & St. John, 2014; Schmidt & Ashwood, 2015). Laboratory authors contribute scholarly
evidence, e.g., personalized healthcare, cost effectiveness (Leibach, 2014), utilization and
operational improvements (Delvin, 2017; Hauser & Shirts, 2014), new technology
implementations (Delvin, 2017; Tan et al., 2017), and patient case studies (Nadder et al., 2018).
Evidence-based research curriculums are incorporated into CLS undergraduate programs
(Landin, 2013). Incidentally, only 20% of the published laboratory utilization studies are
authored by pathologists (Hauser & Shirts, 2014). MLS typically engage in scholarly activities
relative to performance improvement, rather than clinical research (Laudicinia et al., 2011).
Surveys in 2011 showed that 32% MLS performed applied, clinical, or educational research,
although only 18% of surveyed participants were required to do so as a condition of employment
(Laudicinia et al., 2011). Pathologists and laboratory scientists publish articles in journals such as
the Archives of Pathology and Laboratory Medicine (2019), the American Society for Clinical
Laboratory Science (2017), the American Journal of Clinical Pathology (2018), the Clinical

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

54

Leadership & Management Review (n.d.), the American Society for Microbiology Journals
(2019), and the Journal of Applied Laboratory Medicine (2019). According to a 2010-2014
citation analysis the Clinical Laboratory Science journal is the most frequently cited (Delwiche,
2016). Schreiber & Giustini (2019) recommend that pathologists and MLS familiarize
themselves with the h-index used by university researchers as an evaluation of authorship for
professional advancement.
Communication Barriers.
Communication in healthcare is a challenge, requiring ongoing attention, with new and
varied approaches (Adelman, 2012). Effective communicators must overcome barriers “to
engage in more meaningful and successful communication” (Guo, 2011, p. 72). Effective
communication does not happen automatically (Gardner & Winder, 1998). Communication
effectiveness depends on the format (Guo, 2011), delivery (Gardner & Winder, 1998), and
organizational structure (Passiment & Linscott, 2014; Adelman, 2012).
The alternative interests of administrators may act as a barrier to receiving upward
communication messages (Guo, 2011). Information overload (Communication, 2016; Gardner &
Winder, 1998) and a lack of interest or focus (Guo, 2011; Karuppan et al., 2016) hinder effective
listening. Information overload results in selective screening and discarding of information
(Gardner & Winder, 1998). Details are better remembered when the receiver is interested in the
topic (Karuppan et al., 2016).
Organizational charts define the intended communication channels (Passiment &
Linscott, 2014), although hierarchy inherently filters information (Adelman, 2012; Tourish &
Robson, 2004). Power or status can affect the transmission of a message (Guo, 2011). PaLM’s
hierarchical and sub-disciplines may not always be conducive to information flow (Passiment &
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Linscott, 2014). For the scientific personality type, communication does not come easily, nor is
communication routinely addressed in academic science curricula (Passiment & Linscott, 2014).
Communication difficulties within organizational hierarchies require an understanding manager
with excellent people skills.
Successful improvement initiatives require a communication plan for spreading
knowledge throughout the organization (Graber, 2017). Change inevitably results in at least
some level of cognitive dissonance, thus communication should be proactive and intentional to
mitigate resistance (Ryan, 2018). Organizational change requires enough communication with
strong advocacy to overcome internal inertia; yet, too frequent or too strong of communication
has negative effects (Bel, Smirnov, & Wait, 2018).
Themes and Perceptions Tables
Table 1.
PaLM’s Value Chain
PaLM topics

Discussion points

PaLM roles &
knowledge sharing

Roles for laboratorians are changing (Laposata, 2018; Lippi &
Mattiuzzi, 2019; Nadder, 2013; Rutgers, 2017; Wilson, 2015). PaLM
leaders have failed to connect PaLM VBAs with the broader valuebased strategy (Dixon, 2019). Good hospital communication systems
require involvement of laboratorians outside the laboratory (Passiment
& Linscott, 2014) with multidisciplinary teams (IOM, 2015; Wagar et
al., 2019), serving on committees (Wilson, 2014), offering consultation
(Davis et al., 2018; Fydryszewski, 2019; Laposata, 2018), and
interacting with physicians and nurses (Unsworth & Lock, 2013;
Wagar et al., 2019). Existing reimbursement structures disincentivize
hospital-based pathologists from participating outside the laboratory
(Hendricks et al., 2015; Laposata, 2018). Collaboration across
boundaries enhances influence (Henricks et al., 2015) and
organizational knowledge (McFadden, 2014; Nilsson et al., 2018).
Laboratory professionals networking exchanges best practices
(Dickerson et al., 2017; Spaulding et al., 2018). Credentialing ensures
skills enhancement (Delost et al., 2009)
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PaLM competitive
value & customer
service

Improving core competencies enhances value (Fottler et al., 2002;
Gambel et al., 2019; Kratz & Laposata, 2002). Continuing education,
networking, and requiring credentialed staff improve skills (Delost et
al., 2009; Dickerson et al., 2017). Laboratory professionals offer
clinical consultation (COLA, 2015), providing expertise on care teams,
tumor boards, and infection prevention committees (Davis et al., 2018).
Laboratory expertise improves test utilization, antibiotic stewardship,
and transfusion management (Davis et al., 2018; Morgan et al., 2017;
CCCLW, 2016) and reduces diagnostic error, and avoids unnecessary
testing (ASCLS, 2018), improves patient outcomes, reduce infections,
increase patient throughput (Gupta et al., 2019). Laboratorians
communicate results, clarify interpretations, and liaise with clinicians
(Unsworth & Lock, 2013; Wagar et al., 2019). Laboratorians, as
knowledge brokers, disseminate information (Price & St. John, 2014)
from research into practice (Birken et al., 2018; Thompson & Barcott,
2019), improving skills and methods (Lewandrowski et al., 2018;
Grove et al., 2019), transferring knowledge between and across the
system (Puddy & Hall, 2017). Dialog with laboratory professionals
educates all parties (Baird et al., 2018) and improves the organization’s
competitive value (COLA, 2015). Laboratorians providing knowledgebased services improve competitive value (COLA, 2015), educate
clinicians (Process Improvement, 2017), and enforce compliance. Interdisciplinary activities allow for knowledge sharing, and improve skills
and capabilities (Kim et al., 2012; Nilsson et al., 2018). Team efforts,
research projects, consultations add value (COLA, 2015; Davis et al.,
2018; Fydryszewski, 2019; Wagar et al., 2019), which improve
organizational performance (CCCLW, 2016; Davis et al., 2018;
Morgan et al., 2017). Lab leaders improve test selection, utilization,
interpretation, diagnostic and errors (ASCLS, 2018)

PaLM utilization,
efficiency, &
effectiveness

Interdisciplinary participation improves diagnostic errors,
inefficiencies, and ineffectiveness (Bodenheimer & Smith, 2013; IOM,
2015; Raebel et al., 2019). Government payor arbitrary cuts on lab
services lack consideration of medical necessity, harming patient
outcomes (Wilson, 2015; Halstead et al., 2018; Porter et al., 2017).
Demand management and utilization strategies more effectively reduce
costs (Lewandrowski et al., 2017; Wilson, 2015). Reengineering
processes lowers costs without sacrificing quality, safety or outcomes
(Kaplan et al., 2014). Productivity improves by eliminating duplication
of services and delays (Inal et al., 2018; Krintus et al., 2017). Efficient
organizations focus on operations (Schwartz & Pearson, 2013),
improve processes, complications, time (Davis et al., 2018; Inal et al.,
2018; Schmidt et al., 2016; Worster et al., 2017;), and develop
continuous improvement cultures (Hallworth et al., 2015). Effective
organizations adopt best practices (Srivastava & Sushil, 2018) and a
culture of learning (Swayne et al., 2006) to optimize outcomes
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(Glanzman,2017; Hallworth et al., 2015).
PaLM cost savings Cost effectiveness improves with operational efficiency and competent
management (COLA, 2015). Laboratory cost savings may occur as cost
effectiveness, cost containment (COLA, 2015), or operational
efficiency (COLA, 2015; Hallworth et al., 2015; Schmidt et al., 2016).
PaLM reduces costs by implementing utilization strategies
(Lewandrowski et al., 2017), pricing and reimbursement assessments,
stewardship programs, and consultations (Birken et al., 2018; COLA,
2015; Halstead et al., 2018). Other strategies for lowing costs include
mergers (Knowles & Barnes, 2013), integrations, improvements in
operational efficiencies (COLA, 2015), processes, productivity,
utilization (Niemeijer et al., 2011), and quality (Kim et al., 2012) and
contractual relationships (Harrison et al., 2017; Schwartz& Pearson,
2013). Competent PaLM managers reduce costs with market
assessments (Bergeron, 2017; Downs & McMinn, 2017), and analysis
of acquisition costs (Bergeron, 2017), and ROI. PaLM leaders improve
the total cost of care (Passiment & Linscott, 2014).
PaLM testing
quality & data

Standardizations improve quality (Green et al., 2018). Laboratory’s
people assets contribute high-quality necessary for the diagnosis,
prognosis, treatment, and management of human disease (Anonychuk
et al., 2012; Davis et al., 2018). The analytical dimension of
laboratories is the best performing sector of healthcare (Hawkins,
2012). Laboratory test results offer value (Collinson, 2017; Nam, 2015;
Price & St. John, 2014; Schmidt et al., 2016). Value is found in the
testing quality performance (Hawkins, 2012; IOM, 2015; Plebani &
EFLM, 2017; Schmidt & Ashwood, 2015), and the cumulative testing
data (Kroft et al., 2018; Wagar et al., 2019) to benefit the healthcare
system (Gross et al., 2019; Nadder et al., 2018; Swanson et al., 2018).
PaLM data educates providers (Wagar et al., 2019), generates the data
for clinical knowledge (Xu et al., 2015) necessary to improve patient
care efficiency and outcomes (Shirts et al., 2015) and to identify at risk
populations and comorbidities (Gross et al., 2019).

Table 2.
PaLM Leaders and stakeholders
PaLM topics

Discussion points
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A value proposition considers stakeholder’s needs and expectations
(Austin et al., 2016; Karuppan et al., 2016; Price et al., 2016). Cost
improvement strategies need stakeholder buy-in (Henderson-Carter,
2014) to maximum performance (Longenecker & Longenecker, 2014).
VBHC requires stake-holder engagement (Carman et al., 2014; Smith
et al., 2016), stakeholder alignment, development new roles and
technology, and patient inclusion (Glanzman, 2017). The
organizational ecosystem consists of the internal staff, interfaces, and
external stakeholders as a network of governance (Pfannstiel & Rasche,
2017; Swayne et al., 2006). All healthcare stakeholders agree that costs
are high, and outcomes need improved, but what is valued and who is
responsible remains debatable (University of Utah, 2017). The best
value is a shared benefit (Austin et al., 2016; Pennestri & Banfi, 2019;
Porter 2010).

PaLM stakeholders PaLM stakeholders include administrators, patients, the government
and other insurance payers, suppliers, test manufacturers (Price et al.,
2016; Wolcott et al., 2009), and ordering providers (Schmidt et al.,
2016). PaLM leaders assess provider and patient satisfaction (CAP,
2014; Hawkins, 2012). Providers act on test results (Schmidt et al.,
2016), value timely and precise results (Abdallah, 2014; Inal et al.,
2018; Jones, 2009; McCall et al., 2016) and are satisfied with PaLM
quality, reliability, courtesy, test menu adequacy, and results reporting
(Jones et al., 2009; McCall, 2016; Nakhleh et al., 2008). Clinicians
desire improvements in specimen collection and delivery processes
(Koh et al., 2014), and ease of use in computer order entry (McCall et
al., 2016). Patients desire more information for ambiguous results with
next steps instructions (Kelman et al., 2016; Poczter & Giugliano,
2014), and feel empowered with face-to-face consultations (Booth et
al., 2018). Patients desire convenient locations and limited wait times
(Karuppan et al., 2016).
Hospital
administrator’s
concerns

Administrators are still discovering responses for VBHC initiatives
(DeMarco et al., 2016; Spaulding et al., 2018). Hospital administrators
focus on many things including quality, safety, efficiency, personnel,
cost reductions (ACHE, 2019; Green et al., 2018; Newman, 2018),
government mandates, accreditation, financial incentives, and
measurable factors (Tierney, 2017; Tinker, 2018). Top improvement
areas include clinical, financial, processes, patient and employee
satisfaction, and learning and growth (ACHE, 2019; Tierney, 2017).
CEOs acknowledge that improvement initiatives help achieve lower
cost and better outcomes (Cosgrove et al., 2012). Administrators set
goals and objectives, allocate resources, and evaluate performance
(Kaplan et al., 2014; Kim et al., 2012). Administrators are responsible
for communicating change (Salahshor, 2016), especially when
implementing cost control and resource allocations (Madden, 2015).
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Administrators use leadership skills to engage others (Salahshor, 2016)
and manage change (Liang et al., 2013). Administrators seek value in
laboratory’s interactions with the rest of the health system (Schmidt et
al., 2016) and need to ensure the necessary partnerships for the
laboratory (Warren, 2013). Administrators seeking to improve quality
and decrease costs ideally include pathologists (Misialek, 2014) and
laboratory management.
Stakeholders
undervalue PaLM
services

Medical laboratorians are underappreciated (Jordan et al., 2015) and
overlooked (Downs & McMinn, 2017; Shrinkman, 2016). Hospital
administrators lack an understanding of PaLM VBAs (Branda et al.,
2014; Lewandrowski, 2017; Protzman et al., 2015). The paucity of
evidence demonstrating PaLM’s impact on healthcare cost and
outcomes contributes to the under-recognition of services (Anonychuk
et al., 2012). The people assets of laboratories are often undervalued
(Epner, 2017; Garcia et al., 2019; Tulsi, 2019), under-paid, and
underappreciated (Garcia et al., 2019; CCCLW, 2018; ASCLS, 2018).
Appreciation and wage equivalence is necessary to resolve recruitment
and retention issues among laboratorians (CCCLW, 2018; ASCLS,
2018). Hospital leaders that fail to recognize PaLM’s value (Gross et
al., 2019) may consider outsourcing laboratory services (Crawford et
al., 2017; Downs & McMinn, 2017; Futrell, 2013; Mrak et al., 2018)
cutting personnel, or lowering required educational standards (Epner,
2017). Outsourcing tests could improve costs but risk many negative
implications (Ferraro & Panteghini, 2017; Lippi & Mattiuzzi, 2019;
Rogers et al., 2019; Terese, 2019; Weinert et al., 2015;). Competent lab
management weighs sourcing decisions (Weinert et al., 2015).

Table 3.
Effective Communications, Challenges, and Barriers
PaLM topics

Discussion points

VBHC strategies

VBHC implementation requires internal alignment of the business units
and effective communication (Fry & Baum, 2016; Wagar et al., 2019)
with an intentional leadership agenda (Berwick & Hackbarth, 2012).
VBHC strategies involve improving processes and outcomes, while
reducing costs (DeMarco, 2016; Porter et al., 2017). Value increases
with lower costs, improvements in quality and services, and surpassing
rival capabilities (Gambel et al., 2019). VBHC strategies require
commitment to reducing waste, improving outcomes, and saving costs
(Berwick et al., 2008; IOM, 2013). VBHC requires research (Raman,
2014) and a communication plan (Fry & Baum, 2016). Strong
communication systems improve safety (IOM, 2015). The changes
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involved with VBHC require strong advocacy with adequate, effective
communication (Bel et al., 2018; Guo, 2011; Ryan, 2018), and an
alignment of leadership at all levels (Austin et al., 2016; Fry & Baum,
2016). High-impact communications influence policy formulation and
outcomes (Kerns, 2016). The challenges with VBHC implementations
should not be underestimated (AHA, 2017; Chatfield et al., 2017;
Delmatoff & Lazarus, 2017; Porter & Lee, 2016). The need to
communicate is consistently underestimated (Austin et al., 2016;
Kridelbaugh, 2018).
Effective
Effective communication improves organizational outcomes (Otto,
communication and 2017). Transformation is a team effort (Chatfield et al., 2017). VBHC
teamwork
requires effective communication, clear objectives, strong stakeholder
relationships, and performance improvement incentives (Lemire et al.,
2013). Teams create value (Porter & Lee, 2016), although the nature of
healthcare is nested (Carman et al., 2014). Multi-disciplinary activities
increase awareness (IOM, 2013), draw upon organizational knowledge
(Raebel et al., 2019), and promote learning and communication (Nilsson
et al., 2018). Silo planning results in poor communication (Austin et al.,
2016), while a shared vision strengthens alignment and purpose (Austin
et al., 2016; Graber, 2017). Collaborative work crosses boundaries and
builds allies (Hendricks et al., 2015). Team activities connect others
promoting interdepartmental communication, collaboration, and
organizational learning (Carman et al., 2014; Nilsson et al., 2017), social
connection, knowledge and skills dissemination, and job satisfaction
(Carman et al., 2014; Nilsson et al., 2018;) updating the organization
(McFadden et al., 2014).
Integrated systems Communication networks, team efforts, and better staff satisfaction
and communication (Beckett & Kipnis, 2009) help integrated systems to score higher on
VBHC performance metrics. Health systems demonstrate better
organizational learning and efficiencies with change management.
Networking exchanges best practices and protocols (Spaulding et al.,
2018). High-performing organizations promote multidisciplinary
decision-making (Smith et al., 2016).
Challenges to
effective
communication

Communication is a challenge (Adelman, 2012). Ineffective
communication among service-oriented managers is frequent (Kerns,
2016). Inadequate communication from laboratory leaders is an
identified quality gap (Wagar et al., 2013; Weiss et al., 2011), resulting
in a failure to connect VBAs to strategic imperatives (Dixon, 2019).
Decisions made without input from lower ranks disrupt the organization
(Kauppila et al., 2017). Communication mitigates resistance (Ryan,
2018), overcomes inertia (Bel et al., 2018), and provides two-way
clarification for change initiatives to avoid problems and produce
superior outcomes (Gardner & Winder, 1998; Longenecker &
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Longenecker, 2014).
Communication
barriers

Effective communication is not automatic (Gardner & Winder, 1998) or
easy (Passiment & Linscott, 2014) and requires overcoming barriers
(Guo, 2011). Communication effectiveness is influenced by the format
(Guo, 2011), the delivery (Gardner & Winder, 1998), organizational
structure (Adleman, 2012; Passiment & Linscott, 2014; Tourish &
Robson, 2004), and hierarchy (Aldeman, 2012; Passiment & Linscott,
2014). Effective listening is hindered by alternative interests (Guo,
2011), current focus (Karuppan et al., 2016), and/or information
overload (Gardner & Winder, 1998; Communication, 2016). Politics,
reward systems, and coercive powers negatively affect communication
(Kumar & Mishra, 2017). Negative information is suppressed (Tourish
& Robson, 2004), especially in a culture of blame or a lack of
responsiveness (Ahmed, 2019). Upward communication is hindered by
lower-level education and/or experience (Adelman & Stokes, 2012;
Bennett, 1968). Communication is slowed down and inhibited in silos
(Swayne et al., 2006).

Table 4.
Communication and Healthcare Administrators
PaLM topics

Discussion points

Communication
and the hospital
administrator

Leaders define and communicate the purpose (IOM, 2001). Top-down
communication must be frequent, understandable, and in multiple ways
(Salahshor, 2016). Top-down communication is disadvantageous for
communicating change, importance, functional roles, and efforts
needed to achieve outcomes (Longenecker & Longenecker, 2014). The
CEO plays a key role in fostering upward communication with
genuineness, visibility, and approachability (Adelman, 2012; Ashford
et al., 2009). Administrators must tap department knowledge to
improve organizational deficiencies (Adelman & Stokes, 2012;
Salahshor, 2016). Frontline intelligence improves hospital safety,
engagement, and other areas of vulnerability (Wolpaw et al., 2018).
Input from below increases and broadens the information available for
decision-making (Ashford et al., 2009).
Meaningful C-Suite communication requires understanding the mission
and the money (Agovino, 2019). Executives focus on total performance
scores in the clinical domains, safety, engagement, efficiency and cost
reductions (Centers, 2019a). Healthcare administrators prefer concise,
relevant information (Communication, 2016), with details of time, cost,
and efforts (Øvretveit, 2009). Upward communication keeps the
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administrator informed of accomplishments (Kridelbaugh, 2018)
department results, projects, and recommendations (Alder et al., 2019).
Communication
and the laboratory
leader

Some administrators measure ancillary services solely on test volume
and cost (Bergeron, 2017) missing unreimbursed activities (Wilson,
2014). Laboratory leaders need a concerted effort to keep senior
management informed of developments and accomplishments
(Kridelbaugh, 2018). The responsibility to improve upward
communication falls on managers (Alder et al., 2019) to establish
favorable and constructive interfaces (Lippi & Mattiuzzi, 2019).
Leaders ensure bidirectional stakeholder communication, oversee
change and feed-back (Passiment & Linscott, 2014; Ryan, 2018),
influence resistance (Protzman et al., 2015), and build rapport and
credibility (Communication, 2016). Leaders define and communicate
the purpose and establish the necessary teams to create value (IOM,
2001). Pathologists play a major role in performance improvement and
development of the value proposition (Wood, 2016). The nonpathologist laboratorian plays a role promoting patient safety and
quality of care (Kim et al., 2011). DCLSs and MLSs lead VBAs and
communicate with clinical expertise (Laposata, 2018; Nadder et al.,
2018; University of Texas, 2017; Rutgers, 2017; University of Kansas,
2018). Skills for communicating can be improved (Otto, 2017).
Management is responsible for educating and training personnel,
improve verbal skills and knowledge and encourage staff to participate
outside the laboratory (Passiment & Linscott, 2014). Communications
in all forms convey the laboratory’s image, whose professional identity
needs further exploration (Passiment & Linscott, 2014).

PaLM
communications

Proactive communication is a quality gap (Dixon, 2019; Wagar et al.,
2013), necessary for conflict resolution (D’Andreamatteo et al., 2015),
change management (Graber, 2017), culture and climate shaping
(Birken et al., 2018; Kim et al., 2011; Glavas & Goodwin, 2013), and
organizational knowledge sharing (Nilsson et al., 2018; Birken et al.,
2018). Leadership plays an essential role in communication and
improvement activities (COLA, 2015; Kridelbaugh, 2018; McFadden et
al., 2014; Otto, 2017) shaping behaviors (Boland et al., 2017; Glavas &
Goodwin, 2013; Henderson-Carter, 2014). The pathologist needs
communication skills to influence decisions and to interface outside the
laboratory (Wagar et al., 2019) and to improve the laboratory’s value
proposition (Wood, 2016). Laboratory leaders interfacing with others
demonstrate value when communicating cross-functionally (Adelman,
2012; Wagar et al., 2019). Laboratory managers need favorable and
constructive interfaces with hospital administrators (Lippi & Mattiuzzi,
2019).

Benefits of

Upward communications provide status updates or improvement
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suggestions (Alder et al., 2019). Input from below increases and
broadens information available to decision-makers (Ashford et al.,
2009). Demonstrations of improvement activities and cost savings gain
political support (Øvretveit, 2009). Well-performed presentations
establish credibility (Weinholdt, 2006).

Table 5.
Communicating Value – Performance, Metrics, Costs
PaLM topics

Discussion points

Communicating
performance
improvements

VBHC triggers the need for improvements in processes and outcomes
(Gray, 2012; Kaplan et al., 2014; Nilsson et al., 2017; Tierney, 2017).
Communicating VBAs demonstrates transformational efforts (Fusch &
Gillespie, 2012). Assessments fuel improvements (Gambel et al., 2019;
Kaplan et al., 2014) and discover current state gaps (Gupta et al., 2019;
Pynes & Lombardi, 2011). Benchmarking evaluates and compares
(Poister, 2003) across industries (Gambel et al., 2019). Metrics assess,
manage, and help the leadership respond (Sarwar et al., 2015), as well
as gauge improvement outcomes (Burton, 2016). Baseline metrics
show prior improvement states for monitoring continuous efforts
(Brown & Falk, 2013). Performance measures provide a numeric
description (Schmidt & Ashwood, 2015) for coordinating hospital units
(Bergeron, 2017). Balanced measures monitor cross-unit influential
changes (Burton, 2016). Success reports offer a communication tool
(Hartland, 2018). Promotional materials offer marketing collateral
(Kridelbaugh, 2018).

Communicating
with metrics

Performance metrics roll up into dashboards or scorecards (Green et
al., 2018) for communicating KPIs (Azadmanjir et al., 2015; Bergeron,
2017; Burton, 2016), monitoring compliance, utilization, service line
integration, or operational functions (Bergeron, 2017). Laboratories
tend to benchmark with like-kind disciplines rather than performance
improvements (Plebani, 2016: Price et al., 2016). PaLM leaders
collaborate on dashboard analytics (Baird et al., 2018; Ducatman et al.,
2018).

VBHC metrics

Value based metrics in healthcare are expanding (Tierney, 2017). TPS
measures four domains: clinical care, engagement, safety, and
efficiency plus cost reduction (Centers, 2019a; Quality Net, 2019). The
Joint Commission monitors metrics for efficiency, timeliness,
effectiveness, continuity, and safety (Bergeron, 2017). Providers track
processes, wait times, productivity, and financial measures (Larsson &
Tollman, 2017). Best practice measures are those proven to
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communicate consistency in cost reductions, or improvements in
quality, performance, TAT, safety, or another operating outcome
(Gambel et al., 2019). Radar charts communicate outcomes with cost of
care (Thaker et al., 2016). ROI communicates financial and value
advantages (Green et al., 2018; Henderson-Carter, 2014). Spreadsheets
communicate changes and benefits (BaseCase, 2012); SBAR
communicates problems and solutions (Marder, 2018).
Demonstrating cost GPO reports evaluate utilization and costs (Maul et al., 2019). Vendors
savings
assist laboratorians with operational research for implementations
(Epner et al., 2017). Lab data provides evidence of new methods,
instrument comparisons, and clinical practices changes that affect
reimbursements and outcomes (Davis et al., 2018; Landin, 2013). More
published research from PaLM is needed (Davis et al., 2018; Delvin,
2017; Epner et al., 2017; Landin, 2013). TDABC isolates true costs
(Kaplan et al., 2014), demonstrating reliable cost-savings opportunities
(Etges-Eng et al., 2020). TDABC is the gold standard in measuring
healthcare’s true costs (HBS, n.d.)
Summary of the Literature Review
VBHC strategies require identification of improvement opportunities in processes,
outcomes, and costs (IOM, 2013; Porter et al., 2017). Implementation of an effective value-based
strategy requires linking internal business unit activities to organizational objectives (Bryson,
2018; Gambel et al., 2019). PaLM leadership has failed to link value-based initiatives to the
strategic imperatives of the broader organization (Dixon, 2019). Recognition of PaLM’s value
contributions is critical for achieving a successful evidence-based health policy (Misialek, 2014).
Clinical diagnostics is underappreciated (Beastall, 2013; Jordan et al., 2015) and
overlooked by hospital administrators (Downs & McMinn, 2017; Shrinkman, 2016). Hospital
administrators and non-pathology physicians remain unaware of the scope of activities and roles
within laboratory medicine (Branda et al., 2014; Lippi & Plebani, 2017). Laboratory leaders need
a communication strategy (Passiment & Linscott, 2014) that demonstrates the value associated
with PaLM efforts to improve costs (Halstead et al., 2018; Price et al., 2016), efficiencies, and
outcomes (Kaushik et al., 2018; Schmidt & Ashwood, 2015). An effective communication
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strategy requires a credibly perceived information source, competent communicators, and a
clearly defined message (Gardner & Winder, 1998). Laboratory leaders need to encourage
communication on the efforts to improve processes and minimize costs (Sikaris, 2018).
Pathologists need to champion the communication of value to hospital administrators (Gross et
al., 2019).
The mastery and orchestration of value-chain activities, along with core capabilities and
availability of resources, strengthens a value-proposition (Pfannstiel & Rasche, 2017).
Assessment within the value-chain identifies the VBAs of individual healthcare units (Swayne et
al., 2014; Carman et al., 2014) and the services necessary to optimize the value delivery to the
patient (Tierney, 2017). Identification of VBAs provides the information needed to re-engineer
workflows and improve service delivery (Boland et al., 2017). An internal audit of a business
unit’s capabilities and deficiencies provides an assessment for leveraging resource capabilities
and a clear understanding of strengths and weaknesses (Karuppan, Dunlap, & Waldrum, 2016).
Linking internal improvement initiatives to an organization’s broader objectives provides
decision makers with an understanding of the value contributions and aligns the organization
(Bryson, 2018; Carman et al., 2014).
Summary of Section 1 and Transition
Effective messaging requires constructing information around the interests of the receiver
(Gardner & Winder, 1998). Effective communication with hospital administrators making
strategic decisions requires a communication plan (Graber, 2017). Effective messaging to the
laboratory’s stakeholders is necessary for optimizing improvement initiatives (see Figure 4).
While process improvement activities can enhance communication efforts (Carman et al., 2014;
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Fusch & Gillespie, 2012), siloed planning inhibits communication and slows down decisionmaking (Swayne et al., 2006).
Understanding and communicating PaLM VBAs is vital, especially as hospital
reimbursements now require proof of improved performance (Centers, 2019a; QualityNet, 2019).
Effective demonstrations of value from PaLM leaders may justify the laboratory’s share of a
value-based payment (Dixon, 2019). Communication of initiatives demonstrates transformational
efforts (Fusch & Gillespie, 2012), as well as the value associated with those making the
transformation happen, i.e., healthcare’s people assets (Tulsi, 2019).
Section 2: The Project
The focus of this applied business study was the significant problem of the failure of
laboratory leadership to communicate PaLM VBAs to healthcare administrators, resulting in lost
opportunities to demonstrate cost savings. Hospital case selections were made based on care
type, service offerings, and CMS star ratings. Interviews were conducted with hospital-based
administrators and PaLM leaders knowledgeable of VBAs to gain a better understanding of the
demonstrations of improvement activities. Research questions were answered by collecting data
from audio recorded semi-structured interviews that were transcribed and coded (Stake, 2010). A
thematic analysis approach was utilized with the NVivo application to support the examination
of the interview data. The Robbins et al. (1994) model of communication provided guidance for
analyzing communication efforts, including the importance of feedback. The mVCM offered
insight into analyzing PaLM’s value-chain activities.
Purpose Statement
The purpose of this qualitative case study is to add to the body of knowledge by
exploring laboratory leadership’s communication of VBAs to hospital administrators. This larger
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problem was explored through interviews with acute care hospital administrators and laboratory
leaders to discover if and how value-based initiatives are communicated. Laboratory leadership
may use this information to improve communication strategies for value-based initiatives.
Communicating value requires research and a well thought plan (Raman, 2014). A concerted
effort by laboratory leadership is required to keep senior management informed of recent
developments and accomplishments (Kridelbaugh, 2018), and to align initiatives with
organizational objectives and strategy (Karuppan et al., 2016; Passiment & Linscott, 2014).
Hospital administrators can use this information to gain further insight into the value
contributions of PaLM services and ensure implementation of cost savings measures. VBHC
strategies necessitate the identification of improvement opportunities (IOM, 2013).
Implementation success requires a clear communication plan and an alignment of leadership (Fry
& Baum, 2016). Successful strategies link internal business unit activities with broader
organizational objectives (Bryson, 2018; Gambel et al., 2019). Optimal success requires an
alignment at all levels of the organization for better understanding, acceptance, and support of
the value proposition (Austin et al., 2016).
Value must increase for the overall cost of care to decrease (Kaplan et al., 2014). VBHC
delivery requires reducing costs and improving processes without sacrificing outcomes (Porter,
Kaplan, & Frigo, 2017). Value increases with lower costs, improved quality and services, and
enhanced capabilities (Gambel et al., 2019). Certain PaLM activities demonstrate value by
directly improving costs (Halstead et al., 2018; Price et al., 2016), while others improve
efficiency, quality, or skills (Kushik et al., 2018; Lewandrowski et al., 2018; Schmidt &
Ashwood, 2015). The literature remains sparse regarding the value contributions of laboratories,
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which are under recognized as an essential care component (Davis et al., 2018), and requires a
broader perspective assessment (Anonychuk et al., 2012).
Role of the Researcher
The role of a researcher is to present objective research and prevent biases by attempting
to control the research design for validity, credibility, and reliability, despite philosophical
assumptions (Baxter & Jack, 2008; Burns & Grove, 2007). Qualitative research involves gaining
access to a site and permission to collect data (Creswell & Poth, 2018). The role of the researcher
in this study was to identify multiple hospital sites with variability factors; evaluate publicly
available information for each site; and initiate contact with the site’s laboratory leadership and
hospital administrator. Interviews were conducted with selected voluntary participants using the
interview protocol. The goal was to interview at least one hospital administrator, preferably the
CEO or other C-suite representative, and two laboratory leaders at each of the three hospital
sites. Audio-recorded interviews were conducted with voluntary participants, documenting the
setting, and transcribing the interviews. Case-study protocols were closely followed for
collecting, sorting, and analyzing the data. Adequate detail was gathered to enhance the overall
quality and trustworthiness of the study (Baxter & Jack, 2008). The data were analyzed from
each case using a cross case analysis and the evidence was correlated with the literature (Stake,
2006).
I was responsible for formally soliciting volunteerism, acquiring the informed consent
from all participants, alerting participants to the nature of the study (Yin, 2018). Interviews were
scheduled catering to the interviewee’s availability with an understanding that unanticipated
events could change their availability (Yin, 2018). It was important to become an observer when
entering the world of the participant, maintaining constraint and respectfulness (Yin, 2018). Each
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participant read and signed the informed consent and assurance of confidentiality form (see
appendix A). The IRB of Liberty University authorized this study.
Research Methodology
Qualitative inquiry designs of narrative, phenomenology, and ethnography, involve
themes from interview data, yet are more appropriate for capturing the rich details of stories,
describing the essence of a lived experience, or focusing on a culture exploring issues, beliefs, or
behaviors (Creswell & Poth, 2018). Two qualitative study designs offer applicability for this
research, grounded theory and case study. Grounded theory applies to this study, since no
explanation or understanding in the literature exists (Creswell & Poth, 2018) regarding the
communication of laboratory VBAs, other than analytical testing and performance. The
grounded theory design allows new theories to emerge in data collections within healthcare
settings (Astalin, 2013; Butina et al., 2015; McCrae & Purssell, 2016). However, Creswell and
Poth (2018) recommended that grounded theory studies need 20 to 60 individual interviews, with
clarifying re-interviews, which are not feasible due to the time constraints.
Quantitative study designs include descriptive (nonexperimental), correlational
(experimental), and casual comparative (quasi experimental) (Drummond & Murphy-Reyes,
2018). Quantitative research permits an accurate assessment of cause-and-effect relationships
between variables or seeks an explanation from the causal relationships or variable correlations
for prediction, generalization, or explanation (Creswell, 2013). A quantitative design was not
applicable for this study, as cause-and-effect was not the intent of this research. The mixedmethod study is perhaps the most comprehensive design by expanding inquiry and strengthening
conclusions, yet remaining flexible (Tashakkori & Creswell, 2007). Palinkas et al. (2015) noted
the preferable design is the mixed-method for healthcare research due to the complexities
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involved with implementing evidence-based practices and programs. However, as a novice
researcher the management of the dual methods is too difficult (Creswell, 2013).
Discussion of the Case Study
The method for this research was the qualitative multi-case study targeting the
phenomenon of the communication of PaLM VBAs. The qualitative case study is the design of
choice when the problem is poorly understood and needs inductive (data driven) research for a
better understanding (Simon, 2011). Case study research aids in an understanding of a simple or
complex situation by asking how and why type questions, while considering the context of the
situation (Baxter, & Jack, 2008; Yin, 2014) and exploring the processes or activities (Creswell,
2013). A common example of a multiple-case study involves hospitals, where each hospital
represents a single-case (Yin, 2018).
Discussion of Flexible Design
The case study design permits an exploration of programs, events, processes, or activities
(Creswell, 2013). Although a single case may yield invaluable insight, the multi-case study is
stronger (Yin, 2018). Stake (2006) describes the multi-case design as a collective study,
primarily concerned with the quintain or the phenomenon, rather than the individual case.
Multiple cases in this study increase the robustness of the research (Hogan et al., 2018; Long &
Hollin, 1995). The multi-case study requires gathering data and describing situations to gain a
deep understanding of the phenomenon (Leedy & Ormrod, 2015). The collective nature of a
multi-case hospital study allows for exploration of the quintain, underlying principles, and
identification of commonality across multiple sites (Baxter & Jack, 2008). In a cross-case
analysis, the research makes assertions from the evidence of each case, showing either
uniformity (agreement) or disparity (non-agreement) across the cases (Stake, 2006). The
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collective case study design is appropriate for this contemporary issue that involves several
laboratories across multiple sites (Creswell & Poth, 2018).
Summary of Research Methodology
A multi-case design guided the examination of the communication of laboratory leaders
with hospital administrators in different environments (Stake, 2006) with an analysis of each
case. This multi-case study provided an opportunity to gain insight into each case by audio
recording interview responses from participants. This qualitative multi-case case study was
designed to investigate the communication and messaging effectiveness allowing for descriptive
accounts from multiple perspectives with generalizable results (Creswell & Poth, 2018; Stake,
2006). The case study design provides an in-depth analysis of multiple cases, using the logic of
replication in inquiry procedures for each case (Yin, 2014). While the entire study is one case
involving the exploration of the communication of VBAs, the boundaries of the multiple
participant cases were defined (Yin, 2014).
Participants
Participants were limited to the hospital administrators and laboratory leaders able to
supply the necessary information on communicating VBAs by participating in interviews
(Creswell & Poth, 2018; Yin, 2014). The solicitation of voluntary participants began by seeking
interviews with hospital administrators and laboratory leaders from the purposively selected
acute care hospitals. Attempts were made to make initial contact via professional networking
sites, targeting identified hospital executives and laboratory leaders, offering information about
the study, and requesting voluntary participation. Subsequent recruitment attempts were sent via
e-mails to potential hospital participants based on publicly available information obtained from
hospital websites. Names of potential participants were identified by referencing the hospital’s
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website, ACHE, JC, or CAP. Participant referrals were also accepted and found to be the most
effective form of recruitment.
Discussion of Participants
Engaged leaders play a role in the selection and implementation success of VBAs,
ensuring adequate resources and training, role assignments, and performance monitoring
(Carman et al., 2014; Dickerson et al., 2017; Price & St. John, 2014; Wagar et al., 2019).
Leadership authorizes the departmental activities that various disciplines use to create value,
setting the tone for participation (Carman et al., 2014). Wagar et al. (2019) referred to the role of
the laboratory director as an interface, or the critical intersect for “differences in needs, values,
interests, and/or knowledge” (p. 13). The laboratory primary interface factor was an unknown
variable determined by correlating the perspectives from interview responses (Denzin, 1989), as
this information was not available at the time of case sampling. The interviews laboratory leaders
sought included the pathologist, DCLS, and clinical laboratory scientist manager as the primary
hospital interface (Nadder et al., 2018). Healthcare administrators included C-suite leaders
(Buchanan, et. al., 2013).
The participants for this study were over 18 years old, knowledgeable of VBAs, and
worked full time at the selected hospital site for more than one year. Participants voluntarily
agreed to participate in a semi-structured recorded interview, responding to an interview protocol
(see appendix C). Each participant was provided with an opportunity for feedback on his/her
interview transcript for clarity. The laboratory director as the administrator served as the site
sponsor, granting support and access for this study (Carman et al., 2014). The hospital
administrator offered a supplemental perspective of the laboratory leadership’s effectiveness in
communicating VBAs and strategic alignment.
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Ethical Protections
Privacy and confidentiality are important for protecting human participants (Yin, 2018).
Participants were provided with an informed consent (see appendix A), alerting them to the
nature of the study prior to interviews (Yin, 2018). The data were relevant to the research
questions and provided adequate details for analysis and replication (Silverman, 2017). Although
the names of each participant and site were collected, confidentiality was protected by redaction
of identifiers and use of pseudonyms in published reports and presentations. A confidential paper
log, not stored with the electronic files of interview data, links the pseudonyms with the actual
participants and sites. Participants received an e-mailed copy of their interview transcript and
were afforded an opportunity to provide feedback or clarification. All interviewees were
permitted to ask clarifying questions during the interviews or decline to answer questions.
Population and Sampling
The pre-selection of cases in a multi-case study begins with partially identifying cases
before the research begins due to the case binding features of the design (Stake, 2006). Selected
Texas hospital cases were bound by acute care type, onsite 24-hour emergency care and
laboratory services, online access of laboratory results, and publicly reported quality measures.
The multi-case study approach does not rely on representative sampling logic, thus the typical
criteria regarding sample size is irrelevant (Yin, 2014). General guidelines for a small sample
size in qualitative research take into consideration the extensive volume of rich details studied
within each case (Creswell & Poth, 2018). More than one case dilutes the level of detail the
researcher can provide (Wolcott, 2008), while even a small number of cases bolsters
generalizability, notably in qualitative research of professional practices (Stake, 2010).
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Purposively selected cases with information from multiple data sources within each case
achieved the purpose of this study (Creswell & Poth, 2018).
Discussion of Population
The Medicare Hospital Compare (2019) website aided the purposive selection of cases.
Creswell and Poth (2018) pointed out the importance of maximum sampling variation in
population selection, noting that differentiation factors increase the likelihood that the findings
reflect differing perspectives. Differentiation factors include variation in CMS’s star quality
ratings, bed size, and laboratory accreditation agency. The bindings of the population type
created the commonality necessary to draw generalizations among the cases (Patton, 2002).
Initial bindings of Texas acute care hospitals were expanded to hospitals with on-site 24-hour
emergency care and laboratory services, patient online access to laboratory results, public
reporting of quality measures. Case bindings improve the generalizability of findings (Creswell
& Poth, 2018). Specialty hospitals, such as orthopedic or spine centers, pediatric hospitals, heart
centers, and outpatient surgical centers were excluded from this study.
Discussion of Sampling
Purposeful sampling, referred to as theoretical sampling in grounded theory, identifies
information rich cases (McCrae & Purssell, 2016). Purposive sampling, commonly used in
qualitative research, is most effective when resources are limited (McCrae & Purssell, 2016;
Patton, 2002). Whereas convenience sampling offers no inclusion criteria and identifies
participants wherever convenient (McCrae & Purssell, 2016), purposive sampling entails
intentionally selection of cases and participants to yield rich details related to the quintain
(Patton, 2002; Stake, 2006). The main criteria in case selections are the inclusion of diversity,
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relevancy toward the research goals, and a good opportunity to learn about the context (Stake,
2006).
The sampling variables in this study are determined by assessing Medicare’s quality ratings, which demonstrates the organization’s cultural alignment with quality (AHA, 2017;
Medicare, 2019). CMS’ ratings summarize value with up to 57 publicly reported quality
measures that encourage hospitals and providers to reduce unnecessary care and waste
(Medicare, n.d.; Medicare, 2019). The number of hospital beds provided a context for capacity,
as well as a benchmarking tool (Carman et al., 2014; Harrison, 2010). Laboratory accreditation
agencies approved under the federal CLIA laws (Centers, 2019c), represented another sampling
variable. The relevant laboratory accreditation agencies were CAP and JC, which also had a
searchable website for accredited laboratories (CAP, n.d.; JC, 2018).
Table 6.
Sampling Variability Factors
Hospital Site (case)

Characteristics

Hospital beds

Number

Medicare quality rating*

Star rating system (1-5)

Lab accreditation

CAP / JC / other

Primary hospital interface

PATH / DCLS / CLS / O

* Retrieved from www.medicare.gov/hospitalcompare/About/Hospital-overall-ratings.html
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Table 7.
Features of Each Hospital Case

Summary of Population and Sampling
Acute care hospitals were targeted to explore the communication of PaLM VBAs.
Interviews with three hospital administrators and six laboratory leaders provided data from nine
interviews. While the aim of statistical sampling in quantitative research is an inference to the
population (McCrae & Purssell, 2016), qualitative study participants are selected for the
likelihood of having information about the quintain (McCrae & Purssell, 2016; Stake, 2006). The
purposive case selections included bindings of acute care hospitals with onsite 24-hour
emergency care and laboratory services, electronically available laboratory results, and publicly
available quality of care measures from Medicare Hospital Compare (2019). Variations in the
case samplings were the key differentiation factors that included the number of hospital beds; the
star quality rating (Centers, 2021b); the laboratory accreditation agency; and primary interface.
Data Collection & Organization
The most common methods for gathering data in a case study are observations and
interviews with coding and interpretation (Stake, 2006). The interview transcript provides the
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primary source of data with rich details describing each participants’ experiences and the
understood value from those experiences (Rubin & Rubin, 2012). The interviews were primarily
concerned with collecting information about laboratory leaders’ communication of PaLM VBAs,
rather than the interviewee or the hospital site. Probing interview questions invoked comments
concerning the phenomenon using open-ended phrasing in a semi-structured interviews format
(Castillo-Montoya, 2016; Stake, 2006).
Instruments
Data sources included interview transcripts and journaling notes from meetings with
participants (Creswell & Poth, 2018). The interview protocols were the primary instrument of
inquiry (Castillo-Montoya, 2016). No supplemental documents were shared by participants as an
additional data source (Creswell & Poth, 2018). As the primary data collection tool, the
researcher needed to have sufficient resources while working in the field, i.e., a recording device,
adequate power supply, pen and paper, and a cell phone in case assistance was needed (Yin,
2018). The researcher as the instrument of analysis made the judgment for coding, themes, and
contextualization of the data (Nowell et al., 2017).
The participation packet for prospective participants consisted of Informed Consent
(Appendix A), which was e-mailed to participants prior to the interviews. Participants signed the
consent prior to interviews. The inquiry-based recorded conversations occurred using the
Interview Protocol (Appendix C). Social rules of ordinary conversation were followed with a
variety of open-ended questions in quiet settings (Castillo-Montoya, 2016) using guiding scripts
and everyday language (Brinkmann & Kvale, 2015).
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Data Collection Techniques
There are three types of data collection interviews: the unstructured informal
conversation, without interview questions prepared in advance; the semi-structured interview
with a list of themes or key questions guiding the conversation; and the structured or
standardized pre-determined questions, identical for all interviewees (Barcik, 2016). Interviews
occurred face-to-face, although video conferencing with web-based recordings were an option,
e.g., Zoom, WebEx, GoToMeeting, or Skype (Creswell & Poth, 2018). The interviewer
accommodated the requests of all interviewees for face-to-face meeting locations. The interview
protocol included a script to guide the interview processes including introductions, provision of a
confidentiality statement and informed consent, and an option to withdrawal from the study
(Jacob & Furgerson, 2012).
Interviews stayed within the boundaries of predetermined protocols using guided
questions, time limits, and etiquette (Creswell & Poth, 2018). With an interest in the topic, I
utilized the literature review to develop interview questions grounded in the literature (Jacob &
Furgerson, 2012). The semi-structured interviews allowed for collection of verbal responses to
questions, and better acquaintance of the researcher with the site (Creswell & Poth, 2018). Since
the semi-structured interview questions were open-ended, follow-up questions could be used for
clarity (Creswell & Poth, 2018). The alignment of the interview questions with the research
questions (see Table 11) confirmed their purpose and ensured each question’s necessity
(Castillo-Montoya, 2016). Transition statements between questions, as well as thanking each
participant for their responses, were appropriate (Castillo-Montoya, 2016). Audio recorded
interviews were transcribed the same day to capture impressions and ensure that the conceptual
framework was not limiting exploration (Baxter & Jack, 2008; Stake, 2006). While Yin (2014)
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recommended a pilot test to refine the data collection plan and relevant lines of questioning,
Stake (2006) noted that meager budgets and time are lost in pilot testing. Obtaining feedback
following the interviews did not reveal a need to revise the questions once in the field.
Data Organization Techniques
Data collection began by researching the literature for the applied business problem.
Reference literature and study notes were imported, tagged for topics, and stored in Mendeley
V.1.19.4. Other computer applications aided with transcription of the audio-recorded interviews
and the identification of text segments for code labeling (Creswell & Poth, 2018). Interviews
were transcribed ensuring enough conversation detail to enhance the overall quality and
trustworthiness of the study (Baxter & Jack, 2008). Systematic management of the data was
required including the recorded interviews with same-day transcription.
Although computer programs aid in the organization and retrieval of large data files,
expert judgment for conceptualizing and coding the data required human intellect (Nowell et al.,
2017). The highly regarded computer-aided qualitative data analysis software Atlas.ti and
MAXQDA were not utilized for data coding, aggregation, query, and visualization mapping. All
such programs have advantages for optimizing data management and providing the ability to
hyperlink references, but do not eliminate the need to develop codes or analyze texts (Creswell &
Poth, 2018). The disadvantages of these programs include the extra time investment in learning
the program’s functionality, manual set up of coded text tables, inability to see prior codes once
recoding occurs, limited guidance for the end user, and the financial cost (Creswell & Poth,
2018). NVivo provided a tool for improved validity and reliability.
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Summary of Data Collection and Organization
“Knowledge is constructed in the interaction between the interviewer and the
interviewee” (Brinkman & Kvale, 2015, p. 4) as the researcher attempts to understand the
phenomenon (Stake, 2006). Although data collection relies on the individual interviewee, the
unit of analysis is the collective data from all cases, with research conclusions based on multiple
perspectives (Yin, 2018). Interview questions were open-ended, thematic sub-questions aligned
from the research questions and designed to gather data on the communication of VBAs
(Brinkmann & Kvale, 2015; Creswell & Poth, 2018). Interview sessions begin with an
explanation of the study’s purpose and end with thanking participants for participation and
asking additional interviewees referrals (Creswell & Poth, 2018). Data analysis and storage
occurred in NVivo. Consent documents, progress reports, and IRB records related to this study
will be stored for 3 years by Liberty University in accordance with Federal Regulation 45 CRF
46, then destroyed.
Data Analysis
Research in the health sciences frequently utilizes encoding (Creswell & Poth, 2018).
Analysis of coded data involved pulling the data apart, developing categories into established
patterns or themes, and then putting the information back together in a meaningful way
(Creswell & Poth, 2018). The simplest approach applies a theme-based description of the
quintain to each case’s findings (Stake, 2006), although procedures for thematic analysis are
substantially lacking in the literature (Nowell et al., 2017). Thematic analysis produces a
rigorous and high-quality analysis (Clarke & Braun, 2017). Themes surrounding the VBAs,
communication of VBAs, and strategic alignment of VBAs emerged within each case’s
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transcribed and coded interviews. As Stake (2006) recommended a cross-case analysis followed
by a correlation with evidence from the literature was performed.
Coding, Themes, and Emergent Ideas
The first step in data analysis was developing an organized database for the transcribed
interviews and journaling notes (Creswell, 2016). Each transcript was reviewed prior to
beginning the coding process to get a big picture view of each interview and case (Löfgren,
2013). Coding involved determining meaning by bracketing segments of texts and ascribing code
labels to text passages (Creswell, 2016). Direct interpretation of the interview data involved
pulling the data apart and looking at single phrases for meaning (Stake, 2006).
Codes, the smallest units of analysis, capture the information relative to the research
questions (Clarke & Braun, 2017). Groups of codes built the evidence to support themes
(Creswell, 2016; Löfgren, 2013). Aggregated data from each case developed into large clusters
of ideas, which were collapse into themes (Creswell & Poth, 2018). The collapsing of codes,
referred to as reduction, typically consists of 20 to 30 codes reduced to 6 or 7 themes (Creswell,
2016). Bracket resulted in 32 codes that were reduced to 10 overarching themes. The NVivo
software application helped to “store, analyze, report, and visualize the codes and themes”
(Creswell, 2016, p.153). Themes surrounding the types of VBAs, communication, and strategic
alignment emerged within each case’s transcribed and coded interviews.
Immersion into the data with repeated readings was vital to search for meanings and
patterns (Nowell et al., 2017). I analyzed each case for clusters of ideas to code, grouped together
themes, and then analyzed across all cases for similarities and differences (see figure 6). The
research design required linking the collected data and conclusions back to the original research
questions through the process of categorical aggregation (Creswell & Poth, 2018; Yin, 2018).
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Multi-sourced assertions were made and strengthened with supportive evidence from the
literature (Stake, 2006).
Saturation
Thick descriptions allow validation from the reader’s perspective (Stake, 2010), enabling
them to transfer the findings to other situations by use of strong action verbs and quotes
(Creswell & Poth, 2018). Grady (1998) purported that data saturation occurs at the point in
which the interviewer begins to hear the same comments again, and again. Code saturation
identifies the point at which no additional codes are identifiable in the data set, and the codebook
begins to stabilize, which typically occurs with nine interviews (Hennink et al., 2017) as opposed
to meaning saturation which may require 16-24 interviews for a rich textured understanding of
issues. Yin (2014) recognized that even a small number of cases can achieve data saturation.
Nine interviews with rich data from multiple perspectives were adequate to achieve data
saturation.
Cross-Case Synthesis
Individual cases were analyzed before beginning the reductive process and cross-case
analysis (Stake, 2006). Each case analysis factored in the data from the site’s interview with
pertinent details (Creswell & Poth, 2018). Cases were summarized for context with descriptive
findings. I then returned to the data for the broader cross-case analysis (Baxter & Jack, 2008;
Yin, 2003). The main activity when analyzing cross-case data involves applying the findings
back to the original research questions (Stake, 2006) (see Figure 6). Intensive analysis of themes
and subthemes leads to the development of a theoretical proposition, that when cross-referenced
against multiple data sources tests for trueness (Silverman, 2017). The cross-case analysis with
theme correlations were examined based on evidence from the literature (Stake, 2006).
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Evidence-based assertions provide credibility with logical persuasion (Stake, 2006). Cross-case
thematic analysis elucidated differing perspectives, highlighting the similarities and differences,
and generating unanticipated insights applicable to the population (Braun & Clarke, 2006;
Creswell & Poth, 2018; Yin, 2014).
Interpretation and Final Report.
A final report structure consists of an opening vignette, introduction of the cases, research
procedures, extensive narrative of the findings with identified issues, integration of the
interpretations with the literature, and a closing vignette (Creswell & Poth, 2018). Key assertions
were repeated in several ways with illustrations from the interviews improving validity and the
reader’s interpretation (Stake, 2006). The final narrative report consists of a variety of quotations
from the interview data demonstrating multiple perspectives. Pseudonyms protect the
confidentiality of participants and anonymity of the hospitals.
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Figure 6.
Multi-case Study Coding and Analysis Approach

(Creswell & Poth, 2018)
Triangulation.
This study began with consideration for how to use the literature in tandem with the
collected data (triangulation), using the researcher’s lens (Creswell & Poth, 2018). Triangulation
consisted of multiple sources including the literature, to develop a comprehensive understanding
(Carter et al., 2014). Corroborating evidence was derived from different sources, multiple case
interviews, evaluation across multiple cases, and correlation with the literature (Creswell & Poth,
2018). Controversial and important findings required more than a single source as supportive
evidence to ensure that meanings were not overlooked (Stake, 2006). Denzin (1989) advised that
triangulation requires a second, third, or even more perspectives for correlation. Triangulation
from a variety of sources promotes credibility or the trueness of the findings (Baxter & Jack,
2008). Triangulated evidence is credible and substantiating, although the process reveals that
situations are often more complex than initially thought and data disagreements require careful
evaluation (Stake, 2010).
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Summary of Data Analysis
Audio recorded interviews were transcribed and coded. Coding transcripts manually or
with a computer-aided program requires the same effort from the researcher in terms of
bracketing of segments, assigning of code labels, and developing themes (Creswell & Poth,
2018). NVivo was chosen for data storage, sorting, retrieval, concept mapping, and visualization
of the code networks (Nowell et al., 2017). An orderly database preserves the data in a
retrievable format (Yin, 2018).
Interview data was bracketed, coded, and reduced into themes. Nine interviews across
multiple cases achieved data saturation. Analysis and summarization of each case was followed
by a cross-case synthesis. Aggregated themes were examined against the evidence from the
literature which strengthens generalizations. This synthesis plan triangulates the findings for
creditable assertations with logical persuasion (Stake, 2006). Triangulation, the preferred
validation for a post-positivist researcher, required connecting findings to supporting evidence
for corroboration (Creswell & Poth, 2018; Yin, 2014).
Reliability and Validity
LeCompte and Goetz (1982) noted that if quantitative research had a scientific process
for reliability and validity, then qualitative research required parallel internal and external
validation processes. Lincoln and Guba (1985) refined qualitative research concepts of
credibility, transferability, dependability, and confirmability. Reliability in thematic analysis
involves the reproducibility of the study and ensuring minimization of error and bias. Reliability
involves the case study protocol and the database (Yin, 2018), bringing credibility to the research
with confidence in the data and the study’s findings (Burns & Groves, 2007). Credibility
enhances with prolonged involvement in the setting, triangulation, and peer examination of the

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

86

data (Baxter & Jack, 2008). Analysis requires enough detail to enable the reader to determine the
credibility of the methods and the interpretations (Nowell et al., 2017).
Validation was essential for the inquiry to be of value to other researchers (Creswell &
Poth, 2018). The qualitative case study provides a framework for data collection using a
scientific structure for the analysis and validation of findings (Creswell & Poth, 2018). Validity
reduces the likelihood of misinterpretation (Stake, 2006). Strategies of validation involve several
for assessing the accuracy of the findings (Creswell, 2016/2018). The researcher’s philosophical
orientation influences the chosen validation strategy (Creswell, 2016).
Reliability
Reliability occurred within the protocols for the interviews, the participation packet, and
the approval of the human relations review board (Creswell & Poth, 2018). Reliability occurred
by documenting and following the same protocol for each case and interview, using the same
scripts and open-ended questions to ensure credibility and trustworthiness of the data (Stake,
2006; Yin, 2018; Castillo-Montoya, 2016). Additional protocols included the pre-interview
analysis of publicly reported value-based measures for each site, identification of site variability
factors, and same-day journaling by the researcher (Yin, 2018). Reliability of the interview data
was enhanced with a good quality audio recording (Creswell & Poth, 2018) and with the use of
NVivo to calculate encoding (Silverman, 2017).
Validity
A validation strategy that encompasses the reader’s lens involves rich data or thick
descriptions (Creswell & Poth, 2018), that allow the reader to make the decision regarding the
transferability of findings (Lincoln & Guba, 1985; Merriam & Tisdell, 2015). Validation from a
reader’s lens may occur with peer debriefing, allowing others to ask questions about the
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methods, meanings, and interpretations (Creswell & Poth, 2018). The participant lens validation
occurred by permitting participants to review his/her own interview transcript and to offer
clarifying statements (Creswell & Poth, 2018), and accepting clarifications as a form of external
accuracy check (Creswell, 2016; Yin, 2018). A researcher’s philosophical orientation influences
the chosen validation strategy (Creswell, 2016).
Summary of Reliability and Validity
PaLM practitioners live in a quantitative scientific world, performing experiments, data
collections, and test validations (Butina et al., 2015). Laboratory practitioners understand the
need to define the intended use of a test, examine possible sources of error from sample
variations, and follow appropriate testing procedures (Jennings et al., 2009). Qualitative research
methods, however, remain largely unknown in the medical laboratory profession (Butina et al.,
2015). Reliability occurs in this study by repeating the same procedures for each case, utilizing
quality audio recordings with the interview protocols, and using computer software to calculate
encoding. Multiple data sources enhance the credibility of the findings. Trustworthiness
improves with the open-endedness of the interview questions and participants’ review of
transcripts with any clarifications.
Validation in the medical laboratory involves determining wither a test is ready to be
implemented into clinical practice, by identifying and quantifying potential sources of variation,
and analyzing the closeness of agreement between the found value, against the accepted as
conventionally true value or the reference value (Jennings et al., 2009). Similarly, validation in
the qualitative study involves analyzing data similarities and differences across cases and
examining of the closeness in agreement with evidence from peer data and the literature.
Creswell (2016) and Creswell and Poth (2018) recommend choosing at least two comfortable
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validation strategies considering the perspective of the researcher, the participant, and the reader.
For this research, triangulation was used to substantiate the evidence (Stake, 2010) and rich
contextual data from purposively selected cases with a minimum of nine interviews was used to
reach data saturation (Hennink et al., 2017).
Summary of Section 2 and Transition
This multi-case study utilized confidential audio-recorded semi-structured interviews
with laboratory leaders and acute-care hospital administrators to provide evidence of the
communication efforts regarding VBAs. The identification of the common PaLM activities
within the value-chain provides evidence of the essential activities necessary for value creation
and for alignment with VBHC strategies promoting performance improvement, safety, quality
outcomes, and cost savings (Carman et al., 2014; Porter, 1985; Swayne et al., 2006). The
collective nature of this study allowed for the generalization of findings from multiple
perspectives (Stake, 2006; Creswell & Poth, 2018). A maximum sampling variation strategy
utilizing the factors in Table 7, improved the likelihood of credibility in the findings by reflecting
differing perspectives (Creswell & Poth, 2018). Probing interviews provided the primary data
source (Stake, 2006). No other acceptable forms of data were collected in the field including
workplace documents, reports, or job descriptions (Creswell & Poth, 2018; Silverman, 2017;
Yin, 2014). As the primary instrument for the data collection and analysis, I utilized interview
protocols to collect reliable data (Yin, 2018), then transcribed, organized, and coded the
information (Creswell & Poth, 2018). Prior to uploading information into NVivo for a cross-case
thematic analysis, each participant was provided an opportunity to analyze their own transcript
and provide feedback which improved the credibility and validity of the data (Creswell & Poth,
2018; Stake, 2006).

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

89

Section 3: Application to Professional Practice and Implications for Change
Texas PaLM leaders identified activities contributing six forms of value. PaLM VBAs
improved hospital competitiveness, customer service, efficiency, effectiveness, quality, and
costs, i.e., the attributes of the value-chain found in the mVCM framework from Section 1 (see
Fig. 2). Although Texas hospital administrators had not requested demonstrations of value from
laboratory leaders, measures from patient testing, laboratory data, and turnaround times aided
hospitals in the achievement of accreditation and status goals.
Laboratory leaders utilized seven forms of communication when responding to the
requests of hospital leaders. As hospital leaders had not requested cost savings information,
laboratorians only presented cost savings when actively participating in system-wide contract
negotiations. Hospital administrators did not assess PaLM quality or efforts to improve costs.
While cost-savings demonstrations were described as desirable by hospital administrators, costsaving reports were not requested. Hospital administrators acknowledged the value associated
with PaLM’s high-quality testing. PaLM leaders regularly communicated performance data
using a variety of forums, assisting the organization in meeting accreditation and status goals.
Quality, however, is not directly related to healthcare costs (Burke & Ryan, 2014). As Wong &
Hilborne (2021) pointed out, the laboratory’s analytic quality alone is insufficient for achieving
appropriate utilization. Laboratory stewardship, a term implying responsible management of
resources (Jongeward, 2021), was identified as an import role for hospital laboratorians.
Participation on a laboratory stewardship committee brought awareness and support for
improvement opportunities.
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Overview of the Study
Three executive level hospital administrators, three PALM medical directors, and three
laboratory administrative directors were interviewed to gain insight into the communication of
PaLM VBAs. Nine interviews from three purposively selected hospitals cases were targeted for
the achievement of code saturation (Hennink et al., 2017). Scripted interview questions were
designed to capture the details of PaLM leaders’ communication efforts and the perceptions of
hospital administrators (see Section 2, Fig. 7). Interviews were recorded, transcribed, and
uploaded into NVivo software for data organization and coding. Data immersion occurred with
multiple exposures to the data, including the face-to-face interviews, transcription of the audio
recordings, and reading and coding transcripts. Each hospital case was analyzed individually,
followed by cross case categorical aggregation for development of relevant themes and an
analysis of the findings. Three overarching themes emerged from the data: PaLM VBAs, PaLM
communication efforts, and PaLM VBA strategic alignment.
The Robbins et al. (1994) communication model offered guidance for clarifying the
communication sender, message, receiver, and delivery channels (see Section 1, Fig. 1). PaLM
leaders as the messenger of VBAs, and hospital administrators as the receivers of PaLM’s
messaging, were interviewed face-to-face with probing questions aimed at the communication of
PaLM VBAs and the discovery of lost cost savings opportunities. VBAs were categorized based
on the value attributes identified from the participants. VBAs were then applied to the mVCM
conceptual framework (see Fig. 2) and validated with the literature. The identified categories of
PaLM VBAs included competitiveness, cost improvement, customer service, effectiveness,
efficiency, and quality (see Fig 11). The themes of VBA strategic alignment (see Fig. 12) that
emerged were feedback from hospital administrators, assessments for PaLM services, and
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hospital goals. Anticipated versus actual findings were considered then applied back to the
original research questions.
Presentation of Case Findings
The four hospitals and nine interviewees were pseudo named for anonymity. Three of the
hospital laboratories were CAP accredited and one JCO accredited. All four hospitals were JCO
accredited and varied in bed size from 120 to 556. All hospitals were part of a larger health
system found to utilize system level dashboards for quality and performance improvement
reporting. Hospitals H510, H750, and H302 were rated 3-Stars by Medicare, while H642 had
obtained a 4-Star status. The primary laboratory interface identified in each case varied between
the medical director and the administrative director, and no DCLS was identified (see Table 7).
All laboratory participants noted service alterations related to the Covid-19 pandemic. Consistent
with recent workforce studies (ASCP & CHW, 2021), the participants reported hardships
associated with an increased number of patients and testing, workforce shortages, and workflow
changes relative to the Covid-19 pandemic. PaLM leaders discussed the necessity of accurate,
rapid, high-throughput testing for SARS-CoV2. H510 improved laboratory productivity by
shifting phlebotomy services to nursing and adding a technologist position. H302 shifted nursecollected nasal swabbing to the phlebotomists. H710 expanded outreach testing. H642 moved
Covid PCR testing in house and offered specialized training on blood culture collections.
Findings from Case H642
H642 consisted of one interview with Dr. Barb, the laboratory medical director. Dr. Barb,
an engaged physician pathologist, was knowledgeable of PaLM VBAs and communicating with
hospital administrators. Dr. Barb identified herself as the primary interface with hospital

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

92

administration and commented on attending “an extra three-day course with the College of
American Pathology to improve oversight of the clinical pathology side.”
H642 Communication.
Dr. Barb ensured that hospital administration received an annual written report on
pathology activities, and a quarterly report of the clinical laboratory’s quality metrics. Dr. Barb
participated on interdisciplinary committees and attended monthly operational meetings with the
laboratory administrative director. A lack of time was identified as hindering VBA
communication. Dr. Barb stated, “My biggest barrier is giving time to putting the reporting
together.”
H642 VBAs.
Dr. Barb identified many VBAs within the first few interview questions. For instance, she
described how patients benefitted from the implementation of clinical algorithms and the process
improvements made for resulting positive screening tests. A newly hired blood bank specialist
was described by Dr. Barb as enhancing the core competencies of the hospital and a lab-initiated
training project on sterile technique had improved blood culture quality, avoiding downstream
costs. Dr. Barb used her clinical expertise in the selection and implementation of new testing
platforms, which had improved turnaround time, throughput, and costs. Dr. Barb said that the
decision to insource a test had reduced “the costs to the health system from $65 per test to $25
per test saving both time and money.” Dr. Barb also described moving Covid testing in house as
an improvement in efficiency and costs.
H642 VBA Alignment.
No hospital administrator interviews occurred for case H642. Therefore, insights on
hospital strategic goals are limited for this case. Dr. Barb clarified that the laboratory received
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organizational direction from the top, adding that “hospital administration determines which of
the meetings I should attend.” Dr. Barb saw VBHC as an emerging strategy within her health
system, which had not yet been fully developed.
Findings from Case H510
Three H510 interviewees participated in this case study. Mary, the laboratory
administrative director, was interviewed in a private room away from her busy work atmosphere.
Interviews with Dr. Mick, the PaLM medical director, and Dr. Mark, the chief medical officer,
occurred in their respective offices. Identified in case H510 was the use of a surveys to evaluate
PaLM services. Dr. Mick and Mary were engaged PaLM leaders, eager to share their VBA
experiences. Dr. Mark participated with the laboratory on a system level stewardship committee.
H510 Communication.
Mary participated in several multidisciplinary committees, receiving and giving
information with other hospital leaders. Mary led daily huddles with her department and
routinely met with a “one-up in hospital administration to discuss wins and struggles.” Mary
mentioned escorting hospital administrators on tours of the laboratory and reporting laboratory
quality data, performance improvement data, and “any other requested measures.” Mary spoke of
satisfaction surveys, noting the “high scores in the outpatient phlebotomy department.” Dr. Mick
said that customer satisfaction surveys were a primary focus for the organization. Mary
explained that the hospital used three types of surveys for physician feedback, patient
experience, and employee satisfaction.
Dr. Mick attended the medical executive committee for the purpose of giving and
receiving information from physicians and hospital executives. When asked about
communication barriers with hospital administrators, Dr. Mick said “only a lack of engagement”
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could hinder effective communication. Dr. Mick added, “We have a familiar saying with
laboratorians, they tend to hide in the laboratory and very few want to be out there.” Dr. Mick
and Mary participated on the laboratory stewardship committee, described by Dr. Mick as “a
good forum.” Dr. Mick added “if a hospital does not have a laboratory stewardship meeting, then
I would highly suggest they get one, especially if they are part of a system.”
H510 VBAs.
PaLM VBAs were identified by Dr. Mick and Mary. Dr. Mick and Mary monitored
quality assurance in the laboratory with measures for testing quality, accuracy, and turnaround
times. Dr. Mick mentioned that provider notification of critical findings was an important
customer service tool. Mary identified autoverification as an activity that improved efficiency.
Mary offered expertise in the assessment and implementation of new equipment, which had
improved quality, turnaround times, throughput, and costs. Mary identified that the highly
engaged and productive laboratory employees were a value to the organization. When speaking
of hospital participation Mary said, “I try to make sure that the laboratory is participating…being
out there and participating in many things.”
H510 VBA Alignment.
Dr. Mark, the Chief Medical Officer, revealed that the primary assessment of PaLM
services was feedback from customer surveys. Dr. Mark said, “how our physicians rate our
laboratory and pathology services is from a customer perspective, not from a cost perspective.”
Mary knew that hospital administrators assessed customer survey responses and acknowledged
that cost savings efforts from the laboratory were not requested. Mary said her annual
performance evaluation was “based on physician satisfaction and employee retention, the goals
set by hospital administration.” Mary was uncertain if a budget existed for her department other
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than for “the review the lab’s units of service, billable tests, and hours worked.” Dr. Mark was
aware of VBHC, although H510 had not utilized VBHC as a strategy at the time of this study.
Findings from Case H750
Case H750 consisted of three interviews - Luke the laboratory administrative director;
Dr. Lem the PaLM medical director; and Larry the Ancillary Vice President. Interviews were
uninterrupted and took place in each participant’s respective office. Unique to H750 was the
outreach accounts set up by Luke, described as offering “an additional revenue stream and an
expanded market reach.” Larry recognized the high quality associated with PaLM testing as a
downstream cost savings for patients.
H750 Communication.
Luke participated on several committees to receive and share information. Luke
submitted PaLM data to the hospital quality department, the infection control committee, and the
emergency department committee. Dr. Lem participated quarterly on “interdepartmental
structures where administration and pathology communicate with each other…” Dr. Lem stated
that hospital administrators determined which committees he should attend. Luke pointed out
that hospital administration determined if a new laboratory service or assay was needed based on
feedback from “senior leaders and doctors who speak at Med-Exec committee.” Dr. Lem
acknowledged his participation on the hospital’s medical executive committee.
Luke’s primary form of communication with senior leadership was via e-mails. Luke
said, “some senior leaders do come to the laboratory quite often to see the bench work and speak
to the techs.” Luke felt it important to clarify that “the laboratory does hear a lot of support from
hospital administration.” Luke said, “I want to brag on my senior leadership because they are
very supportive”, adding “My staff know who they are, they say hello in the hallways, and they
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know our names, which I think this is really important.” However, issues on VBA
communication and feedback were identified at H750.
H750 VBAs.
Luke identified many PaLM VBAs, including a laboratory outreach that he set up after
seeking input from hospital administrators. Small (2016) recognized that hospital administrators
were unconvinced of the value in a hospital-based laboratory outreach. Shrinkman (2016), on the
other hand, stated that “a successful hospital laboratory outreach could furnish more than half of
a hospital’s pre-tax earnings while accounting for less than 10 percent of its overall cost.” Luke
had developed contracts with clients, established a fee schedule, and implemented processes for
reporting results and issuing client bills. While Luke had not determined the actual revenue from
this outreach project, he felt value had been provided to the hospital in terms of new patients and
satisfied physician partners. Luke identified pre-analytical VBAs including employee training
and monitoring of customer service skills, handwashing protocols, and AIDET. Luke recognized
the value associated with safety protocols, patient identification, and bedside labeling. Luke
noted the post-analytic value associated with calling of critical values and the information
displayed with test result for patients and providers.
Dr. Lem recognized PaLM expertise and utilization efforts as value-adding. Dr. Lem said
that the clinical expertise of the laboratorians was a necessity for improving blood product
wastage and for educating providers. Larry recognized the value associated with competent
laboratory staff performing high-quality testing, emphasizing the value of cost avoidance and an
improved length of stay. Larry offered an example of how the laboratory accurately and quickly
identifies catheter-associated urinary tract infections, which “impact hospital quality and length
of stay, tying into our hospital’s profitability.”
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H750 VBA Alignment.
When asked about how the laboratory’s services align with hospital goals, Larry
emphasized that quality alignment is the hospital goal. Larry said, “It is about the right patient,
getting the right treatment, and the right antibiotics, at the right time.” When speaking of
PaLM’s analytical quality, Larry noted “the laboratory has things they report…and it rolls up
into the quality meeting for the hospital.” Larry was uncertain about other PaLM VBAs, stating
that the laboratory, “does a good job, I guess…I think that we get what we need from the
laboratory, so the laboratory must do a good job.” Larry clarified that he was unaware of
laboratory examples “that directly affects a value-based topic” other than quality. Larry had not
heard of VBHC as a strategy.
Findings from Case H302
Case H302 consisted of two interviews – one with Terry, a laboratory administrative
director, and another with Tracy, a hospital executive officer. Tracy said that “the primary
interface for laboratory tends to be the laboratory administrative director.” Terry agreed, adding
that the ancillary VP communicated with “finance, revenue, and the CMIO.” The H302 hospital
system had separated the governance of laboratory services, laboratory informatics, and
laboratory revenue and finance from the rest of hospital system
H302 Communication.
Terry noted that the laboratory “works very directly, hand-in-hand with the Risk and
Quality departments.” Terry purposefully placed employees from the laboratory on hospital
committees “to share the data for reporting to Medicare.” Terry offered an example of the
laboratory reporting on the adherence of bedside patient identification and labeling, and data on
compliance with sepsis protocols. H302 PaLM employees regularly attended interdisciplinary
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meetings. Tracy noted that laboratorians responded with specific data when asked by hospital
administration. Terry said his laboratory “most recently offered information related to labor and
delivery and Covid infections.” Terry communicated with hospital executives via e-mail and
recalled an e-mail response stating, “as usual I agree with your recommendations.”
H302 VBAs.
Terry felt that systemwide reporting structures and processes were in flux at the time of
his interview. Terry participated in a system-wide laboratory collaborative with RFPs which
“resulted in a million dollars a year in operational cost savings.” Terry spoke of other
systemwide collaborations that resulted in new equipment, automation, and operational
workflow improvements. Terry stated a laboratory goal was to improve value by “inventory
optimization and combined purchasing power” with system integration efforts.
Terry identified laboratory test results as valuable to pharmacy in choosing medication
therapies, Xray in performing contrast dye procedures, and infection control in opting for
isolation precautions. Tracy identified the value associated with accurate and timely laboratory
test results and the oversight of point of care testing. Tracy also identified the value associated
with the laboratory’s data reports shared with a variety of hospital groups. Terry saw value in the
laboratorian’s expertise participating on “hospital pharmacy and therapeutics committee. … and
discussion groups related to things like quality metrics and blood utilization.” Terry added that
H302 laboratorians participated in data analysis for Medicare reportables by “pulling out
numbers for turnaround times, positivity rates, and other metrics.” Terry recognized value with
test utilization efforts and in participation “on ordering pathway groups…playing a big role” in
establishing order sets and offering clinical expertise. Terry ensured that PaLM employees were
integral to hospital committees and clinical care teams, expressing that visibility and
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multidisciplinary participation were essential for the future of medical laboratorians.
H302 VBA Alignment.
Tracy, when asked about the strategic objective of the health system, was “not sure that
the ancillary service lines were directly involved with strategic objectives.” Her perception was
that “the services lines follow the lead of the decisions made at the executive level.” Terry
admitted to “waiting for administration to reach out” and at times “deploying other corporate
groups to trigger needed conversations.” Tracy acknowledged that the laboratory’s performance
metrics helped the organization achieve desirable status goals. Tracy said, “I would say that if
the laboratory is providing accurate and timely information, then our hospital is more able to
meet regulatory standards.” Tracy offered examples of VBAs with the laboratory’s informational
prompts in computer systems intended to guide physicians toward the achievement of core
measures. Terry felt that PaLM services helped other departments like the ICU and the
emergency room to meet their goals.
Themes Discovered
I assigned code labels to the texts of the interview transcripts, then organized codes into
themes (Creswell & Poth, 2018). The NVivo software application aided in the coding and
organization of the data. Creswell and Poth (2018) recognized that counting references and codes
was a contentious matter since “not all qualitative researchers feel comfortable counting and
reporting” (p. 192). However, the NVivo application automatically performed the code counts, as
seen in Figures 7, 8, and 9. The column labeled files represents the nine interviews, and the
reference column represents the number of times a code appears in the transcripts. Seven forms
of communication emerged, as well as issues with communication (see Figure 7). Six types of
PaLM VBAs were categorized based on the mVCM conceptual framework. The theme of PaLM
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VBA strategic alignment developed from the responses of hospital administrators, assessments
utilized for PaLM services, and strategic goals identified of hospitals. The findings from each
case were analyzed, along with a broader cross-case analysis.
Interpretation of Themes
The typical format for a multi-case study is to present a detailed description of each case
followed by a cross-case analysis of identified themes (Creswell & Poth, 2018). Themes of
communication developed from the methods utilized by PaLM leaders to communicate with
hospital administrators. Themes of PaLM VBAs developed from the responses of hospital
administrators and laboratory leaders that identified PaLM services. The theme of alignment
with hospital goals developed from coding the feedback offered by hospital administrators,
assessments utilized for PaLM services, and identification of hospital strategic goals.
PaLM communication themes encompassed the ways in which PaLM leaders communicate
VBAs, the issues identified with communication, and the channels used for sharing information
(see Figure 7, 10). Communication from PaLM leaders occurred in a variety of formats including
verbal or written reporting, data analysis, e-mails, texts, and presentations. PaLM leaders
communicated VBAs with quality metrics, data reports, data on system dashboards, and
presentations at meetings.
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Figure 7.
NVivo Database, Communication Files and References Frequency

Themes of PaLM VBAs developed from coding the value attributes of activities within
the interview texts. The mVCM conceptual framework (see Section 1, Fig. 2) guided the
identification of the VBAs. Themes of PaLM value included competitiveness, cost improvement,
customer service, effectiveness, efficiency, and quality (see Section 2, Fig. 8 & 11). As noted by
Carman et al. (2014) many activities offered more than one type of value. Thus, VBAs were first
categorized based on the value described by the participants, then aligned with the literature. The
identified PaLM activities that impacted cost improvements included efforts to cut costs, avoid
costs, and contain costs. Themes of customer service were derived from coding the activities that
impacted the patient experience and physician satisfaction. Activities improving effectiveness
included the optimization of resources and utilization efforts. Efficiencies were derived from
multi-disciplinary actions, standardization efforts, turnaround time optimization, and
technologies and testing platforms. VBAs associated with quality and performance
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improvements were identified in the pre-analytic, analytic, and post-analytic phases, and
included expert consultations and data analytics.
Figure 8.
NVivo database, VBA Codes File and References Frequency

The theme of VBA alignment with hospital goals developed from the coding of feedback
from hospital administrators, identification of hospital strategic goals, and assessments utilized
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for PaLM services (see Figure 9). Interview questions 1, 2, 7, and 17 were the primary source of
information on alignment with hospital goals.
Figure 9.
NVivo Database, Hospital Goals Alignment, Files and References Frequency

Representation and Visualization of Data
Multiple exposures to transcript data were essential for data immersion (Thomas, 2006).
Audio recorded interviews were transcribed which required listening to the audio recordings
repeatedly for accuracy. The transcription process increased familiarity with the raw data, aiding
in the identification of connections or themes for coding. The coding was based on repeating
concepts or phrases, using an inductive approach. The findings developed by categorial
aggregation; a form of data analysis discussed by Stake (1995) where collections of instances
form relevant meanings.
The categories for PaLM communication efforts are displayed in Figure 10. PaLM VBAs
are displayed in Figure 11. Themes of VBA alignment with hospital strategic goals are displayed
in Figure 12. Creswell and Poth (2018) note that researchers typically develop 25-30 tenative
codes. Three distinct themes emerged from this study.
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Themes of PaLM Communication
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Themes of VBA

105

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

106

Figure 12.
Themes of PaLM VBA Alignment with Hospital Goals

Relationship of the Findings
Data collection relied on participant responses to interview questions; however, the unit
of analysis was the collective data from all cases with the conclusions based on multiple
perspectives (Yin, 2018). Thematic analysis examines differing perspectives, highlighting the
similarities and differences, generating unanticipated insights (Braun & Clarke, 2006; Creswell
& Poth, 2018) for naturalistic generalizations applicable to the population (Yin, 2014). The main
activity analyzing the cross-case data involved applying the findings back to the original research
questions (Stake, 2006). The intensive analysis of themes and subthemes led to the development
of assertations and generalizations, that when cross-referenced against the multiple data sources
from the literature, tested for trueness of the findings (Silverman, 2017). A summary of
anticipated versus the actual research findings are listed in Table 8.
Relationship to the Research Questions
RQ1. What value-based cost savings opportunities have laboratory leaders presented to
hospital administrators? PaLM leaders presented to system level leaders’ information on
successfully negotiated RFPs for new testing platforms, automation, and standardizations which
had resulted in significant operational cost savings. PaLM leaders knew of other potential cost
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savings relative to improvements in blood product and test utilization, testing algorithms, and
reference test gatekeeping. Details of these cost savings had not been presented by laboratorians
to hospital administrators due to a lack of time and knowledge on how to present, and conflict
avoidance. Dr. Lem felt that “conversations regarding physician’s want versus costs…” were
associated with risks and at times a conflict of interests.
H302 and H510 hospital administrators expressed that PaLM leaders were not
forthcoming with cost savings initiatives and laboratorians tended to offer only the information
requested. While one hospital executive expressed that financial savings or “cost avoidance
reports would be nice,” laboratorians stated they were not specifically asked to provide cost
savings information. Laboratory leaders felt that demonstrations of cost savings were too
difficult due to a lack of access to per unit cost information, a lack of time necessary to put
together a financial presentation, and the need to avoid conflicts of interests.
RQ2. What value-based opportunities are perceived as effectively communicated by
laboratory leaders to hospital administrators? Hospital administrators had difficulty identifying
any PaLM VBAs other than high-quality test results, productivity, and performance data. Two
hospital administrators noted a reliance on physician satisfaction surveys to measure PaLM
services. The H510 hospital executive said, “If the physicians believe that PaLM provides a good
service with timely and accurate results, then the (survey) score will be high. The higher the
score, the more likely we are to know that the physicians will make the hospital a place to
practice.”
Hospital administrators perceived value in PaLM’s accurate and timely test results, which
the H750 hospital administrator described as “improving patient care, helping patients to get well
sooner and go home sooner.” The H510 hospital administrator noted assessing the laboratory’s
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productivity, a measure of ancillary performance recognized by Bergeron (2017). Although, as
Wilson (2014) pointed out, productivity as a performance measure fails to capture the
unreimbursed value contributions. Nordin and Kork (2017) suggested that the more appropriate
indicators to measure performance were organizational learning and value gained.
The H302 and H750 hospital administrators expressed that the laboratory’s cumulative
data helped the hospital meet reportable measures and accreditation goals. The M510 hospital
administrator remarked that after attending a laboratory stewardship meeting, he learned that “a
lot of physicians over order lab tests” and interventions could improve utilization. Terry had
presented to H302 hospital executives his laboratory’s efforts to streamline services across the
health system. Dr. Mark knew that such efforts improved value with economies of scale savings
for maintenance, contracts, and testing supplies.
H510 and H302 laboratory leaders recognized the laboratory’s participation on hospital
committees was essential. However, PaLM leaders also noted that hospital administrators did not
typically attend interdisciplinary hospital meetings where the laboratory’s information was
reported. All PaLM medical directors noted attending medical staff committees as requested by
hospital administrators. The H642 PaLM medical director mentioned offering a focused annual
report on pathology services as stipulated in her contract.
RQ3. How do hospital-based laboratory leaders communicate PaLM VBAs to hospital
administrators? Laboratory directors verbally reported at monthly meetings with a one-up in
hospital administration. PaLM medical directors participated in medical staff forums which were
attended by hospital administrators. Laboratorians participated on committees and hospital
events communicating testing data, order volumes, and turnaround times at various forums.
Laboratory leaders communicated regularly with hospital physicians and department managers
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on patient’s clinical testing needs. Laboratory administrative directors communicated capital
expenditure needs to the chief financial officer. Hospital administrators with access to system
level dashboards could see PaLM’s reportable performance data.
RQ4. What PaLM VBAs do administrators perceive as aligning with value-based
objectives? The results of this study cannot confirm alignment with VBHC strategies. The H302
hospital administrator said that ancillary service lines were not directly involved with strategic
objectives. However, due to the soft descriptives of value (Kirkpatrick et al., 2015), many VBAs
were identifiable from participant interviews, some of which aligned with hospital accreditation
and status goals.
Hospital administrators assessed PaLM services based on satisfaction surveys. H510 and
H750 laboratory directors noted that a clean safe environment with skilled and courteous
phlebotomists improved patient satisfaction. H510 laboratory leaders identified that preadmission and pre-employment laboratory testing improved hospital workplace safety. Hospital
administrators generally recognized as desirable the laboratory test result and analysis of results.
Tinker (2018) and Tierney (2017) also recognized these attributes as value adding. However,
hospital administrators did not identify PaLM VBAs as aligning with a VBHC strategy or cost
savings.
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Relationship to the Conceptual Framework and Anticipated Themes
The primary conceptual framework by Robbins et al. (1994) offers simplistic structure
for message transference (see Fig. 1). The sender of PaLM’s value message was identified as the
primary laboratory interface to hospital administration. The hospital administrator’s primary
interface for the laboratory was the laboratory administrative director and/or medical director.
No cases utilized a DCLS at the time of this research. The message analyzed was PaLM VBAs
and the receiver of information was the hospital administrator. Guo (2011) pointed out that
effective communication more likely occurs with feedback as a reaction to the message, which
permits an opportunity for clarification. Without feedback, one-way communication from the
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sender is less accurate, and the sender cannot know the message was received or accurately
understood (Gardner & Winder, 1998). While the H750 medical director felt the laboratory
“received feedback, in terms of the hospital goals set for the department”, other feedback on
PaLM VBAs had not been recognized by hospital administrators. Dr. Mick said that the primary
source for feedback was from the physician satisfaction surveys. Mary said, “I’m not sure that
we’ve gotten a lot of feedback from administration about our activities. It would have been nice
to have some recognition…” PaLM leaders identified the barriers to communication as
organizational layers, lack of adequate information, conflicts of interest, perceptions of
information or sender insignificance, conflicting priorities, lack of time, and a culture of sharing
only requested information.
A secondary conceptual framework on value in service delivery and support activities
combined the concepts of Porter (1985), Swayne et al. (2006), and Carman et al. (2014) as a
strategic thinking map. Swayne et al. (2006) purported that value increases when primary
production activities improve efficiency and effectiveness, quality, safety, satisfaction, and costs.
Porter (1985) and Burns et al. (2001) suggested that value also enhances from the support
activities that improve an organization’s culture, structure, and strategic resources, i.e.,
improvements regulatory compliance, culture, skills development, and partnerships. Similarly,
Medicare’s Hospital Value Based Payment program (Centers, 2019c) incentivizes improvements
in safety, patient outcomes, engagement, efficiencies, and cost reductions.
The PaLM value adding themes emerged from this study within the service delivery and
environmental support tracks, aligning with the mVCM conceptual framework (see Table 9).
While interview questions were not specifically designed for the identification and classification
of PaLM VBAs, themes did emerge for competitiveness, cost improvement, customer service,
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efficiency, effectiveness, optimization of technology, and quality. Many PaLM VBAs
overlapped in value attributes. Some mVCM concepts were not overtly apparent, i.e., PaLM
VBAs improving cultural support, collaborative partnerships, and regulatory compliance, merely
because this study was not designed as an in-depth analysis of PaLM’s value chain. Interview
questions were not designed to explore all the value endeavors within PaLM’s entire value
creating ecosystem and the identified PaLM customers in this study included only the patients
and hospital care providers.
Table 9.
mVCM Conceptual Framework and VBA Themes Alignment

Relationship to the Literature
The findings were evaluated in relationship to the literature review from section 1. The
findings were analyzed for similarities and differences with the literature. The information
obtained from the PaLM leaders and hospital administrators was examined relative to strategic
alignment, value classification, and communication efforts, including barriers and feedback.

COMMUNICATING THE VALUE CONTRIBUTIONS OF PaLM

114

PaLM Alignment with VBHC.
VBHC strategies contribute a structure for the identification and measurement of
improvement needs (Kaplan et al., 2014). Optimal success in strategic alignment endeavors
requires linking internal business unit activities with broader organizational objectives (Bryson,
2018; Gambel et al., 2019). Alignment at all levels of the organization delivers a better
understanding, acceptance, and support of the value proposition (Austin et al., 2016).
This research did not confirm that VBHC strategies were selected for Texas acute care
hospitals. Dr. Barb acknowledged that her facility was only in the beginning stages of VBHC
planning. Dr. Mark said that “Texas hospitals have been slow to adopt a value-based strategy.”
Larry had not heard of VBHC as a strategy for his facility. At the time of this study, however,
Texas Health and Human Services had implemented a VBHC focus on the quality of care and
holding providers accountable for the cost of care (Texas, 2021).
Marlow et al. (2016) noted that hospital CEOs typically focus on the patient experience,
customers satisfaction, clinical quality, and costs. Hospital administrators also focus on safety,
efficiency, personnel shortages, and cost reductions (ACHE, 2019; Green et al., 2018; Newman,
2018), as well as government mandates, accreditation requirements, and reportable measures
(Tinker, 2018; Tierney, 2017). Collectively these numerous goals improve value, despite any
ambiguity in the reporting of value-based outcomes (Porter, Larsson, & Lee, 2016).
Sarwar et al. (2015) noted that metrics allow leadership to determine the degree of
adherence to organizational goals. The PaLM metrics identified in this study were relative to
organizational performance goals, quality efforts, and satisfaction survey scores. H302 Terry said
that PaLM contributed data for a variety of hospital status recognitions, which Tracy confirmed
included Joint Commission accreditation, Magnet Status, LeapFrog status, and Primary Stroke
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Center designation status. Tinker (2018) and Tierney (2017) remarked that accreditation
requirements, government mandates, and financial incentives determine which reportable
measures were chosen by hospital leadership. Tracy and Larry acknowledged that PaLM’s
performance metrics helped the organization to achieve desired status goals.
Wagar et al (2019) noted that laboratorians were data driven. Laboratorians communicate
well with quality metrics (Bergeron, 2017; Bixho & Melanson, 2017). Sarwar et al. (2015) and
Schmidt and Ashwood (2015) recognized that laboratories used performance indicators for many
things, including finance, productivity, regulatory compliance, and processes such as analytical
performance, turnaround times, down times, wait times, or staffing efficiency. Sarwar et al.
(2015) said that leaders utilized these types of metrics to assess, manage, and respond. H510
Mary said that she reported laboratory quality and performance improvement measures on a
system operational dashboard. Visible performance metrics roll-up into system dashboards
(Green et al., 2018), revealing the opportunities for team collaboration (Gupta et al., 2019). H510
Dr. Mick noted that laboratory metrics could reveal a need for a change in a process or the need
for new equipment. Ducatman et al. (2018) recognized that laboratory dashboards effectively
monitor, communicate, and educate. H750 Larry noted that laboratory quality measures were
viewed on system-level dashboards. H750 Luke discussed monitoring laboratory dashboard
metrics for workflows and efficiencies. Assessments of internal performances aid in the
identification corrective adjustments needed (Gambel et al., 2019). Passiment and Linscott
(2014) point out that unmeasured or unverbalized outcomes lead to many projects going
unnoticed.
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PaLM Value Chain (VBAs).
Kirpatrick et al. (2015) defined value with soft descriptives such as effectiveness,
efficiency, safety, and satisfaction. Davis et al. (2018) described value as the clinical care process
improvements in efficiency, patient experience, outcomes, and cost reductions that affect
Medicare reimbursements. Kim et al. (2012) recognized quality enhancements as value
improving. Together, these healthcare related value attributes make up the categories of a value
chain. VBAs emerging from the coded interview transcripts were categorized into themes using
the mVCM framework as guidance (see Table 9). These included six value improvements, e.g.,
competitiveness, customer service, efficiency, effectiveness, quality, and costs (see Fig. 8)
PaLM Competitiveness – Core Competencies, Skills Development.
Value enhancements improve strategic resources and core competencies, i.e., internal
skills, capabilities, and technologies (Fottler, Ford, & Heaton, 2002; Kratz & Laposata, 2002;
Swayne et al., 2006). Gambel et al. (2019) noted that internal resources and capabilities require
development and nurturing for a sustained competitive advantage. This study found no evidence
of Texas hospitals supporting the internal strengthening of laboratorians. Yet, hospital
laboratorians with clinical expertise and adequate skill sets (University of Kansas, 2019; Wagar
et al., 2019) were identified as educating others. Terry identified the importance of laboratorians
“participating on most hospital committees.” Terry said, “Our lab leadership felt strongly that
the laboratory needed to be represented at the table. We know that laboratorians are often
invisible, but by our participation on committees…we bring back information to the laboratory
for ways we can help. If our laboratorians did not attend these committees, important information
would be missed.”
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Ahmed (2019) pointed out that higher-level directors tend not see the value insights from
lower-level employees. Luke bragged on his “senior leadership because they are very supportive
of the laboratory… My staff know who they are, say hello in the hallway, and they know our
names.” Mary identified a major issue as a lack of laboratory employee retention and wage
equivalence. Mary and Luke mentioned that employee retention was an evaluation goal for
laboratory leaders. CCCLW (2018) and ASCLS (2018) noted that laboratory’s retention issues
required professional visibility, workforce appreciation, and wage equivalency with similarly
educated professions.
Gross et al. (2019) noted that strong laboratory leadership is a necessity to highlight the
laboratory as a core asset and to communicate the laboratory’s value to healthcare administrators.
Strong leaders require an understanding of the factors affecting employees, as well as their
employees’ contributions to good hospital citizenship (Glavas & Goodwin, 2013; HendersonCarter, 2014). The concept of hospital citizenship, also discussed by Boland et al. (2017), refers
to the roles and responsibilities of all staff contributing to improving patient care. A laboratory’s
people assets contribute the high-quality work necessary for the diagnosis, prognosis, treatment,
and management of human disease (Anonychuk et al., 2012; Davis et al., 2018). Dr. Barb
recognized that her “well-trained team of phlebotomists with a competitive ratio reporting” as
“very focused on supporting the mission of the hospital.” Dr. Barb also recognized that adding a
blood bank specialist enhanced the hospital’s core competencies. Stroh (2015) pointed out that
ideally, the entire organization keeps a watchful eye on opportunities, risks, and trends. Dr. Lem
spoke of the importance of the “blood bank supervisor attending meetings: that are interdepartmental and identified the importance of the laboratory’s clinical expertise in “gatekeeping
test orders, improving blood product wastage, and educating providers.”
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Laboratorians offer an intangible asset. Kaplan and Norton (2004) pointed out that highly
educated and competent staff are an intangible resource, difficult for competitors to imitate and
offering a sustainable competitive advantage. Swayne et al. (2006) warned that such intangible
resources should not be underestimated.
PaLM Customer Service – Provider Satisfaction and Patient Experience.
Fottler et al. (2002) recognized that benchmarking service quality and customer value
depends on the customer’s perspective. PaLM customers in this study were identified as the
patient and care providers. Surveys ranked phlebotomy services and the physician satisfaction of
laboratory services at H642, H510, and H750 as a condition of CAP accreditation (CAP, 2014).
Mary at H510 said that a 3rd party surveyed staff physicians annually. Dr. Mick said that surveys
were “sent out for anonymous response… with a variety of questions to be rated on a scale of 1
to 5, or poor, fair, good, satisfactory, excellent, etc.” Dr. Mark said that “If the physicians believe
that the laboratory provides a good service with timely and accurate results, then scores will be
high. The higher the score, the more likely we are to know that the physicians will make our
hospital a place to practice.” Generally, as McCall (2016) and Jones et al. (2009) noted,
providers are satisfied with the quality and reliability of laboratory testing, the courtesy of the
laboratory staff, and the adequacy of test order menus. H750 hospital administrator Terry said
that hospital surveys found that the laboratory added value to patient care by “ensuring that our
test results are accurate and timely.” Inal et al. (2016) noted the value associated with accurate
and timely laboratory test results to healthcare providers.
A key aspect in any value-proposition takes into consideration the stakeholder’s needs
and expectations (Price et al., 2016). Tracy remarked that meeting Medicare’s quality star rating
required ancillary services to “understand strategic decisions from the needs of the customer, our
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patient’s perspective.” A hospital’s value is defined by Medicare in Quality Star ratings (Centers,
2021). Passiment and Linscott (2014) noted that patients appreciate easily retrievable test results.
Luke spoke of improving the patient experience with online access in real time to laboratory test
results and identified patient satisfaction stating, “patients have access to their test results and
know what questions to ask before the provider arrives”. Luke said, “We encourage patients to
use the portal and we tell them the results will be available in a few hours. It is usually pretty
quick and saves a lot of phone calls.” Luke identified the interfacing of laboratory results to an
online portal as a VBA that improves satisfaction and efficiency.
Nilsson et al. (2017) recognized the multiple understandings of value exist for the patient.
Larry discussed the patient laboratory experience in terms of quality. Larry tied laboratory
quality to profitability, citing laboratory high-quality testing aids “patients in getting the right
treatment, getting well sooner, and going home sooner.” Karuppan et al. (2016) recognized that
patients desire convenient service locations with limited wait times. Mary remarked that the
H510 outpatient satisfaction surveys were good and said that patients appreciated the
convenience of the draw station inside the hospital. Mary spoke of defending the outpatient
phlebotomy location as an advocacy for the patients. Luke described an aesthetic overhaul of the
outpatient phlebotomy area as necessary to improve the patient’s experience. Luke said, “I think
we’ve really brought value to the hospital by doing improvements in that [phlebotomy] area.”
Koh et al. (2014) stated that some patient surveys reveal a dissatisfaction with specimen
collections and phlebotomy services. While participants did not directly discuss the patient’s
venipuncture experience, Luke described value to the patient with the preanalytical quality that
ensured by “AIDET, patient safety, and hand hygiene embedded in our employee training.”
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PaLM Efficiency - Process Improvements, Turnaround Times, & Standardizations
Sustainable cost reductions require the identification and modification of inefficient and
ineffective processes (Porter et al., 2017). Dr. Barb identified a process improvement relative to
HIV screening and confirmatory testing. Dr. Barb’s efforts to standardize resulted in patients
experiencing less delays and appropriate treatment. Karuppan et al. (2016) recognized that
internal activities are part of the larger processes, needing to be designed and managed for
optimal value delivery. Mary’s laboratory had streamlined and consolidated testing,
implementing new equipment and adding autoverification of test results, which improved
turnaround times and subsequently the emergency room’s throughput. Mary also implemented
process changes to help her staff visually recognize and prioritize “STAT specimens from the
emergency room patients.” Likewise, Dr. Mick recognized the need for a process change that
prioritized “stroke patient testing over all other routine or random test orders.” Schmidt et al.
(2016) and Worster et al. (2017) recognized that efficient laboratories utilize a managerial focus
on projects that improve processes, time, and complications.
Swayne et al. (2006) recognized that standardizations add value. Dr. Mark recognized
value as associated with “standardizing and streamlining services so that everyone across the
system uses the same measures and equipment”. Standardizations within the supply chain,
according to Dr. Mark, add value “with an economy of scale in the purchase of maintenance
contracts and testing supplies.” Similarly, Terry noted that standardizations of systemwide RFP
processes had resulted in major technology upgrades with significant cost savings.
Standardizations leads to improvements in quality (Green et al., 2018). Terry noted that
systems integrations and order set standardizations improved quality. Luke identified
standardization with bedside patient identification and labeling, a quality process required by the
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Joint Commission. Batalden and Davidoff (2007) recognized that some standardizations require
measurement to enforce compliance. Larry recognized that the laboratory’s “hardwiring
processes and continual monitoring” shortened the patient’s length of stay in the emergency
room.
Efficient organizations adopt best practices (Srivastava & Sushil, 2018). Laboratory
autoverification, recognized by Krintus et al. (2017) as a best practice, was implemented at
H510. Dr. Mick and Mary noted that autoverification had replaced the manual release of test
results and greatly improved processes and turnaround times. Luke was “looking into” how his
laboratory might implement autoverification. Larry recognized that new equipment with
interfaced results had eliminated the need for manual results entry. Larry said, “Consistently, we
are looking to invest in better equipment that improves our turnaround times and makes it
easier.” Dr. Mick identified that relocating the pathology frozen section room to “just outside the
operating room would reduce operating time for the patient…” Efficient organizations strive for
continuous improvement to optimize outcomes (Hallworth et al., 2015).
All interviewed laboratory leaders mentioned reporting out measures for STAT
turnaround times. Mary reported monthly STAT turnaround times at an emergency room
meeting and on a system dashboard. Gambel et al. (2019) recognized the reporting of turnaround
times was a best practice proven to communicate consistency. Hainen and Coberly (2018)
identified STAT turnaround times as a visible performance measure. Dr. Mick knew that new
instrumentation with a specimen track system had improved efficiency. Tracy stated that her
organization purchased better equipment to improve STAT turnaround times. Mary spoke of an
automated track system as a “hands free improvement, allowing technical staff to focus on
critical thinking tasks.” Larry recalled switching from laboratory testing to point-of-care testing
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in the past but said that now “newer technology with instrument interfaces were outperforming
point of care devices.” Turnaround times offer a measurement of efficient processes (Sarwar et
al., 2015).
PaLM Effectiveness – Utilization, Optimization, & Interdisciplinary Participation
ASCLS (2018) recognizes that medical laboratorians offer valuable expertise in test
selection and results interpretation, that reduces diagnostic error and avoids unnecessary testing.
Wilson (2015) and Lewandrowski et al. (2017) discussed that effectiveness of care was improved
with test order demand management approaches and test algorithms. Engaging laboratory leaders
can optimize organizational resources, identify improvement opportunities, and improve care
effectiveness
Utilization. Terry recognized value in the utilization dimension saying, “We play a big
role and nobody outside the laboratory puts that into play except us.” Laboratory leadership
drives utilization improvements by analyzing data and communicating with physicians
(Lewandrowski et al., 2017). Dr. Lem described test utilization as a needs analysis ensuring “the
appropriate utilization of high-end testing”. Noting healthcare’s limited resources, Dr. Lem
added, “We have to make sure there is a clinical necessity to run that test since these state-of-theart tests are quite expensive. We want to make sure they are done for the appropriate reason.” Dr.
Lem had “eliminated low-volume, high-cost tests” which he described as “a poor utilization of
resources.” Dr. Mick had taken steps to remove tests from computer order sets to ensure the
appropriateness of test orders. Dr. Lem noted that effective utilization required identification of
“tests that are not warranted anymore or had fallen out of favor clinically.” Standardizing order
menus and eliminating unnecessary testing was a project Dr. Lem described as highly effective
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“especially in terms of batch testing and order sets, to make sure that physicians were ordering
only the tests required and getting rid of tests that are not clinical useful.”
Resource optimization. Healthcare administrators implementing VBHC strategies must
carefully consider the specific internal strengthening actions and resource allocations necessary
for success (Bryson, 2018). High performing organizations enable all stakeholders to engage in
optimization and resource allocation decisions (Carmen et al., 2014). Luke saw an opportunity to
optimize existing resources and enhance revenues by performing outreach testing. Larry
recognized that a new laboratory analyzer with high throughput and rapid turnaround times was
optimal over “the expensive point of care testing platforms used by nursing.” Mary participated
in resource optimization efforts “by combining purchasing power with sister laboratories” for
significant cost savings.
Raebel et al. (2019) pointed out that PaLM expertise is instrumental in the identification,
prioritization, and selection of improvement initiatives. Dr. Barb and Terry recognized the
laboratory’s informational prompts on electronic test orders and helpful comments on test results
reinforced transfusion guidelines and stroke measures. Terry offered the example: “If the
hospital stroke measures state a targeted goal for LDL is less than 100, or if best practice for
transfusing is only when hemoglobin is less than 7, the [laboratory] informational prompts help
our organization meet these goals.”
Interdisciplinary Participation. Laboratorians demonstrate clinical expertise
participating on multidisciplinary teams (IOM, 2015; Wagar, Eltoum, & Cohen, 2019). Aldeman
(2012) and Wagar et al. (2019) recognized the value of laboratory leaders interfacing with other
healthcare professionals and communicating cross-functionally in hospitals. Dr. Barb recognized
the value of her clinical expertise during the Covid pandemic as she participated in daily and
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weekly interdisciplinary meetings. Mary reported Covid testing results information daily during
multidisciplinary incident command calls. Medical technologists at H510 and H750 presented
convalescent plasma education. Wagar (2019) recognized the importance of laboratorians
liaising with physicians and nurses. Nilsson et al. (2018) recognized that interdisciplinary
meetings improve organizational knowledge.
Dr. Mick described “presenting information to committees or… discussing cases at grand
rounds or tumor boards” as an “opportunity to educate others.” Terry, noting PharmD’s
integration with clinical care teams, commented that “The laboratory may not be doing
integration at the nursing floor level yet, but we are doing it [integrating] at the hospital
infrastructure level, within IT, quality, and finance. We' re getting out there, into all of these
various settings.” Laboratory professionals add value in healthcare as clinical consultants,
sharing clinical expertise on care teams, tumor boards, infection prevention committees, clinical
utilization and antibiotic stewardship committees, performance improvement teams, and
transfusion management programs (CCCLW, 2016; COLA, 2015; Davis et al., 2018; Morgan et
al., 2017).
Terry shared that multidisciplinary meeting attendance allowed laboratory leaders to
bring back valuable information “to laboratory leadership who can help determine the feasibility
of requests.” McFadden (2014) noted that organizational operations were refined and updated
with the dissemination of knowledge. “If our laboratory did not attend these committees, they
would miss important information. For instance, if the ER has a goal of 1 hour for results, the
laboratory can help meet that goal,” said Terry. Likewise, Mary recognized the importance of
multidisciplinary meeting attendance for educating and sharing change information. Terry was
hopeful that hospital administration would say “how can we survive without laboratorians being
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part of the team?” Terry sought to “lock the laboratory in place at different levels of the
organization.” Such visibility, supportive efforts, consultation, and information sharing
improves value and recognition (COLA, 2015).
PaLM Quality – Specimen Phases, Safety, & Data
Hawkins (2012) stated that the analytical dimension of laboratories was the best
performing sector of healthcare. Price and St. John (2014) identified the value associated with
the laboratory test as the information communicated from the result. The “laboratory data is an
integral part of patient care decisions throughout the hospital,” said Terry who offered examples
of assisting pharmacy in medication therapy options, Xray in contrast dye procedures, and
infection control in isolation precaution needs. The ASCLS (2005) recognized that laboratory
test results offered value for determining the effectiveness of nutritional and medical treatments,
drug or cancer therapies, and optimal antibiotic therapies.
Hawkins (2012), MacMillan (2014), and Waibel et al. (2018) mentioned that quality and
cost savings were associated with the extra-analytical phases of laboratory testing. Laboratory
quality begins with specimen collection quality, described by Larry as “ensuring the right patient
is getting the right treatment.” Terry and Luke identified the laboratory’s role in clinical
procedures such as finger and heel sticks, venous and therapeutic phlebotomy, and
nasopharyngeal specimen collections. Mary identified the laboratory’s participation in bone
marrow aspirations.
Luke had requested capital for bedside label printers as “a safety improvement project.”
Dr. Barb noted that customer service surveys with HCAHPS asked, “How is the courtesy of the
person who drew your blood?” Luke recognized specialized teaching and the monitoring of
“AIDET, handwashing, and labeling” as value adding. Dr. Barb also mentioned specialized
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training in blood culture collections that improved the patient’s quality of care. At Dr. Mick’s
hospital, where nurses performed most specimen collections, the laboratory contributed value by
educating nurses on specimen collection timeliness, technique, and transport. Plebani & EFLM
(2017) noted that optimal analytical performance depends on the quality assurance of extraanalytical phases.
Palm Data. Laboratory test results provide the data necessary to improve healthcare’s
utilization, quality, outcomes (Shirts et al., 2015), and costs (Xu et al., 2015). Dr. Mick identified
the importance of laboratorians analyzing and sharing test data information. Dr. Mick said, “We
attend a quality committee, where laboratory data is reviewed, and offer feedback … our data
goes to collaborative and the medical executive committee…or may be used in informal
meetings with physicians.” Terry noted that data from the laboratory was reported to the
“quality management group, infection prevention group, and risk management group.” Terry
acknowledged that “the laboratory controls an unbelievable amount of data” and “instead of just
knowing how to perform a glucose test, we know the answers to a million questions from our
data, relevant to the treatment of populations.” Terry felt strongly that the laboratory must
“maintain its own laboratory informatics group, separate from the hospital informatics group...
because the laboratory is so complex that nobody, nobody except a laboratorian, will have the
answers to those questions.” Downs and McMinn (2017) stressed that the value of laboratory
would become more transparent as health systems delve into population health. Medical
laboratorians have adequate skill sets and expertise for the management of population health
strategies (Swanson et al., 2018).
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PaLM Cost Improvements –Sourcing, Cost per tests, and Cost Avoidance.
COLA (2015) pointed out that laboratory cost savings occur in the forms of cost
effectiveness, cost containment, and operational efficiency. Cost effectiveness involves assessing
competitiveness, pricing, and profitability (Downs & McMinn, 2017). Luke used his laboratory
expertise to determine the best sourcing options for testing. Luke determined the potential
profitability of an outreach market stating, “If we grew our outreach test revenue on a larger
scale, we could potentially make a lot of money.” Luke determined laboratory pricing and markup based on Medicare’s laboratory fee schedule. Dr. Barb considered a different sourcing
decision by assessing the cost effectiveness of insourcing Covid testing. Dr. Barb clarified that
her decision had “reduced turnaround times in half… and the cost per test” by 62%. While
Rogers et al. (2019) stated that outsourcing low volume tests may improve hospital laboratory
costs, this study finds no direct evidence to support outsourcing as a cost-effective measure.
COLA (2015) noted that cost effectiveness requires improvements in operational
efficiencies, quality, and per unit costs, guided by competent laboratory management (COLA,
2015). Passiment and Linscott (2014) stated that competent laboratory management was essential
to identify cost improvement opportunities. Mary worked with system level laboratory directors
to “determine how best to streamline services” and identify cost savings “on maintenance,
contracts, and testing supplies”. However, hospital administrators had not asked Mary to
demonstrate her cost savings efforts. Lewandowski et al. (2017) recognized that laboratorians
play a significant role in the investigation of testing methods and new tests. Terry had assessed
contracts for laboratory equipment and supplies optimization that combined system purchasing
power for significant operational cost savings. System level contractual relationships minimize
costs (Harrison, Harrison, Howey, & Schwartz & Pearson, 2013).
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Appropriate utilization improves the effectiveness of care, while demand management
decreases direct and downstream costs of care (Lewandrowski et al., 2017; Wilson, 2015). Dr.
Mick stated that the laboratory stewardship committee functioned to improve utilization and “the
provision of value-based laboratory services and quality.” Dr. Mark spoke of avoiding costs with
the “judicious use of transfusions.” Dr. Mick discussed a C. difficile test orders as inappropriate,
i.e., without liquid stool or a history of antibiotics. “Good stewardship”, said Dr. Mick, “required
us to remove this test from the standard order set…avoiding the delay of results and the
unnecessary testing.” Laboratory stewardship, per Halstead and Sautter (2018) eliminates waste,
and ensures the right tests are ordered for the right patient care. Dr. Mick felt that a laboratory
stewardship committee sought “to deliver an entire value – or in other words an appropriate
utilization, with quick turnaround, quality results, and cost savings.”
Larry emphasized that the laboratory’s high-quality assurance efforts avoided costs
because “the quality of care and length of stay directly ties to the hospital’s profitability.” Larry
clarified that “accurate information on blood cultures, urine cultures, and throat cultures,
specifically determines the correct antibiotics necessary to treat the patient.” Dr. Barb
emphasized cost avoidance with a reduction in blood culture contamination rates. PaLM leaders
expressed a lack of access to per unit cost information and the knowledge to present cost
avoidance efforts.
The Hospital Administrator.
The executive level administrator, as the primary decision maker, owns the strategic
formulation and planning responsibility, while lower-level employees implement activities and
support customer service relationships (Davis et al., 2012). Tracy articulated this point when she
said, “I’m not sure that the ancillary service lines are directly involved with the strategic
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objectives of the health system. Rather these services lines follow the lead of the decisions made
at the executive level.” Tracy added that if hospital administration asked a specific question of
laboratory leaders, then an answer would be provided. Terry corroborated that waiting “for
administration to reach out” was common before offering information. Mary said, “The
laboratory helps by providing what administration asks for.” Adelman and Stokes (2012) noted
that leaders who establish trust, build relationships, and remain visible encourage feedback from
employees.
Texas hospital administrators utilized metrics to assess PaLM services for quality,
turnaround times, and customer satisfaction. H710 and H510 hospital administrators evaluated
PaLM services by physician and employee satisfaction. Mary’s annual performance was graded
on physician satisfaction, and employee engagement and retention measures. Concerning
physician satisfaction, Dr. Mark said, “If the physicians believe that laboratory and pathology
services provide a good service with timely and accurate results… they will be more likely to
practice at this hospital.” While uncertain how H642 hospital administrators analyzed PaLM
performance, Dr. Barb concluded that “they recognize we have some opportunities.” These
opportunities were not elaborated. Texas hospital administrators did not use value-based
performance measures for assessments – i.e., competitiveness, efficiency, effectiveness, and cost
improvement. Nordi and Kork (2017) expressed that more appropriate measurables should be
organizational learning and value gains.
Effective communication requires feedback, defined as the reaction to the message,
which permits clarification (Guo, 2011). Feedback offered by Texas hospital administrators was
limited to the customer satisfaction scores for laboratories. Feedback on other types of VBAs
were not offered by hospital administrators. When asked about feedback from hospital
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administration, Mary said, “What feedback have I gotten? From administration? I’m not sure that
I have gotten a lot of feedback from administration about our activities…I am not sure that there
were any kudos for the laboratory even during Covid. It’s all about nursing.”
Longenecker and Longenecker (2014) discussed that a lack of two-way communication
regarding improvement initiatives causes significant problems. An ASCP survey found that the
lack of appreciation was a dissatisfier among laboratorians (Garcia et al., 2019). Passiment and
Linscott (2014) wrote that “The mystery of the laboratory is perpetuated by the lack of an
organized, systematic, flexible, and bi-directional exchange of information, ideas, standards, and
beliefs between the laboratory and its customers, i.e., effective communication.” (p.451).
PaLM’s Messaging.
The laboratory’s primary interface with hospital administrators was the laboratory
administrative director and the PaLM medical director. No DCLSs were identified in this study.
Wood (2016) noted that ideally the hospital-based pathologist plays a major proactive role in the
development of the laboratory’s value proposition. Wagar et al. (2019) discussed the importance
of the hospital pathologist having excellent communication skills, interfacing outside the
laboratory, and being involved in clinical laboratory activities. However, Dr. Barb identified
inadequate “time for putting together reports” as a barrier in involvement and in demonstrating
the laboratory’s VBAs. While success reports offer a powerful communication tool (Hartland,
2018), Hendricks et al. (2015) noted that most hospital pathologists already have a day job with
little time left to devote to outside of pathology reporting.
Lippi and Mattiuzzi (2019) pointed out that the laboratory manager establishes favorable
and constructive interfaces with hospital administrators. Passiment and Linscott (2014) felt that
laboratory management owned the responsibility for improving communication skills. Alder et
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al. (2019) posited that education and training was necessary for reporting upward on
improvement projects and departmental results. Successful initiatives require a communication
plan that shares knowledge with the organization (Graber, 2017). Terry expressed that PaLM’s
value messaging should help hospital administrators “stop and think because they’re really good
people, but sometimes the (laboratory) message gets washed out.” Information overload does
hinder effective listening for the hospital administrator, resulting in the selective screening and
discarding of information (Communication, 2016; Gardner & Winder, 1998).
Tracy noted the importance of having “a trusted relationship between hospital
administration and ancillary directors.” Establishing relationships builds rapport and improves
credibility (Communication, 2016). Tracy discussed the laboratory’s “credibility, accountability,
and responsibility,” a phrase also used by Terry. Effective communication requires a credibly
perceived information source, competent communicators, and a clearly defined message
(Gardner & Winder, 1998). Karuppan et al. (2016) noted that managers should communicate
with the executives interested in their efforts, since details are better remembered by interested
receivers.
PaLM’s Communication Barriers.
Lord (n.d.) noted that improvements in communication are essential for the delivery of
VBHC. While organizational charts define the intended communication channels (Passiment &
Linscott, 2014), Tourih and Robson (2004) recognized that hierarchy inherently filters
information. Terry said that “Organizational layers, with many differing cultural thought
processes, present a challenge for delivering a cohesive message of value.” Both Tracy and Terry
recognized that organizational layers presented a challenge for effective communication. Tracy
stated that another communication barrier “…could be that laboratory leaders lack an
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understanding of the premise to our questions on improving value”, adding that “questions about
improving value tend to be thought of as cutting costs, suggesting a loss of funding, or FTE’s.”
Guo (2011) warned that positions of status can affect messaging.
Communication on improvement activities demonstrates the efforts to transform
operations (Fusch & Gillespie, 2012). When asked about the laboratory’s value message, Dr.
Mark said, “I do not think that laboratory overall does a great job of reporting their initiatives to
the global c-suite.” Dr. Mark wished “the laboratory could take one of its initiatives … add a
cost avoidance measure over the past year with it and demonstrate savings.” Dr. Mick knew that
many laboratory VBAs “improved all three aspects of a value strategy - shortening time,
providing quality care, and reducing the cost of care.” However, when asked about sharing this
information, Dr. Mick suggested this “might occur if we had time and could justify what the
changes are doing.” Dr. Mark, Dr. Mick, and Terry expressed that a lack of access to
information was a barrier for laboratorians reporting. Terry identified the challenge of
calculating per unit costs, while Dr. Barb was uncertain how to express cost avoidance.
PaLM’s Communication of Value.
Laboratory leaders need an effective value-presentation message (Gross et al., 2019) and
recognition of value is the critical first step (Misialek, 2014). Terry suggested that PaLM’s value
message needed to be presented as “a business case.” Terry described his efforts with other
system laboratory leaders in the negotiation of laboratory equipment contracts. Terry presented
to system executives a new corporate purchasing agreement with projected savings, expected
outcomes, and a six-month monitoring plan for actualized savings. Hospital administrators prefer
such concise and relevant information (Communication, 2016). A well-performed public
presentation tailored toward the executive level establishes credibility (Weinholdt, 2006).
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Demonstrations with a certainty of the cost savings and effectiveness of improvements, help to
gain political support (Øvretveit, 2009). Terry understood that credibility was important in his
presentation. Terry said that hospital administrators were “approached many times in a day with
false promises of better quality and monetary savings”. Terry was aware that hospital executives
are skeptical of bold savings solutions without details on the time, costs, and the necessary
efforts (Øvretveit, 2009).
Touring hospital administrators around the laboratory offered laboratory leaders an
opportunity for Show-and-Tell. Luke said that H750 hospital administrators visited his
laboratory to see the work-in-progress. A finance executive at H510 visited Mary’s laboratory to
see the new specimen track system after implementation. Such Gemba walks improve a senior
leader’s accessibility to line-level employees and demonstrate their commitment (Protzman et
al., 2015).
Multidisciplinary forums offer laboratorians a platform to present VBAs. Mary presented
data on process improvements and quality at the hospital’s quality meetings, although she noted
that hospital administrators did not attend this type of meeting. Dr. Mick also recognized that
hospital administrators rarely attend clinical meetings, and missed the information shared at
clinical forums. Larry felt that since all hospital quality information rolled up into one large
report for hospital administration, then hospital executives were aware of the laboratory’s data
presentations. Tracy noted that data from the laboratory was reported to “quality management,
infection prevention, and risk management” committees. Terry added that laboratorians
presented at the hospital’s pharmacy and therapeutics committee. “We’ve developed a whole
discussion group related to things like laboratory quality metrics and blood utilization,” Terry
said.
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Wagar et al. (2019) noted that laboratorians demonstrate value by interfacing with others
in healthcare. Organizational value is delivered communicating cross-functionally in hospital
meetings (Adelman, 2012). Porter and Lee (2016) pointed out that value creation in healthcare
does not occur in specialty silos, but rather in the teams working across the care cycle. Good
communication systems require laboratory leadership to be involved outside of the laboratory
(Passiment & Linscott, 2014). The networking of physicians with administrators aids in an
exchange of healthcare best practices and protocols (Spaulding et al., 2018). Dr. Mick gave
knowledge-based information when attending “tumor boards, collaboratives, and the medical
executive committee.” Dr. Lem attended quarterly blood transfusion meetings. Dr. Mick
attended system-level laboratory stewardship meetings. Dr. Barb attended hospital operational
meetings. Interdisciplinary participation improves diagnostic errors (IOM, 2015), inefficiencies,
and ineffectiveness (Bodenheimer & Smith, 2013; Laposata, 2018b; Raebel et al., 2019). COLA
(2015) recognized that laboratorians offer a knowledge-based service to clinicians that improves
organizational competitive value. Terry assigned laboratory supervisors to attend most of the
hospital interdepartmental meetings. Terry said laboratorians at H302 were “put in front of these
groups to provide answers and bring back information...”. Regarding the conveyance of value,
Terry said, “We don't attempt to structure a time to convey that message, we attempt to be where
the questions are being asked.” Working collaboratively and effectively across organizational
boundaries enhances PaLM’s influence and builds strong allies with institutional leaders
(Henricks et al., 2015). Nilsson et al. (2018) recognized that interdepartmental communication
and collaboration are the best ways to promote organizational learning.
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PaLM’s Communication Methods.
Laboratorians presented information to hospital administrators via e-mail and text
messages. Luke estimated that 95% of his communication occurred via e-mail. Luke added, “I
don’t like verbal communication for anything official because I don’t have a record of it.” Dr.
Lem also communicated with emails, saying “…we e-mail a letter to administration, and
administration in turn sends it out the medical staff.” Guo (2011) pointed out that communication
with e-mail, while flexible and time saving, could be problematic. Mary chose texting for daily
communication with Dr. Mark. Mary also met monthly with Dr. Mark for a face-to-face meeting.
Dr. Lem and Dr. Mick met quarterly with the hospital administration for information sharing.
Laboratorians communicated on system level dashboards for performance improvement
projects and developed written reports for a variety of committee meetings. Mary tracked H510
PaLM performance data on a spreadsheet. Spreadsheets can demonstrate the clinical and
economic benefits of new technologies (BaseCase, 2013). Mary and Dr. Mick noted the
performance improvements made with a new track system were monitored with turnaround times
in a spreadsheet. Dr. Barb reported pathology quality and performance metrics to hospital
administration annually but said “on the clinical side (of laboratory), I don’t know that we do as
good of a job turning in a written report.” Miller (2019) warns that simply reporting
performance metrics does not necessarily “improve quality or costs to any meaningful degree”
(p. 445). Mary was uncertain how hospital administration assessed her laboratory’s quality
efforts. Mary said, “they [administration] do not ask us for anything, we just try to give our
assistance with the hospital quality measures by offering blood culture contamination rates.”
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Relationship to the Problem
The general problem addressed in this study was the failure of laboratory leadership to
communicate PaLM VBAs to healthcare administrators, resulting in lost opportunities to
demonstrate cost savings. This research finds that laboratory leaders regularly communicate with
hospital administrators but not about cost savings. Luke and Mary met monthly with a one-up in
administration. Dr. Barb, Dr. Lem, and Dr. Mick met quarterly with hospital administrators at
medical staff meetings. PaLM leaders regularly met with multidisciplinary committees.
Marlow et al. (2016) noted that the typical interests of a hospital CEO is on the patient
experience, satisfaction, and cost reductions. Luke disclosed to hospital administrators that his
remodeling project had improved patient experience. Dr. Mick, Dr. Lem, Luke, and Mary
discussed satisfaction surveys responses with hospital administrators. Employee engagement,
retention, and physician satisfaction were part of Mary’s and Dr. Mick’s annual performance
goals. PaLM cost savings activities, other than participation in system level contract
negotiations, had not been discussed with hospital administrators.
Improving costs and processes without sacrificing patient outcomes is the strategy for
VBHC delivery (Porter et al., 2017). Dr. Lem noted that conflicts occur regarding costs vs.
physicians wants. Dr. Lem said, “Issues arise when physicians want to order a multitude of
testing that may not be required.” Conversations about costs relative to a patient’s care were
described by Dr. Lem as “difficult” and “associated with risks to the patient.” Value discussions
were described by Tracy as “raising defenses” and “ill-perceived as cutting positions.” Epner
(2017) warned that linking cost savings to reductions in personnel or educational requirements
leads to negative impacts on patients and outcomes. Dr. Mark described point-of-care testing as
“a way to reduce FTEs and demonstrate cost savings” with nursing performing this type of
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testing. Administrator Larry, with a nursing background, viewed point-of-care testing as a
higher-cost, jeopardizing the use of laboratory’s higher-quality test, with risks associated with a
“longer patient length of stay and downstream costs.”
COLA (2015) noted the importance of cost effectiveness in healthcare, which requires
competent management and operational improvements. Davis et al. (2018) and Thakkar et al.
(2015) discuss value from the consultative services of laboratorians. Improvements in
efficiencies and costs were realized by Dr. Barb moving Covid testing in house and developing a
test order algorithm. Dr. Mick discussed cost effectiveness with order algorithms for emergency
room patients. Passiment and Linscott (2014) pointed out that competent laboratory management
is a necessity for the identification of cost improvement opportunities. Dr. Mark, Dr. Mick, and
Mary identified cost and efficiency improvements while working with laboratory leaders on the
system stewardship committee. Dr. Mark described system level efforts as streamlining services
and saving costs on “maintenance, contracts, and testing supplies”.
Gross et al. (2019) discussed the need for value-defending conversations from laboratory
leaders, championing the laboratory as core asset offering data “to vast array of enterprise
strategies” (p. 616). This study found that laboratory leaders presented data to various
committees including infection prevention, blood management, sepsis and stroke, hospital
quality, risk, and pharmacy and therapeutics. Laboratory data was useful in assisting hospitals in
meeting department goals. Dr. Mick described laboratory data as useful for the quality,
collaborative, and medical executive committees. Tracy, Mary, and Luke identified the quality,
infection prevention, and risk management groups as utilizers of PaLM data. Terry identified
pharmacy and therapeutics committee, and radiology using laboratory’s data.
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PaLM leaders connected their department’s activities with the measures recognized by
Marlow et al. (2016) i.e., the patient experience, physician satisfaction, and clinical quality.
Activities for laboratory data with analysis support hospital accreditation and status goals with
the publicly reportable measures identified by Tinker (2018) and Tierney (2017). However,
PaLM leaders in this study did not connect the value of their activities to a VBHC strategy.
Spaulding et al. (2018) pointed out that healthcare administrators were still in the discovery
phase of VBHC. B642 hospital administrators were “just beginning to look at VBHC,” according
to Dr. Barb. H750 hospital administrators had not discussed VBHC as a strategy. Dr. Mark
pointed out that Texas hospitals “were slow to adopt VBHC strategies.” Tierney (2017) noted
that hospital administrators establishing value-based management offices remained “unable to
articulate or demonstrate value” (p.22).
Tessier (2018) proposed that laboratorians need a comprehensive annual report detailing
value delivery with time studies, year-end accomplishments, committee attendance, process
improvements, patient experience scores, and even social media reviews. While Dr. Barb had
developed a year-end pathology summary for hospital administration according to the terms of
her pathology contract, she recognized the report as inadequate for detailing the clinical
laboratory’s activities. Dr. Barb expressed the importance of not merely telling “a story and then
moving on” but rather “presenting and bragging about ourselves.” Kridelbaugh (2018) noted that
regularly prepared promotional materials offered a form of marketing collateral for the
laboratory. PaLM leaders expressed barriers to reporting VBAs as a lack of time, competing
priorities, conflicts of interest, and a culture of presenting only what is asked for.
The specific problem addressed in this study was that laboratory leaders in acute care
hospitals fail to communicate VBAs to healthcare administrators, resulting in lost opportunities
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to demonstrate cost savings. PaLM leaders were responsive to the requests of hospital
administrators and aligned certain PaLM activities with hospital goals. Although Texas based
hospitals were not following VBHC strategies at the time of this study, PaLM leaders identified
many value contributions to the organization and recognized laboratorians as a core competency
for success. Cost savings were not shared because as Dr. Mark stated, “We rate our laboratory
and pathology services from a customer perspective, not from a cost perspective.” Likewise,
Mary commented “Our administrators have not asked for cost improvements.” Terry responded
with “We really do not offer information unless specifically asked.”
Some cost improvement ideas were not shared with hospital administrators due to the
perceptions of PaLM leaders. Some process improvement initiatives with test order algorithms,
preliminary reports, and instrument functionality were deemed as too difficult to explain to nonclinical hospital administrators. Luke said, “even if I explained they may still not understand.”
Dhand (2019) recommended avoiding medical jargon when communicating with hospital
administrators, depending on their clinical background. Luke had not shared a financial report on
his outreach program because he felt it was too insignificant. Luke also noted that administrators
had not requested cost savings information.
PaLM leaders presented quality data on system dashboards and at committee meetings
but avoided presenting cost savings. PaLM leaders expressed barriers in reporting cost savings as
a lack of per unit costs information and a lack of knowledge on how-to present cost avoidance.
Dr. Mick explained that “sharing of VBAs would require proof that we can provide a better
value.” Dr. Barb complained of a lack of time to develop such a report. Maul et al. (2019)
recognized that group purchasing organizations aid presentations by providing per unit cost
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reports for supplies. Kaplan et al. (2014) recommended time-driven activity-based (TD-ABC)
costing to demonstrate cost savings.
COLA (2015) states that cost savings occur in the forms of cost effectiveness, cost
containment, and operational efficiencies. Dr. Barb identified that a new test would reduce the
empirical use of anti-fungal medication as a cost-effective measure and training on the sterility
techniques for blood cultures would result in down-stream cost savings. Similarly, Fletcher
(2018) demonstrated cost effectiveness with a 3-hour reflexive troponin order to rule out
myocardial infarction which avoided $2000 per admission. Cost improvements and efficiencies
require the guidance of competent laboratory management to optimize cost effectiveness and
minimize waste (COLA, 2015). Larry described the H750 laboratory director as “constantly
looking for better ways and better machinery to improve patient testing.” Price et al. (2016)
recognized that PaLM expertise is associated with cost reductions. As Larry noted, “The optimal
cost avoidance improves the patient’s length of stay.”
Utilization activities for laboratory testing improve direct and downstream costs (Schmidt
& Ashwood, 2015). Appropriate utilization improves effectiveness of care and avoids
downstream costs (Lewandrowski et al., 2017). Dr. Lem identified appropriate test utilization as
eliminating “low-volume, high-cost tests that were not cost-effective or necessary…and were a
poor utilization of resources.” Dr. Lem described laboratorians as the “expert gatekeeper, making
sure that tests are required” and “setting parameters for ordering and spending.” Dr. Mick and
Dr. Mark recognized PaLM expertise as necessary for educating providers on appropriate
utilization and waste improvements. Shirts et al. (2015) discussed prospective and variable types
of cost savings in efforts to develop electronic alerts for duplicate orders, prompts on
unnecessary orders, rules for combining and canceling orders, and results with comments with
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instruction. Such systems-based interventions aim toward appropriate laboratory test utilization
offering a sustained cost savings (Sadowski et al., 2017). PaLM leaders at H302, H642, and
H510 noted utilizing systems-based utilization initiatives.
Summary of Research
RQ1 was designed to provide insight into the communication of cost savings by PaLM
leaders to hospital administrators. It was anticipated that PaLM leaders had failed to present cost
savings opportunities to hospital administrators (see Table 8). However, PaLM leaders
participating in system level contract negotiations demonstrate cost savings to hospital
administrators. PaLM participants in this study knew of VBAs and cost savings opportunities
that had not been communicated and noted that discussions of cost savings could be problematic.
RQ2 sought to identify from hospital administrators’ perceptions, the effectively
communicated PaLM VBAs by laboratorians. It was anticipated that hospital administrators were
unaware of PaLM VBAs (see Table 8). However, hospital administrators perceived that PaLM’s
high-quality testing improved the patient’s length of stay and downstream patient care costs.
Hospital administrators measured PaLM’s value with productivity metrics, and with physician
and patient satisfaction surveys. They recognized potential value associated with improving test
utilization and the streamlining of services and equipment. Laboratorians identified other types
of value, such as knowledge sharing by participation on multidisciplinary committees, hospital
quality, medical staff, and ad hoc discussion groups.
RQ3 delved into the communication of VBAs by PaLM leaders. It was anticipated that
PaLM leaders failed to communicate VBAs with hospital administrators (see Table 8). PaLM
leaders noted directly communicating with physicians and nurses, and hospital leaders in finance,
revenue, and other ancillary departments. Laboratory leaders developed and analyzed electronic
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reports for test data, test volumes, and testing times which were accessible to hospital leadership.
Quality departments utilized the laboratory’s data to monitor efforts toward the achievement of
hospital goals and reporting of performance measure to Medicare. Laboratory leaders
communicated with system dashboards for testing information. PaLM leaders presented verbally
at quality and clinical forums, medical staff meetings, and one-on-one meetings with hospital
administrators. They utilized texting and emailing as a primary form of communication and
provided tours of the department to hospital administrators.
RQ4 was designed to assess the alignment of PaLM VBAs with value-based objectives. I
anticipated that hospital administrators would be pursuing value-based objectives and that
phlebotomy customer service and turnaround times were monitored (see Table 8). VBHC
strategies however, had not been implemented in Texas acute care hospitals at the time of this
study and thus PaLM services were not aligned with value-based objectives. Nevertheless, PaLM
leaders sought activity alignment with hospital goals for the patient experience, physician
satisfaction, hospital accreditation, and status designation. Hospital administrators were unable to
identify PaLM activities contributing to cost savings or a VBHC strategy.
Summary of the Problem.
The problem explored in this study was the failure of PaLM leaders to communicate
VBAs to hospital administrators. While hospital administrators described PaLM leaders as not
forthcoming with cost savings information, laboratory leaders expressed that hospital
administrators had not requested cost savings information. Texas hospital administrators had not
implemented VBHC strategies, nor requested demonstrations of VBHC activities. They assessed
laboratory services based on physician and patient surveys, productivity, and turnaround time.
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Laboratory leaders responded to requests for data and reported-out information that contributed
toward the hospital’s accreditation and status goals.
Porter et al. (2017) noted that healthcare cost reductions require the identification and
modification of inefficient and ineffective processes. While some activities directly improve
costs (Halstead et al., 2018; Price et al., 2016), other activities indirectly improve costs with
improvements in efficiency, quality, or skills (Kushik et al., 2018; Lewandrowski et al., 2018;
Schmidt & Ashwood, 2015). This study identifies PaLM cost savings within the service and
support tracks of the mVCM (see Figure 2).
Laboratorians demonstrate value in the provision of direct patient care with bone marrow
aspirations, thyroid biopsies, nasal swabs, and phlebotomy services. Laboratorians demonstrate
value in activities to interface test results; optimize results information; ensure accurate and
timely results; improve preanalytic, analytic, and post analytic quality; streamline and
standardize processes; and consolidate system level purchasing. Laboratory leaders optimized
hospital networks by establishing outreach testing that improves hospital revenue, continuity of
care, and access to patient testing results. Laboratory leaders recognize value in activities that
ensure appropriate utilization of testing, which subsequently offers cost savings and improves
effectiveness of care.
Summary of the Purpose.
This qualitative case study adds to the body of knowledge by exploring the
communication of PaLM VBAs. The interviews with PaLM leaders and hospital administrators
identified a misalignment between the laboratory assessments utilized by hospital administrators
and the value-based contributions of laboratorians. From the responses to scripted interview
questions, themes emerged of PaLM VBAs, PaLM communication efforts, and PaLM strategic
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alignment. Interviews with leaders in Texas acute care hospitals offered insights into the
communication efforts of laboratory leaders. PaLM leaders primarily shared requested
information via e-mails, departmental tours, dashboards, and by liaising with hospital nurses and
physicians at multidisciplinary meetings. The barriers for communicating PaLM VBAs were
identified as a lack of access to information, organizational layers, perceptions of information
insignificance, avoidance of conflict, a lack of time, and a culture of sharing only what is
requested. PaLM leaders identified difficulty obtaining per unit cost information, developing cost
avoidance reports, and finding time to develop presentations.
VBHC strategies necessitate an identification of improvement opportunities (IOM, 2013).
Improvements require a clear communication plan and an alignment of leadership (Frye &
Baum, 2016). The information obtained in this study offers insight into improvement
opportunities, communication forums, and PaLM’s value contributions. This information
furthers the understanding of PaLM VBAs for hospital leaders implementing a VBHC strategy.
Laboratory leaders seeking to align with VBHC strategies will find insights to identify value and
the activities that contribute value. This study promotes the value contributions of laboratorians,
described by Davis et al. (2018) as essential but under-recognized. This study contributes the
need described by Anonychuk et al. (2012) for a broader perspective assessment of the
laboratory’s value contributions.
Summary of Findings
The purpose of this study was not an exploration of the degree to which Texas hospitals
had adopted VBHC strategies. However, Texas Medicaid contracts were implementing valuebased payment models at the time of this research (Texas HHS, 2021). Spaulding et al. (2018)
noted that a hospital’s ability to score well under a VBHC reimbursement model depended on
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the organization’s ability to learn and implement change. While VBHC strategies had not yet
been adopted in Texas hospitals, hospital administrators desired laboratory leaders to be more
forthcoming with value improvements and cost savings information. Likewise, PaLM leaders
expressed a desire for more appreciation of their knowledge and efforts. Kirkpatrick et al.
(2015) discussed that value increases as quality and costs improve. This research identified
some PaLM activities that directly reduced costs, while other PaLM activities improved quality,
efficiency, and/or effectiveness for an indirect cost savings. PaLM leaders also described VBAs
that offered enhancements to customer service and organizational competitiveness.
Hospital administrators recognized that high-quality laboratory testing is vital for the
diagnosis, prognosis, treatment, and management of human disease (Anonychuk et al., 2012;
Davis et al., 2018). While hospital administrators recognized the value of PaLM’s high-quality
testing as improving patient care and length of stay, they assessed the laboratory’s services based
on productivity and physician satisfaction surveys. Hospital-based laboratorians offer valuable
expertise that can improve test and transfusion utilization, test results interpretations, and
diagnostic accuracy.
Hospital administrators gained insights from the data presented by laboratorians.
Laboratorians communicated data on system level dashboards. Laboratorians offer other valueadding contributions such as disseminating clinical information, attending multidisciplinary
meetings, direct patient care, providing expert consultation, and educating others in the
organization. PALM leaders recognized the value of well-trained phlebotomists, qualified
medical technicians, and highly educated clinical scientists as a core competency for hospitals,
which were not identified by hospital administrators.
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Hospital administrators were unaware of PaLM leader’s efforts to align with hospital
goals and Medicare reportable measures. Laboratory data and interpretive expertise contributed
to the hospital’s achievement of Joint Commission accreditation, Magnet status honoring nursing
value (Brennan, 2019), and Leapfrog recognition of patient safety (Leapfrog, n.d.). However, the
lack of feedback from hospital administrators on the laboratory’s contributions was a source of
frustration for laboratorians, one of whom expressed, “It’s all about nursing.”
Laboratory leaders communicated operational challenges with hospital administrators
using texting, emails, and verbally. Laboratorians communicated clinical information to patients,
nurses, and physicians. PaLM leaders communicated hospital business leaders and offered
departmental tours. While pathologists provided an annual report to administrators on pathology
services, these reports did not communicate clinical laboratory VBAs.
Laboratory leaders utilized expertise and business skills in negotiating equipment and
supply contracts and expanding outreach services. Some hospital administrators recognized this
value., however they did not request cost savings demonstrations from laboratory leaders. Cost
discussions were perceived as a potential risk rather than a desired value. COLA (2015)
recommended that laboratory management present cost improvements as a form of cost
effectiveness and/or operational efficiency. PaLM leaders acknowledged difficulty ascertaining
per unit cost information and presenting cost avoidance efforts. While laboratory leaders could
describe VBAs that avoided costs, improved downstream costs, and optimized efficiency and
effectiveness, communication barriers presented a challenge. They identified these barriers as
a lack of time and knowledge and perceptions of insignificance. PaLM leaders did describe their
efforts to improve test utilization, however these utilization efforts were not necessarily
benchmarked or presented as a cost savings to hospital administrators.
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Conclusions
PaLM leaders have yet to fully explain their full range of clinical and management
activities (Burns, 2018). Laboratory professionals have the necessary skill sets to generate and
interpret data, establish reference ranges, present test results with clinical information, improve
order menus, assess laboratory data for health disparities and reduce healthcare costs (Wheeler et
al., 2021). Hospital laboratorians involved with data analysis, process improvements, and the
dissemination of knowledge improve patient outcomes (Howanitz & Howanitz, 2001).
Organizational knowledge, skills, and methods improve with cross functional communication
(Grove et al., 2019; Lewandrowski et al., 2018; McFadden, 2014).
The delivery of VBHC with process improvements and cost reductions (Porter et al,
2017) requires an understanding of the value streams and the value within healthcare (Miller,
2019; Protzman et al., 2015). Hospital administrators seeking to implement the rich objectives of
a VBHC strategy (Larsson & Tollman, 2017) need awareness and inclusion of the laboratory for
optimal success (Misialek, 2014). Recognizing value is a critical step for success (Misialek,
2014). As Kridelbaugh (2018) pointed out, a concerted effort by laboratory leadership is
necessary to keep senior management informed of recent developments and accomplishments.
Hospital administrators cannot fix organizational deficiencies without tapping into departmental
knowledge (Salahshor, 2016). Perhaps convincing others of the need for change is a step in the
right direction (Green et al., 2018).
Application to Professional Practice
During the two years taken to complete this multi-case study, national healthcare
expenditures in the United States grew 9.7% to $4.1 trillion, accounting for 19.7% of GDP in
2020 (Centers, 2021a). Healthcare systems around the world continue to struggle with rising
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costs (Porter & Lee 2013). While Porter and Teisberg offered theoretical guidance in 2006 for
VBHC, the associated complexities with value have presented barriers to implementation
strategies (Zanotto et al., 2021). The work of solving healthcare’s unsustainability and
inefficiencies (Cosgrove et al., 2013; IOM, 2013) guided by a triple aim (Berwick et al., 2008)
has evolved into a quadruple aim, adding the goal of improving the lives healthcare workers
(Bodenheimer & Sinsky, 2014).
PaLM’s innovative testing technologies proved pivotal during the Covid-19 pandemic for
achieving more accurate and efficient diagnosis and improved patient outcomes (Arshoff, et al.,
2021). However, the reported vacancy rates for laboratory professionals reached critical highs
(ASCLS, 2020). Subsequently, nearly 2.8 million healthcare workers quit their jobs in what has
been dubbed the Great Resignation (Wallask, 2022). As the demand for laboratory testing
increases, the number of qualified personnel to perform laboratory testing continues to decline
(ASCP & CWH, 2021). Laboratory leaders continue to report the need for qualified personnel,
solutions to staffing challenges, and wages commensurate with education and experience (Garcia
et al., 2021).
Improving General Business Practice
Hospital administrators need to recognize the value contributions from laboratorians and
need to “provide opportunities career progression, increased pay, and elevated titles” (ASCP &
CWH, 2021, p.5). Hospital administrators need awareness and inclusion of laboratorians
(Misialek, 2014) offering unique solutions that improve healthcare’s inefficiencies,
ineffectiveness, costs, and outcomes (Ashoff et al., 2021). Laboratorians with advanced
education play an important role in improving patient safety and care (Zaucha, 2021).
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Implementation of a VBHC strategy requires engaged healthcare managers and experts
like the laboratorian in data collection and technological advances (Tsai, Porter, & Adams,
2018). To achieve the goals of VBHC, laboratorians must communicate and be involved outside
of the laboratory (Passiment & Linscott, 2014). Value creation in healthcare does not occur in
specialty silos, but rather in the working teams across the care cycle (Porter & Lee, 2016).
Organizational leaders must encourage the building of trusted relationships and effective
communications (Aldeman & Stokes, 2012) with PaLM services. Laboratorians need to share
their expertise by serving on hospital committees, taking on assignments with nursing units, and
being a recognizable liaison (Passiment & Linscott, 2014). Such interfacing with other healthcare
experts enhances professional influence and demonstrates value (Wagar et al., 2019).
Additionally, interdisciplinary participation improves diagnostic errors (IOM, 2015),
inefficiencies, and ineffectiveness (Bodenheimer & Smith, 2013; Laposata, 2018b; Raebel et al.,
2019). Organizational knowledge improves with shared experiences among and between
employees (Nilsson et al., 2018) and the differing perspectives refine, update, and transform the
organization (McFadden et al., 2014).
Laboratorians offer knowledge-based services to clinicians that improve competitive
value (COLA, 2015). Organizations that commit to knowledge sharing and skills improvement
enhance the hospital’s competitive advantage (Gambel et al., 2019; Swayne et al., 2006).
Surveys indicate that most executives believe the laboratory offers an important function in
healthcare delivery (Economist, 2018). Texas hospital administrators perceived the value of
PaLM’s high-quality testing efforts but were unaware of other roles and the scope of activities
(Branda et al., 2014), and overlooking the laboratory when seeking value improvement
opportunities (Downs & McMinn, 2017; Shrinkman, 2016). Hospital administrators did not
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identify the PaLM VBAs improving organizational knowledge, care effectiveness, patient
outcomes, quality, safety, and profitability. Protzman et al. (2015) noted that hospital
administrators lack a clear understanding of the value streams and the interconnectivity of
processes.
Potential Application Strategies
The need for healthcare and the consequent care delivery expenses continue to rise
exponentially. VBHC strategies offer theoretical guidance, however presenting value has proven
complex, and the communication value has many variables. The Covid-19 pandemic drew
attention to the laboratory’s value contributions toward accurate and timely diagnoses (Linder,
2020, ASCP & CWH, 2021). Yet the laboratory profession continues to struggle with staffing
challenges, qualified personnel, and wages equivalence (Garcia et al., 2021). This study offers
recommendations for hospital administrators seeking to improve value in the patient experience,
employee satisfaction, and costs. Hospital administrators reviewing this study have access to the
PaLM concepts that improve value with process improvements, outsourcing, equipment
contracts, supplies standardizations, revenue generation, cost saving, improved utilization, and
knowledge sharing. Transparency and analysis of the value chain is necessary if value is to
increase (Schmidt, Flores, & Montgomery, 2020). The categories within the value-chain are the
proven essentials of value creation (Swayne et al., 2006).
PaLM Assessments.
Texas hospital administrators assess laboratory services based on turnaround times,
productivity, and customer survey responses using relatively easy-to-access data measures
(Nilsson et al., 2018). Such volume and structural assessments, while vague on the provision of
value (Lazar et a., 2013), improve with higher educated employees, technological advances, and
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capital investments (Sheiner & Malinovskaya, 2017). However, siloed performance assessments
fail to capture organizational improvements (Plebani, 2016; Price et al., 2016) or to facilitate
behavioral changes from the patient perspective (Nordkin, et al., 2017).
This study identified a misalignment between the assessments utilized by Texas hospital
administrators for PaLM services and the value contributions recognized by laboratory leaders.
There is no single set of core metrics universally accepted for the measurement of value
(Carmicheal et al., 2016). Process compliant track-and-trend measures distract from the “more
significant goal of improving health outcomes” (Teisberg et al., 2020, p. 682). Although as
Orefield (2000) points out, patient outcomes are really a measure of process results. Ideally,
selected value measures judge in a manner consistent with the main goals of the health system
(Sikaris, 2017) with guidance by the quadruple aim of improving the patient experience, health
outcomes, costs, and the team’s well-being (Arnetz et al., 2020).
Hospital administrators seeking to improve organizational efficiency (Vrijsen et al.,
2020) may adopt different assessments for laboratory services, such as a measurement for the
number of inpatient laboratory tests per patient day, the volume of laboratory orders cancelled, or
the number of specimens rejected as measures of process errors (Stottler & Kratz, 2012;
Hawkins, 2012). Since most laboratory failures occur in the pre-analytic phase (McCray, 2009)
improving process defects would facilitate better productivity (Hallworth, 2015) and quality
(Chawla et al., 2010). Identifying and correcting errors consumes inordinate resources (Carlson,
2012), while reducing errors improves organizational efficiency (Tsai et al., 2019).
Hospital administrators utilize patient satisfaction surveys to assess laboratory services.
Surveys have shown that patients value access to their own health information (COLA, 2019b)
and easily retrievable laboratory test results (Passiment & Linscott, 2014). Thus, patient centric
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feedback could clarify the laboratory’s discussion of access to the online patient portal for test
results. Since patients want readability, relevance, and next steps from PaLM test reports
(Kelman et al., 2016; Poczter & Giugliano, 2014) and feel empowered with face-to-face
consultations (Booth et al., 2018), patient surveys should assess these attributes.
Measuring ancillary services solely on test volume and cost (Bergeron, 2017) misses
other important unreimbursed activities (Wilson, 2014). Optimal assessments avoid siloed
performance measures, rather focusing on organizational learning and partnership development
(Johannessen, 2021). Networking for example, could be viewed as unproductive but facilitates
the exchange of best practices and protocols in healthcare (Spaulding et al., 2018). Hospital
administrators promoting team activities provide connection opportunities, promote learning and
the dissemination of knowledge and skills, and seek to enhance employee satisfaction (Nilsson et
al., 2018; Carman et al., 2014). Assessing PaLM leadership’s involvement with hospital
committees and stewardship programs offers an actionable form of intelligence.
PaLM Involvement & Communication of Value.
Patient care improves when laboratorians are involved with decision support systems,
order sets, algorithms (Sarkis, 2017), utilization efforts, electronic demand management, and
reference test gatekeeping (Lewandowski & Sluss, 2017). Utilization efforts enhance the
patient’s experience by eliminating unwarranted testing, unnecessary downstream follow ups,
prolonged hospital stays, and iatrogenic anemia (Gupta et al., 2017). Clinical outcomes improve
when laboratorians partner with clinicians (Patel & Fang, 2018). Interdisciplinary participation
improves diagnostic errors (IOM, 2015). Surveys indicate that 60% of healthcare providers
would appreciate clinical laboratorians offering diagnostic related education (Economist, 2018).
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Organizations that commit to knowledge sharing and skills improvement enhance their
competitive advantage (Gambel et al., 2019; Swayne et al., 2006).
Laboratory leaders demonstrate value by interfacing with other healthcare professionals
(Wagar et al., 2019) and communicating cross-functionally (Adelman, 2012). Communicating
PaLM VBAs to hospital administrators demonstrates the efforts that transform operations (Fusch
& Gillespie, 2012). PaLM leaders need an improved communication strategy (Passiment &
Linscott, 2014) with more involvement in hospital operations, and more publishment of evidence
regarding their efforts to improve clinical, operational, and economic outcomes (Davis et al.,
2018; Delvin, 2017; Epner et al., 2017; Landin, 2013). Well-performed presentations establish
professional credibility (Weinholdt, 2006).
PaLM’s Role in Healthcare Costs.
Laboratorians play a vital role in cost-effectiveness, error reduction, and improved patient
outcomes (Nadder, 2013). Competent laboratory management guides improvements in
operational efficiencies and per unit cost savings (COLA, 2015). Consultation with doctorate
level CLSs results in improved care and significant cost savings (Hendren & Gunsolus, 2018).
Costs improve by eliminating orders variations and low-value testing that generates waste (Wong
& Hilborne, 2021). Healthcare costs needlessly increase without the judicious use of laboratory
resources (Lewandrowski et al., 2017). Sustainable cost reductions are found in the identification
and modification of inefficient and ineffective processes (Porter et al, 2017). Implementing waste
elimination measures reduces healthcare costs (Shrank et al., 2019).
VBHC necessitates thinking in terms of value ROI, rather than financial ROI (Green et
al., 2018). Value metrics for diagnostic services ideally demonstrate outcomes achieved relative
to the cost of care (European, 2017), although few organizations accurately measure costs in
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healthcare (Lee et al., 2016). PaLM professionals use a variety of cost descriptives including cost
containment, cost effectiveness, cost reductions (COLA, 2015), downstream costs, cost
avoidance (Schmidt & Ashwood, 2015), cost savings, cost improvements, (Halstead et al., 2018;
IOM, 2013; Price et al., 2016), prospective cost, variable costs (Shirts et al., 2015), and cost
effectiveness (Misialek, 2014). Most agree that true costs in healthcare depend on the actual
resources involved in care delivery (HBS, n.d.). The cost reducing activities of this study were
identified within the activities of the value chain. PaLM leaders need a better understanding of
the value-chain and a better presentation of cost savings efforts for hospital administrators. Timedriven activity-based costing seems well suited to capture the effects of process changes on cost
variation (Kaplan & Price, 2011).
Summary of the Applications to Professional Practice
VBHC strategy implementations necessitate the need for field experts, like laboratorians.
Hospital administrators studying VBHC need an awareness of the value from PaLM experts.
Healthcare value does not occur in specialty siloes (Porter & Lee, 2016), but rather in interfacing
and interdisciplinary participation (IOM, 2015) with shared experiences. The hospital
administrators in this study did not perceive the PaLM value associated with improvements to
organizational knowledge, profitability, safety, or costs. As Protzman et al. (2015) pointed out,
hospital administrators lack a clear understanding of PaLM’s value chain. Mismatched
assessments need to be redirected (Arnetz et al., 2020) toward the quadruple aim and the goals of
the health system (Sikaris, 2017). PaLM professionals have failed to connect the laboratory’s
critical value-adding activities to strategic imperatives (Dixon, 2019). Rather than faulting either,
collaborative efforts should be emphasized (Henricks et al., 2015) and tapping into the
laboratory’s value chain.
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Recommendations for Further Study
The value offerings of PaLM improve health care, enhance organizational performance,
and reduce costs (Orfield, 2000). PaLM expertise is instrumental for VBHC strategies that
require the identification, selection, and prioritization of improvement initiatives (Raebel et al.,
2019). The contributions of laboratorians improve outcomes and lower costs, albeit these
contributions have been ineffectively communicated to hospital administrators. Monitoring
continuous improvement targets within the value chain aims for operational excellence (Gambel
et al., 2019). Hospital administrators need more awareness of PaLMs value chain and incentives
to remove barriers for laboratory professionals. Laboratorians need further exploration of their
profession’s value chain and a well thought out communication plan.
Value Chain Development
The value chain is utilized by business analysts to evaluate the opportunities that
maximize profitability and competitive advantage (Gambel et al., 2019). The current climate in
healthcare requires a justification of activities and expenditures from every sector as a
demonstration of value (Nadder et al., 2018). PaLM leaders need to further explore the
laboratory industry value chain. Developing methods to quantify and communicate a laboratory’s
VBA is critical for the profession (Davis et al., 2018). The PaLM industry has not fully
explained their range of clinical and management activities (Burns, 2018). PaLM’s value-chain
contributions require further investigation (Hallworth et al., 2015) with more research delving
into the laboratory’s value creating ecosystem (see Fig 4.0). Effective value frameworks need to
be accessible to stakeholders, as each stakeholder has differing perspectives and priorities
(Thaker et al., 2016). The value-adding services from hospital laboratories (COLA, 2015) need
to be communicated to hospital administrators making strategic decisions.
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Cost Recognition
Laboratory leaders need further clarity on how to demonstrate value and cost savings
with published articles and peer reviewed literature. Laboratorians need examples for sharing
their knowledge on how-to implement VBAs, chronicling obstacles and successes. The valueadding skills and methods utilized by laboratorians need to be communicated outside the
laboratory profession, demonstrating the magnitude of cost savings lying within PaLM’s value
chain (Kiechle et al., 2014; Reedy & Procop, 2019). Likewise, healthcare administrators need
more understanding of the cost producers within their facility (Schmidt et al., 2020).
Implementation of value-based initiatives depends on cost-assessment methods like
TDABC to demonstrate reliable information on cost-savings opportunities (Etges-Eng et al.,
2020). TDABC is rapidly becoming the standard measurement for healthcare’s true costs
replacing surrogate measurement based on procedural charges and reimbursement rates (Thaker,
2016). TDABC enables an accurate cost estimation (Kaplan, 2017) and provides cost data details
with process maps for attributing costs to resource utilization and for motivating hospital
departments (Kaplan & Porter, 2011). TDABC allows for detailing direct and indirect costs by
identifying patient-specific resource consumption (Etges-Eng et al., 2020), and making visible
the high cost of redundant processes (Kaplan & Porter, 2011).
Communication and Appreciation
Ineffective communication is the most frequently reported deficiency among serviceoriented managers (Kerns, 2016). Effective communication begins with a desire to communicate
(Guo, 2011), the skills for which can be learned and improved (Otto, 2017). The development of
methods to quantify and communicate the laboratory’s value offerings are critically important
(Davis et al., 2018), requiring research and well thought out plan (Raman, 2014).
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PaLM leaders communicate using e-mails, departmental tours, dashboards, and face-toface conversations, but remain challenged with barriers for communicating value-based
initiatives. Laboratory leaders need a tailored persuasive message that aligns their VBAs with the
concerns and priorities of the hospital administrators (Gross et al., 2019). The transformational
efforts of hospital laboratorians need to be communicated to the healthcare administrators
responsible for setting the goals and objectives, monitoring performance, and allocating
resources.
Laboratorians are data driven (Wagar et al., 2019) and communicate well with metrics on
quality projects (Bergeron, 2017; Bixho & Melanson, 2017). Metrics that reflect performance
improvements can highlight areas of need (Sarwar et al., 2015) and offer insights to hospital
administrators. Equipment vendors implementing new laboratory technologies can aid laboratory
leaders with demonstrating cost savings and the value associated with improving diagnostic
accuracy and timeliness (Epner et al., 2017). Success reports provide a useful communication
tool (Hartland, 2018). Radar charts within Excel provide a visual framework for integrated
outcomes with cost information (Thaker, et al., 2016). Laboratory professionals need further
development of how to document and publish VBAs (Delvin, 2017; Landin, 2013). Wellperformed public presentations tailored toward the executive level establishes credibility
(Weinholdt, 2006) and well-prepared promotional materials offer a form of marketing collateral
(Kridelbaugh, 2018). Demonstrating with certainty the effectiveness of VBAs and the gains in
cost savings provides the necessary political support (Øvretveit, 2009).
Reflections and Final Thoughts
According to Church and Naugler (2020), PaLM is a service business focused on
operational efficiency and quality testing. They posited that organizing hospital laboratories into
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factories performing chemistry, hematology, microbiology, pathology, and genetics testing with
siloed performance measures of productivity devalues the essential clinical offerings of
laboratorians as partners in patient care. Improving evidence of PaLM’s professional and
industry value aids in the recognition and appraisal of laboratory services. Laboratory
“professionals are poised to contribute to more effective and efficient diagnostic and therapeutic
protocols and should be invited to be part of guideline development panels” (AACC, 2017,
par.6.). However, as the demand for laboratory testing increases, the number of qualified
personnel to perform laboratory testing declines (ASCP & CWH, 2021). Hospital administrators
must recognize the value contributions of laboratorians with pay equivalence and “provide
opportunities for career progression, increased pay, and elevated titles” (ASCP & CWH, 2021,
p.5).
Demonstrations of the laboratory’s value contributions is essential to resolving workforce
shortages (ASLCS, 2018). Appreciation, professional visibility, and wage equivalency are
necessary to address the laboratory’s recruitment and retention issues (ASCLS, 2018; CCCLW,
2018; Han, Carter & Champion, 2018). Optimization of skill sets, and professional
acknowledgement improves employee satisfaction (Carman et al., 2014; Nilsson et al., 2018).
High-performing organizations seek to ensure the engagement of all stakeholders when
optimizing value (Carmen et al., 2014), empowering the entire organization to keep a watchful
eye on the organization’s transformation (Stroh, 2015).
Personal & Professional Growth
I have longed for more knowledge on the value contributions of my profession. As with
most long-term laboratory professionals, my scientific knowledge and clinical training are quite
extensive. However, this research has afforded me two years to focus solely on communicating
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PaLM VBAs, and to reflect on my own responsibilities as a laboratory leader. I own the
responsibility to ensure skills development, continuous learning, professional networking, and
adequately credentialed staff (Delost et al., 2009; Dickerson et al., 2017; Lorenz et al., 2018) and
to advocate for the publishment of articles by laboratorians.
This research has broadened my understanding of the perceptions of hospital
administrators concerning the laboratory’s value, and the perceptions of PaLM leaders
concerning the barriers to communicating value and cost savings. I have gained an understanding
of what it will take to improve value in healthcare, and to strengthen the laboratory profession. I
strongly recommend with evidence that hospital administrators implementing VBHC strategies
include laboratory professionals in hospital improvement activities. Connecting laboratorians
with other healthcare professionals promotes organizational learning and knowledge
dissemination.
Biblical Perspective
All humanity is inherently hard-wired to create and to desire meaningful work (Genesis
2:15; VanDuzer, 2010). The work of this research, as a culmination of my life’s work, has brought
me great satisfaction. I am reminded that God defined the value of His work as very good in
Genesis 1:31. Being created in God’s image, we are inherently gifted to perform excellent work
(Keller & Alsdorf, 2012) and to be good stewards of His resources. As a reflection of His image,
all healthcare workers are designed and assigned to create value, to bring order, and to
communicate with others (Van Duzer, 2010; Genesis 1:27). Our instructions for Paradise on this
earth are to work, and to keep working, maintaining the garden given to us (Keller & Alsdorf,
2012; Bohlin, 2016). And when our work is done, we rest, even as God rested (Genesis 2:2).
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Laboratorians are exhausted as the toll of the two-year Covid-19 pandemic nears an end. It
seems little wonder the triple aim of VBHC morphed a fourth objective, i.e., to improve the lives
of healthcare workers. But we are built for this work and to perform it with dignity (Keller &
Alsdorf, 2012). I pray that as a PaLM leader I will help others to identify value in their work and
to achieve their optimal potential. May our work one day be viewed as well done.
Summary of The Study and Conclusions
This study involves interviews with three Texas hospital administrators and six PaLM
leaders from four purposively selected hospitals. All hospitals were acute care and JCO
accredited with variations in bed size and laboratory accreditation agencies. All laboratory
participants noted service alterations related to the Covid-19 pandemic. Data collected from the
nine interviews, followed by a coding of case themes and in-depth cross-case categorical
analysis, revealed that while operational challenges were regularly communicated to hospital
administrators, demonstrations of PaLM VBA and cost savings were lacking.
The data indicated that Texas laboratories contribute many activities that improve value
in healthcare. However, hospital administrators did not request value demonstrations or cost
savings from laboratory leaders. Laboratory leaders communicated regularly with hospital
leaders on the information needed to achieve hospital accreditation and status goals, but PALM
VBAs and cost savings information were not part of these objectives. Integrated system
activities, equipment and supply contracts negotiations, multidisciplinary interactions, and
stewardship committees offered opportunities for laboratorians to demonstrate value.
The findings of each case are discussed with quoted examples for the three overarching
themes that emerged: PaLM VBAs, PaLM communication, and PaLM’s strategic alignment with
hospital goals. Seven forms of communication with hospital administrators were identified. Six
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forms of value were categorized based on the interviewee responses, then evaluated against the
literature and the mVCM framework in section 1 (see Fig. 2). The laboratory’s alignment with
hospital objectives was distinguished by the feedback from hospital administrators, the
assessments utilized for PaLM services, and the identified hospital goals (see Section 2. Fig. 9,
11). The actual versus anticipated findings are summarized in section 3 (see Table 8). A
communication model by Robbins et al. (1994) identifies the components necessary for effective
communication (see Fig. 1). This study identified that PaLM leaders have an opportunity to
clarify the profession’s value message to hospital administrators and to demonstrate value
contributions and cost savings. It is noteworthy that none of the four hospital cases had
implemented VBHC strategies or utilized a doctorate level CLS as an interface for hospital
administrators. Perhaps VBHC and this new doctoral role for laboratorians will advance the
effective communication of PaLM’s value.
The need for healthcare and the associated rising costs continue to expand exponentially.
The complexities and barriers for demonstrating value must be conquered for VBHC strategies
to be effective. The Covid-19 pandemic occurring during this study highlighted the value of
hospital laboratorians and the need for a quadruple aim. Inadvertently, the data revealed that a
lack of qualified laboratory personnel without wage equivalence to similar educated
professionals lowers value in healthcare. Hospital administrators need recognition of PaLM’s
value. Laboratorians need “opportunities for career progression, increased pay, and elevated
titles” (ASCP & CWH, 2021, p.5). Hospital administrators need an awareness of the value chain
and the interconnectivity of process to implement VBHC strategies. VBHC will present leaders
with an opportunity to clarify value and to demonstrate cost savings. Active engagement from
PaLM leaders outside the laboratory, participating on teams across the care cycle, interfacing
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with other healthcare professionals, providing influence, and presenting value demonstrations is
essential to improving healthcare value and lowering costs.
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Appendix A: Informed Consent for Participation in Research
Communicating the Value Contributions of
Pathology and Laboratory Medicine (PaLM)
to Healthcare Administrators,
Evidence from a Multiple Case Study
You are invited to be in a research study on the communication of Pathology and
Laboratory Medicine’s value. You were selected as possible participant because you are 18 years
of age or older, currently employed or contracted full time as either a hospital administrator or
laboratory leader at an acute care hospital with on-site laboratory services, and knowledge of
value-based activities. You have been in your position for at least 1 year. Please read this
participation form and ask any questions you may have before agreeing to be in this study. A
doctoral candidate in the School of Business at Liberty University, is conducting this study.
Background information: The purpose of this study is to provide evidence of the communication between hospital laboratory leadership and hospital administrators concerning value-based
activities (VBAs) – i.e., the activities that improve value, generally, referred to as improvement
approaches. VBAs result in improvements in quality, the patient experience, efficiency, and
ultimately cost. A value-based strategy lowers costs, improves quality or provision of service
excellence, or surpasses rival capabilities. The current climate in healthcare requires a
justification of the activities and expenditures from every sector, demonstrating value to the
patient and the health system. This study explores the communication of value-based activities to
better understand the effectiveness of value demonstrations and the alignment of these activities
with value-based strategies promoting performance improvements, quality & safety, and cost
reductions.
Procedures: If you agree to be in this study, I will ask that you do the following:
• Participate in an audio-recorded interview. This should take approximately 50 minutes to
complete.
• Review your post interview transcript for accuracy and provide a response. The transcript
will be emailed to you within a few days after the interview and should take less than 20
minutes to review.
Risks: The risks involved in this study are minimal, which means they are equal to the risks you
may encounter in everyday life.
Benefits: Participants should not expect to receive a direct benefit from taking part in this study.
Benefits are to society and include an increased knowledge of value demonstrations for
healthcare professionals.
Compensation: Participants will not be compensated for participating in this study.
Confidentiality: The records of this study will be kept private. In any reports that I might
publish, I will not include any information to make it possible to identify the subjects. Research
records will be securely stored, and only the researcher will have access to the records. I may
share the data collected in published literature or with researchers of future research studies.
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However, if I share collected data, I will remove any identifying information that could identify
participants or sites prior sharing the data.
• Participants will be assigned a pseudonym. I will conduct the interview in a location where
others will not easily overhear our conversation.
• Data will be stored on a password locked computer and may be used in future presentations.
After three years, all electronic records will be deleted.
• Interviews will be recorded and transcribed. Recordings will be stored on a password locked
computer for three years and then erased. Only the researcher will have access to these
recordings.
Voluntary Nature of the Study: Participation in this study is voluntary. Your decision to
participate or not to participate will not affect your current or future relations with Liberty
University. If you decide to participate, you are free to decline answering any questions or to
withdraw from the study.
How to withdrawal from the study: If you choose to withdraw from this study, please contact
the researcher at the email address / phone number included in the next paragraph. Should you
choose to withdraw, the data collected from you will be destroyed immediately and will not be
included in this study.
Contacts and Questions: The researcher conducting this study is a doctoral student. You may
ask any question you have now. If you have questions later, you are encouraged to contact the
researcher. You may also contact the researcher’s faculty chair.
If you have any questions or concerns regarding this study and would like to speak with someone
other than the researcher, please contact the Institutional Review Board.
Please notify the researcher if you would like a copy of this information for your records.
Statement of Consent: I have read and understand the above information. I have asked
questions and received answers. I consent to participate in this study.
The researcher as my permission to audio-record my responses as participation in this study.
Signature of Participant: __________________________________________Date: _______________
Signature of Investigator: _________________________________________ Date: _______________
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Appendix B: Participant Recruitment Letter
[date]
[Recipient]
[Title]
[Company]
[Address]
[City, State, Zip]
Dear Hospital Administrator or Laboratory Leader,
I need your help. As a doctoral student in Healthcare Administration at Liberty University’s
School of Business, I am conducting research as a requirement for my degree.
The purpose of my study is to provide evidence of the communication between hospital
laboratory leaders and hospital administrators concerning value-based activities (VBAs) – i.e.,
activities that improve value, generally referred to as improvement approaches. Value based
activities result in improvements in quality, the patient experience, efficiency, and ultimately
cost. A value-based strategy lowers costs, improves quality or the provision of service
excellence, or surpasses rival capabilities. The current climate in healthcare requires a
justification of the activities and expenditures from every sector, demonstrating value to the
patient and the health system. This study explores the communication of PaLM VBAs to better
understand the effectiveness of value demonstrations and the alignment of activities with valuebased strategies that promote performance improvements, quality & safety, and cost reductions.
Participants will be asked to participate in an audio-recorded interview. This will take
approximately 50 minutes to complete. Participants will also be asked to review their interview
transcript for accuracy. Interview transcript will be emailed to participants after the interview. It
should take less than 20 minutes to complete the review and provide feedback. This study may
benefit the healthcare industry and laboratorians by increasing the knowledge of value
demonstrations.
Participants sought for this study must currently be 18 years of age or older and be a hospital
administrator and laboratory leader knowledgeable of value-based activities (VBAs).
Participants must be full-time employed or contracted with an acute care hospital for at least one
year. Participant names and other identifying information requested as part of this study will
remain confidential information.
For participation, please e-mail ___________to schedule an interview. A consent document
attached to this message will also be available at the time of the interview. The consent
document contains information about this research. Please review the consent document as it will
be signed at the time of your interview.
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Appendix C: Interview Protocol

Participant Pseudonym / Title

Date/time of interview:

Length of employment

Interview start time:

Hospital Pseudonym:

Interview stop time:

Introduction
[Script] Hello. My name is ______. Thank you for your willingness to participate in the
interview aspect of my study. I am a doctoral researcher working on my required dissertation.
The purpose of my study is to provide evidence of value communications between hospital
laboratory leaders and hospital administrators.
If you have not already done so, please take a moment to read and sign the Informed Consent for
Participation in Research. Feel free to ask me any questions you may have about this study, or the
processes involved. [Collect Informed Consent signature]
Verbal
Explanation
of the study

Please allow me to read a few statements concerning this study
The purpose of my study is to provide evidence of the communication between hospital
laboratory leaders and hospital administrators concerning value-based activities (VBAs).
VBAs improve value and are generally referred to as improvement approaches and
include activities that result in improvements in quality, the patient experience,
efficiency, and ultimately improve costs.
A value-based strategy lowers costs, improves quality or provision of services, or
surpasses rival capabilities. The current climate in healthcare requires a justification of
the activities and expenditures from every sector, demonstrating value to the patient and
the health system.
This study explores the communication of VBAs by pathologists or laboratory
leaders to better understand the effectiveness of value demonstrations and the alignment
of these activities with VBHC strategies that promote performance improvements,
quality & safety, and cost reductions.
Allow
[Script: Allow for unstructured discussion]
response
My use of the term lab or laboratory refers to hospital services provided by either
pathology or laboratory medicine departments. Kindly respond to the following
questions. It’s okay if you don’t have or know an answer.
Introductory [Present publicly available information and allow open discussion for how laboratory
question
might fit into these public scores]
How does hospital administration assess laboratory and pathology services?
How does this information align with the hospital’s performance goals?
TABLE 10
[Proceed with questions in Table 10 according to interviewee type]
Closing
Thank you for your time today. I’ll be sending you a copy transcript of our
statement
interview in a few days. Please review it and either confirm its accuracy or add
further comments or clarifications.
[Script: Review e-mail address accuracy]
End
Who else would you recommend that I interview for this study? Please send an
introductory email on my behalf.
[Script: Gather referral name and e-mail address, and assign pseudonyms]
Notes
[Researcher journals thoughts / impressions]
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Table 10.
Case Study Interview Questions
Task
Case Notes
Laboratory Leadership Interview Questions
Describe for me several activities implemented by the laboratory to improve
services.
How have you communicated these activities to administration?
Describe some initiatives of laboratory that improve value for the hospital
How have you shared these value-based activities with hospital administration?
How might these activities align with a value-based strategy?
What feedback has hospital administration provided to you concerning these
activities?
When you discuss these activities with administration, how do you present your
message?
What feedback has administration provided regarding these recommendations?
What barriers do you perceive in communicating lab’s value-based activities to
administration?
[Differentia- Who would you say is the primary interface from Pathology and Laboratory
tion factor]
services to the hospital? Path / DCLS / CLS Manager / other
Hospital Administrator Interview Questions
Describe how laboratory leadership communicates initiatives with you
How does laboratory leadership make you aware of cost savings opportunities?
How have other value-based activities been presented to you?
What are some examples of effective initiatives presented by the laboratory?
How do the lab’s value-based activities align with the strategic objectives of the
hospital?
How might the laboratory improve communication of value-based initiatives to
you?
What barriers do you perceive for the laboratory being able to effectively
communicate their value-based initiatives?
[Differentia- Who would you say is the primary interface from Pathology and Laboratory
tion factor]
services to the hospital? Path / DCLS / CLS Manager / other
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Table 11.
Research Questions alignment with Interview Questions
Research Questions /
Interview Questions

Describe for me several
activities implemented
by the laboratory to
improve services.
How have you
communicated these
activities to
administration?
Describe some initiatives
of the laboratory that
improve value for the
hospital
How have you shared
these VBAs with
hospital administration?
How might these
activities align with a
value-based strategy?
What feedback has
hospital administration
provided to you
concerning these
activities?
When you discuss these
activities with
administration, how do
you present the
message?
What feedback has
administration provided
regarding these
recommendations?
What barriers do you
perceive in
communicating lab’s
value-based activities to
administration?

What value-base What value-based How do
cost savings
opportunities are
hospital-based
opportunities
perceived as
laboratory
has laboratory
effectively
leaders
leadership
communicated by communicate
presented to
laboratory leaders PaLM VBAs to
hospital
to hospital
hospital
administrators? administrators?
administrators?
Laboratory Leadership Interview Questions

What PaLM
VBAs do
hospital
administrators
perceive as
aligning with
the value-based
objectives?

X

X

X

X

X

X

X

X

X

X
X

X

X

X
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Hospital Administrator Interview Questions
Describe how laboratory
leadership
communicates initiatives
with you
How does laboratory
leadership make you
aware of cost savings
opportunities?
How have other valuebased activities been
presented to you?
What are some examples
of effective initiatives
presented by the
laboratory?
How do the lab’s VBAs
align with the strategic
objectives of the
hospital?
How might the
laboratory improve
communication of valuebased initiatives to you?
What barriers do you
perceive for laboratory
being able to effectively
communicate their
value-based initiatives?

X

X

X

X

X

X

X

X

X

X

X

X

X

